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Abstract 
The adenovirus protein E4orf4 kills cancer cells but not normal primary cells. 
The possibility of developing a drug that mimicks the killing by E4orf4 for 
cancer therapy is therefore of great interest but its mechanisms of action first 
need to be elucidated. Studies over the past decade have shown that E4orf4 
induces p53-independent, caspase-independent cell death in a PP2A Ba-
dependent manner. In an effort to better understand its mechanism of action and 
identify putative cell death targets, the localization to function relationship of 
E4orf4-induced cell death was investigated. Here, 1 show that E4orf4 has a 
predominant nuclear localization following expression even though small 
amounts are observed in the cytoplasm and that, in addition, it can induce cell 
death both from the nucleus and from the cytoplasm when artificially targeted to 
these sites using well-characterized, exogenous localization signaIs. 
Furthermore, 1 identify an arginine-rich signal in E4orf4 spanning residues 66 to 
75 (E4ARM) that mediates nuclear and nucleolar localization of E4orf4 and 1 
show that, importantly, it contributes to at least 50% of E4orf4-induced cell death 
activity. Finally, 1 demonstrate that wild-type E4orf4 associates with several 
nUclear bodies such as viral replication centers, nUcleoli, perinuclear bodies and 
PML bodies during adenovirus infection but that association with these structures 
is not essential for virus growth as mutants that are defective for E4orf4 
expression generally replicate as efficiently as wild-type virus. However, 1 also 
show that a virus encoding a mutant form of E4orf4 accumulating at PML bodies 
during infection has a dominant negative effect on virus growth, thus 
highlighting the functional importance of nuclear bodies during cellular growth 
and adenovirus infection. 
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.. ~ ..... Résumé 
La protéine E4orf4 de l'adénovirus humain tue les cellules cancéreuses mais ne 
tue pas les cellules primaires normales. La possibilité de développer un 
traitement contre le cancer tout en utilisant une molécule ayant les propriétés 
d'E4orf4 est donc très intéressante, mais les méchanismes d'action d'E4orf4 
doivent, tout d'abord, être élucidés. Les études des dernières années portant sur 
E4orf4 ont démontré que la mort cellulaire induite par E4orf4 est indépendante 
de p53 et des caspases mais toutefois dépendante de PP2A Ba. Afin de pouvoir 
mieux comprendre les méchanismes d'action d'E4orf4 et afin d'identifier les 
protéines cellulaires ciblées par cette dernière et impliquées dans le processus de 
mort cellulaire, la relation localisation-fonction d'E4orf4 a été étudiée. Les 
résultats des études presentées dans cet ouvrage démontrent, premièrement, 
qu'E4orf4 a une localisation prédominamment nucléaire suite à son expression 
même si un peu de la protéine se retrouve aussi dans le cytoplasme. E4orf4 est 
aussi capable d'induire la mort cellulaire à partir du noyau ou du cytoplasme de 
la cellule lorsque cette dernière est artificiellement transportée dans l'un ou 
l'autre de ces compartiments au moyen de signaux de localisation cellulaire 
connus. Les résultats présentés dans cet ouvrage ont aussi, en deuxième lieu, 
permis d'identifier qu'E4orf4 contient un signal riche en arginines couvrant les 
résidus 66 à 75 (E4ARM), qui sert à transporter E4orf4 dans le noyau et les 
nucléoles de la cellule, et qui contribue de façon significative (au moins 50%) à 
l'activité de mort cellulaire d'E4orf4. Finalement, les résulats présentés dans cet 
ouvrage ont aussi permis de démontrer que la protéine wild-type E4orf4 s'associe 
avec plusieurs corps nucleaires tels les centres de réplication viraux, les 
nucléoles, les corps périnucléaires ainsi que les corps PML durant l'infection par 
l'adénovirus, mais que l'association d'E4orf4 avec ces corps nucléaires n'est pas 
essentielle pour la croissance du virus puisque des virus mutants ne pouvant 
exprimer E4orf4 ont une croissance virale normale semblable à celle de 
l'adénovirus wild-type. Par contre, les résultats de ces études permettent aussi de 
conclure que les corps nucléaires ont une importance fonctionnelle pour la 
croissance cellulaire ainsi que pour la croissance virale puisqu'un virus 
exprimant une forme mutante d'E4orf4 s'accumulant aux corps PML et inhibe la 
croissance virale. 
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CHAPTERl:GENERALINTRODUCTION 
1.1 ADENOVIRUSES 
1.1.2 Etiology and classification 
Adenoviruses were first discovered and identified in 1953 in studies geared to 
identify the infectious agent causing the common cold (Rowe et al., 1953). Even 
though adenoviruses do not cause the common cold they generally result in the 
infection of the lower respiratory tract (Dingle and Langmuir, 1968; Ginsberg et 
al., 1955), while infection of the eye (Jawetz, 1959) or of the gastro-intestinal 
tract (Y olken et al., 1982) has also been observed in sorne cases (Figure 1-1). 
Adenoviruses are endemic in the world: 80% of children reaching age 5 have 
been exposed to the virus. 
Adenoviruses are part of the Adenoviridae family of viruses. This family is 
divided in two genera: the Mastadenoviruses and the Aviadenoviruses. While 
Mastadenoviruses infect mammals such as humans, monkeys, mice, horses and 
dogs, Aviadenoviruses infect birds (Norrby et al., 1976). 
More than 50 different human adenovirus serotypes have been identified to this 
day. These serotypes are divided in 6 subgroups (A to F) based on their ability to 
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Figure 1-1. Adenovirus classification and pathology. 
More than 50 different human adenovirus serotypes exist. They are classified 
into 6 subgroups, which are evolutionarily conserved. Adenoviruses typically 
infect the respiratory tract but can also cause infection of the eye or the gastro-
intestinal tract. Adapted from (Bailey and Mautner, 1994). 
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Distance Subgroup Disease Serotypes 
C infections 1,2,5,6 
of the lower respiratory tract 
persistent infections 8,9,10,13,15,17,19,20, D of the tonsils and adenoids 22 - 30, 32, 33, 36 - 39,42 - 49,51 
keratoconjunctivitis 
3,7,11,14,16,21, B 34,35,50 
respiratory disease 
E 4 
F 40,41 
gastroenteritic infections 
A 12,18,31 
agglutinate red blood cells (Rosen, 1960). While serotypes belonging to 
subgroups A and B and two serotypes belonging to subgroup D have been shown 
to cause tumours when injected in rodents subcutaneously, serotypes belonging 
to subgroups C, E and F as well as most serotypes belonging to subgroup D are 
only mildly oncogenic or not oncogenic at all when directly injected in rodents. 
However, all serotypes tested to this day transform cultured primary rodent cells 
while subsequent injection of these transformed cells in rodents cause tumours. 
In contrast, no adenovirus serotypes have been shown to cause tumours in 
humans. The reason for this remains obscure. Serotypes 2 and 5 (Ad2 and Ad5) 
are the most widely studied serotypes and belong to subgroup C (Shenk, 2001) 
(Figure 1-2). 
1.1.3 Virion 
Adenoviruses are icosahedral in shape and measure from 70 to 100 nm in 
diameter. Virions consist of a protein shell called the capsid that surrounds the 
viral core genome. They are composed of proteins II to IX, which are structural 
proteins encoded by regions LI to L5 of the virus genome. Numbers ascribed to 
these proteins come from the order of the molecular weight (smallest to greatest) 
in which they were identified. The capsid has two roles: it protects the core 
genome and mediates the entry of the virus in cells. It is made of 252 units called 
capsomeres, of which 240 are hexons (protein II) and 12 are pentons (protein III). 
Pentons, hexons and fibers (protein IV) are the major structural proteins. 
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Figure 1-2. Transformation of rodent cells by adenovirus. 
A subset of adenovirus serotypes have been shown to cause tumours when 
injected into rodents, while the other serotypes have only been shown to be 
mildly oncogenic or non-oncogenic at aH. AH serotypes have, however, been 
shown to transform cultured rodent ceHs, which are tumourogenic when injected 
in animaIs. Adapted from (Ankerst et al., 1974; Huebner et al., 1962; Trentin et 
al., 1962). 
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Pentons serve as the base for protruding fibers. Fibers are essential for virus 
attachment and cell entry. Minor structural proteins include proteins ilIa, VI, 
VIII and IX. These proteins are also part of the virus capsid but their positions 
and functions are less well defmed. 
The core genome consists of four different proteins bound to the viral DNA. 
Proteins V, VII and mil (protein X) are arginine-rich proteins that contact the 
viral DNA, protect it and keep it folded. pTP, the fourth protein, covalently 
binds the end of the double-stranded linear genome and serves as a primer for 
viral replication in the cell nucleus (Shenk, 2001) (Figure 1-3). 
1.1.4 Genome 
Adenoviruses infecting a wide range of mammals and birds (Adenoviridae) have 
a double-stranded linear genome that varies in size from 34-44 kilobase pairs 
(kbp) and share a similar genome organization. The genome is typically divided 
into 100 map units and is organized into a DNA strand oriented to the right called 
the r-strand, as weIl as a strand oriented to the left called the l-strand. Each end 
of the genome also has an inverted terminal repeat that is bound to the pTP 
protein. These features are required for viral DNA replication. 
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Figure 1-3. Structure of the adenovirus virion. 
The adenovirus virion is composed of a core genome surrounded by a caps id. 
The core consists of the viral DNA bound to proteins V, VII and mJl. The capsid 
is the outer shell that protects the core genome and that mediates entry of the 
virus in the cell. It is made of major structural proteins called pentons, hexons 
and fibers. Adapted from (Shenk, 2001). 
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The adenovirus genome is divided into five early transcription units, ElA, ElB, 
E2, E3 and E4; two delayed transcription units, IX and IV A2; and one major late 
unit that generates five family of RNAs, LI to L5, upon processing. AU of these 
transcription units are transcribed by RNA polymerase II. The virus also 
produces one or two (depending on the serotype) RNA polymerase 111-
transcribed RNA called virus-associated (VA) RNA (Figure 1-4). 
1.1.5 Infectious cycle 
Adenovirus infection is divided into an early phase and a late phase, separated by 
the onset of viral DNA replication. During the early phase of the infection, early 
transcription units El to E4 produce altematively spliced RNAs that give rise to 
regulatory proteins that prepare the cell for optimal viral DNA replication. 
Similarly and following viral replication, the major late transcription unit 
produces one RNA that also becomes altematively spliced and gives rise to 
structural proteins involved in DNA packaging and assembly of virus particles 
(Figure 1-5). 
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Figure 1-4. The adenovirus genome. 
The adenovirus genome is composed of early genes and late genes. Early genes 
comprise regions El to E4 and late genes, regions LI to L5. Early genes express 
gene products that generally prepare the cell for the onset of viral repli cation, 
inducing cell cycle entry and progression as well as survival and inhibition of 
apoptosis, whereas late genes express gene products that form the structure of the 
virus and that induce host cell shutoff and maximize viral production. Adapted 
from (Tauber and Dobner, 2001). 
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Figure 1-5. The adenovirus life cycle. 
Adenovirus frrst interacts with the Cocsackie adenovirus receptor (CAR) and the 
integrin receptor at the cell surface. The virus is then endocytosed, the capsid is 
shed, after which the core genome is transported to the nucleus via the 
microtubule network. Early genes start being expressed as soon as the viral 
genome reaches the nucleus (around 2 hpi). Viral DNA replication follows (8-10 
hpi) and the late phase of the infection begins with the expression of late genes 
(10-24 hpi). The cell fmally breaks down and releases the progeny virion (24-36 
hpi). Adapted from (Shenk, 2001). 
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1.1.6 Adsorption and entry into cells 
Adenovirus enters cells by binding to the cellular Coxsackie- and Adenovirus 
Receptor (CAR) as well as integrins. These interactions are mediated via the 
viral fiber and penton base proteins, respectively. The interaction of penton 
proteins with integrins has been shown to be mediated through an 
arginine/glycine/aspartate (RGD) motif present in the penton base. RGD-
containing peptides have thus been shown to prevent entry of adenovirus in cells. 
Once bound to the receptor proteins, adenovirus is then endocytosed and moves 
to endosomes, where its capsid dissociates due to the low pH environment. 
Naked virus particles then move towards the nucleus by associating with and 
moving along microtubules. This process is thought to be mediated through 
hexon proteins. The virus then reaches the nuclear pore complexes (NPC) and 
starts producing early viral proteins in the nucleus. Approximately 60 minutes 
are thought to be necessary from entry of the virus into cells to the start of 
transcription of the early gene transcription units. 
1.1.7 ElA proteins 
ElA is the frrst transcription unit expressed following entry of the virus genome 
into the cell nucleus. ElA produces two major mRNAs, species of 13S and 12S, 
during the early phase of the infection and three other mRNAs during the late 
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phase of the infection. The 13S and 12S species encode gene products that are 
289 and 243 residues in length (289R and 243R), respectively, and are the major 
gene products that have been characterized to this day. Both proteins contain 
conserved regions 1 and 2 (CRI and CR2, respectively), while 289R contains an 
additional 46 amine acid termed conserved region 3 (CR3) due to alternative 
splicing. CRI, CR2 and CR3 are regions involved in protein-protein interactions. 
While CRI and CR2 are required to drive cell cycle entry and progression 
((Braithwaite et al., 1983; Spindler et al., 1985; Zerler et al., 1987) and are thus 
the main determinants for adenovirus E1A-induced oncogenic transformation 
(Howe et al., 1990; Stein et al., 1990), CR3 is essential to activate early viral 
gene expression (Berk et al., 1979; Jones and Shenk, 1979). 
The interactions of ElA CR2 with RB protein family members has been 
extensively studied and weIl characterized. Under normal conditions in quiescent 
cells, which are the natural targets of adenovirus infection, Rb family members 
are bound to E2F family of transcription factors and prevent the latter from 
activating the cell cycle. Adenoviruses, however, have devised a way to induce 
unscheduled cell cycle entry and progression to enhance replication by binding 
the Rb family members Rb, p107 and p130 (Barbeau et al., 1992; Dyson and 
Harlow, 1992) through an LXCXE motif (Nevins et al., 1997). Binding to these 
factors displaces bound E2Fs, which become free to activate the transcription of 
cell cycle-dependent genes such as cyclin-dependent kinase 2 (CDK2) and 
cyclins A and E, driving cells from the Go phase to the S phase. In addition to 
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ElA CR2, functions performed by the ElA CRI region are required, in order to 
drive the cell cycle to completion (Howe et al., 1990; Stein et al., 1990). 
However, these functions still remain poody understood but involve association 
with chromatin-modifying complex proteins such as p300/CBP (Stein et al., 
1990), p400 (Fuchs et al., 2001), PCAF (Lang and Hearing, 2003), TRRAP 
(Deleu et al., 2001; Fuchs et al., 2001), as weIl as with CDK inhibitors such as 
p21 and p27, and proteasome components. How these interactions contribute to 
the stimulation of DNA synthesis as weIl as transformation remains unclear. 
Finally, ElA CR3 activates aIl early viral promoters (Webster and Ricciardi, 
1991) by associating with cellular transcription factors present at these promoters 
rather than by binding DNA directly (Liu and Green, 1994). Binding to MED23, 
a subunit of the Mediator complex, has been shown to be the key interaction that 
drives transcriptional activation. Indeed, ElA CR3 transactivation function is 
completely ablated in Med23-/- cells (Stevens et al., 2002). The interaction of 
MED23 with ElA CR3 is highly stable (not disrupted by 2M KCI) and is thought 
to play an essential role in tethering the ElA 289R protein to the promoters, 
thereby powerfully stimulating transcription rate as weIl as reinitiation (Boyer et 
al., 1999). 
ElA is believed to be the major oncogene of human adenoviruses, and both CR2, 
CRI and an amino terminal region are required for cell transformation. Although 
ElA alone can transform cells, the process is usually abortive unless at least one 
of the major E1B products is also present (see below). 
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1.1.8 EIB proteins 
Expression of adenovirus ElA in cells leads to elevated levels of the p53 tumour 
suppressor protein as well as to its stabilization. This, in turn, causes p53-
dependent and independent apoptosis and death of E1A-transformed cells. 
Apoptosis or programmed cell death is an intrinsic cellular pro gram used by 
multicellular organisms to eliminate damaged, unneeded or infected cells (Kerr et 
al., 1972; Riedl and Shi, 2004). Adenovirus encodes two proteins from the E1B 
region, E1B55K and E1B19K, in order to block this effect, thus allowing survival 
of E1A-transformed cells and ensuring efficient viral replication (Figure 1-6). 
E1B55K inhibits p53-dependent apoptosis in two major ways. First, it binds 
(Sarnow et al., 1982) the activation domain of p53 and prevents the 
transcriptional activation of p53-dependent genes without displacing p53 from its 
DNA binding site (Yew et al., 1994). Inhibition ofp53 trancriptional activation 
by E1B55K strongly correlates with a defect in E1A-induced transformation 
(Teodoro and Branton, 1997; Yew and Berk, 1992). Proteins encoded by both 
the ElA and E1B regions are therefore needed to induce cell cycle progression 
and transformation (Howe et al., 1990; Stein et al., 1990). Second, E1B55K can 
also form a ubiquitin ligase complex together with E4orf6, another early viral 
protein encoded by the E4 region, and the cellular proteins elongin B, elongin C, 
15 
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Figure 1-6. Induction and inhibition of apoptosis by adenovirus. 
Adenovirus ElA is the frrst gene product expressed by the virus. This protein not 
only promotes cell cycle entry and progression through its amino terminus, CRI 
and CR2 regions but also induces p53-dependent and -independent apoptosis 
through CR3 region. p53-dependent apoptosis is blocked by two other viral 
proteins encoded by the E1B region, E1B55K and E1B19K. p53-independent 
apoptosis is, on the other hand, mediated by a protein encoded by the E4 region, 
E4orf4. Adapted from (Branton and Roopchand, 2001). 
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cullin 5 and Rbx-1 (Querido et al., 2001). This complex is similar to the 
previously characterized E3 ligase SCF (Zheng et al., 2002) and VBC (Kamura et 
al., 2001) complexes and functions in targeting proteins for degradation. 
E1B55K has been suggested to recognize target substrates for degradation by the 
virus, while E4orf6 appears to be important in the formation and assembly 
(Blanchette et al., 2004; Querido et al., 2001). Indeed, two motifs termed BC-
boxes in E4orf6 have been shown to be essential for the formation and function 
ofthis ligase complex (Blanchette et al., 2004). The main proteins identified thus 
far and targeted for degradation by this complex inc1ude the tumour suppressor 
protein p53 (Querido et al., 2001) as weIl as components of the Mrell-RAD50-
NBS1 (MRN) DNA double-strand break repair complex (Stracker et al., 2002), 
although other targets are believed to exist. 
E1B19K, on the other hand, inhibits E1A-induced apoptosis (White et al., 1991) 
in a p53-independent fashion (Debbas and White, 1993) by functioning as a Bc1-
2-like suppressor of apoptosis. E1B19K binds the proapoptotic proteins Bax and 
Bak (Cuconati et al., 2002; Han et al., 1996). Bex and Bak are Bc1-2 family 
proteins that have been shown to oligomerize and to form pores in mitochondria. 
This process in turn results in the release of cytochrome C and SmaclDIABLO 
from the mitochondria and activates caspases 9 and 3. E1B19K, like Bc1-2, 
prevents caspase activation by sequestering and inhibiting the function of Bax 
and Bak (Cuconati et al., 2002). 
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1.1.9 E2 proteins 
Two transcripts sharing the same promoter are produced by the E2 region of 
adenovirus, E2A and E2B. E2A encodes the DNA binding protein (DBP) while 
E2B encodes the adenovirus polymerase (Ad pol) and pre-terminal protein (pTP). 
These proteins are aIl essential for virus replication. While Ad pol and pTP exist 
as heterodimers in cells prior to replication, bind origins of replications located at 
both ends of the linear double-stranded genome, and initiate DNA replication at 
these origins (Lichy et al., 1982), DBP together with the host cellular proteins 
nuc1ear factor 1, nuc1ear factor II/Oct -1 and type 1 topoisomerase nuc1ear factor 
III enhance further DNA replication (Pruijn et al., 1986) (see section 1.1.12). 
Ad Pol was initially identified in studies involving Ad2 infected HeLa cells in 
which a unique DNA polymerase activity has been identified (Enomoto et al., 
1981; Ikeda et al., 1981). It was first studied using mutagenesis (Liu et al., 2000) 
and found to be essential for adenovirus replication using in vitro systems 
(Challberg and Kelly, 1979). Ad pol is one of the several protein-priming 
polymerases found in the pol Cl family (Field et al., 1984). It has 3' to 5' 
proofreading exonuc1ease activity like aIl other known polymerases (Field et al., 
1984) and shares structural similarity ("thumb", "palm" and "finger" 
suddomains) with polymerases encoded by phages <1>29 and RB69 (Liu et al., 
2000). 
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DBP is expressed abundantly during adenovirus infection. It was the first 
adenovirus non-structural protein to be identified and purified and has been 
shown to bind single-stranded DNA with high affinity even though it can also 
bind double-stranded DNA and RNA (van der Vliet and Levine, 1973). DBP is 
essential for chain elongation during viral replication but not for initiation even 
though it enhances this process (Kenny and Hurwitz, 1988). DBP has an amino-
terminal domain that is involved in host-range determination and a carboxy-
terminal domain that mediates binding to DNA and viral replication (Vos et al., 
1988). 
pTP is a precursor protein that plays an active role during the initiation step of 
virus replication. Late during infection it is cleaved and becomes attached to 
both 5' ends of the linear viral genome (Challberg et al., 1980). The Ad protease, 
a gene product encoded by the L3 region, has been shown to be responsible for 
this cleavage (Rancourt et al., 1994). 
1.1.10 E3 proteins 
The E3 region of the adenovirus genome produces one single pre-mRNA that 
undergoes alternative splicing and gives rise to at least 9 overlapping open 
reading frames (Chow et al., 1979; Cladaras et al., 1985). At least 7 proteins 
have been shown to be encoded by this common mRNA during virus infection: 
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E3-12.5K, E3-6.7K, E3-gp19K, the adenovirus death protein (ADP; formerly 
called E3-11.6K), receptor intemalization and degradation protein a (RIDa; 
formerly called E3-lOAK), RID~ (formerly called E3-14.5K) and E3-14.7K 
(Cladaras and Wold, 1985). All these proteins have been shown to be involved 
in counteracting the innate and acquired immune response of the ho st to 
adenovirus infection except for E3-12.5K and ADP. The function of E3-12.5K 
remains unknown while ADP has been shown to be required during late infection 
for efficient release of progeny virions (Tollefson et al., 1996). 
More specifically, E3-gp19K blocks MHC class 1 antigen presentation at the cell 
surface by binding these molecules and targeting them for sequestration in the 
endoplasmic reticulum (ER) lumen. E3-gp19K thus dampens cytotoxic T 
lypmphocyte (CTL)-mediated killing during infection (Andersson et al., 1985). 
The RID complex stimulates the clearance and degradation of Fas (Elsing and 
Burgert, 1998) and TRAIL (TNF-related apoptosis-inducing ligand) (Benedict et 
al., 2001) receptors at the cell surface as weIl as counteracts the action of the 
tumour necrosis a (TNF a) factor (Friedman and Horwitz, 2002). These proteins 
are well known to be involved in various aspects of apoptosis. E3-6.7K functions 
together with the RID complex and is involved in downregulating TRAIL-
induced apoptosis (Benedict et al., 2001). E3-14.7K inhibits TNF- and TRAIL-
mediated apoptosis (Gooding et al., 1990). 
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Deletion of the E3 region from the adenovirus genome does not affect virus 
replication in tissue culture (Kelly and Lewis, 1973) or in the infected host 
(Ginsberg et al., 1989). However, its importance in the wild has been shown in 
experiments using cotton rats, which are known to be good models of human 
adenovirus infection (Ginsberg et al., 1989). 
1.1.11 E4 proteins 
1.1.11.1 E4orJ1 
Early region 4 (E4) open reading frame 1 (ORF1) (E4orfl) is one of the early 
viral proteins encoded by the E4 region of the adenovirus genome. Most of what 
is known about this protein cornes from studies involving the highly oncogenic 
Ad9 serotype rather than the mildly/non-oncogenic Ad2 or Ad5 serotypes. 
However, since the amino acid sequence of E40rfl appears to be conserved 
among serotypes, the Ad9 functions identified may also be true for other Ad 
serotypes. 
E4orfl, rather than EIA-encoded proteins, is the main oncogenic determinant for 
Ad9-induced mammary tumorogenesis (Thomas et al., 1999). Ad9 E40rfl has 
been shown to induce transformation of CREF rat embryo fibroblasts by 
promoting the constitutive activation of phosphotidylinositol 3-kinase (PI3K) 
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addition, a segment of the Ad9 E40rf2 DNA sequence has also been shown to be 
important in Ad9 E4orf1-mediated mammary gland transformation (Thomas et 
al.,2001) 
1.1.11.3 E4orf3 
The adenovirus E4 region encodes two proteins with at least partially redundant 
roles (Bridge and Ketner, 1989; Huang and Hearing, 1989) that are particularly 
important for efficient viral replication: the early region 4 (E4) open reading 
frame 3 (ORF3) (E40rf3) and open reading frame 6 (ORF6) (E4orf6) proteins. 
Deletion of E40rf3 and E4orf6, separately or in combination, in the Ad5 genome 
has shown that both proteins are involved in DNA replication (Bridge et al., 
1993), viral late protein synthesis, shutoff of ho st protein synthesis, as weIl as 
production of progeny virions (Huang and Hearing, 1989). E40rf3 and E4orf6 
have also been found to regulate the accumulation of late viral rnRNA (Nordqvist 
and Akusjarvi, 1990) by stimulating constitutive splicing of the major late 5' 
leader sequence common to aIl of these messages (Nordqvist et al., 1994). 
Furthermore, E40rf3, acting synergistically with E4orf6, has been demonstrated 
to cooperate with ElA and E1B in the transformation of baby rat kidney cells 
(Nevels et al., 1999) (Nevels et al., 2001). 
E40rf3, on its own, has also been shown to disrupt PML bodies and to induce the 
formation track-like fibrous structures in the nucleus of cells (Carvalho et al., 
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independently of growth factor stimulation (Frese et al., 2003). Similarly, Ad5 
E40rfl has also been shown to activate PI3K in human small airway epithelial 
cells (SAEC), the primary targets of the virus during a lytic infection. E4orfl, 
together with another E4-encoded protein, E4orf4, activates cap-dependent 
translation in a nutrient-independent manner (O'Shea et al., 2005). Binding of the 
carboxy-terminus of Ad9 E40rfl to the PDZ domains (Weiss et al., 1997) of 
negative regulators of cell growth DIgl (Lee et al., 1997), MUPPI (Glaunsinger 
et al., 2001), MAGI-l and ZO-2 (Glaunsinger et al., 2001) has been shown to be 
required for transfonnation. These proteins serve as scaffolds at the plasma 
membrane, and particularly at regions of cell-cell contact, and mediate 
interactions between cell surface receptors and cytoplasmic signaling molecules 
(Sheng and Sala, 2001). More recently, studies using Ad9 E40rfl as a tool to 
probe cellular oncogenic mechanisms have allowed researchers to establish for 
the first time that DIgl is a tumour suppressor and that E40rfl specifically 
requires its activity to induce PI3K-mediated oncogenic transfonnation (Frese et 
al.,2006). 
1.1.11.2 E4orj2 
Little is known about the adenovirus early region 4 (E4) open reading frame 2 
(ORF2) (E4orf2) protein except for the fact that it is conserved among 
adenovirus serotypes, expressed earl y during Ad5 infection, and does not appear 
to associate with any known cellular proteins (Dix and Leppard, 1995). In 
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1995). Track formation depends on the association of E4orf3 with a subset of 
PML proteins, PML isoform II (Hoppe et al., 2006). PML bodies are spherical 
structures that form in the nucleus of most cell types and that have been shown to 
be involved in many cellular processes such as DNA repair, antiviral response, 
protein degradation, apoptosis, gene regulation and tumour suppression (Dellaire 
and Bazett-Jones, 2004) (see section 1.4.8). Their disruption by many viruses is 
common (Moller and Schmitz, 2003) and has been directly linked with efficient 
viral replication in the case of adenovirus infection (Doucas et al., 1996). PML 
as weIl as DNA double-strand break repair (DSBR) machinery components are 
believed to be redistributed to nuclear tracks and to aggresomes (juxtanuclear 
bodies surrounding centrosomes), respectively, in order to be inactivated. Recent 
studies have indeed shown that the aggresome degrades at least sorne Mrell, an 
important component of the Mrell-Rad50-NBSl (MRN) DSBR system, in order 
to prevent concatenation (ligation) of linear viral genomes (Weiden and 
Ginsberg, 1994) and ensure efficient viral replication (Araujo et al., 2005; Liu et 
al., 2005; Stracker et al., 2002). E4orf3 has been demonstrated to collaborate 
with the early viral proteins EIB55K and E4orf6, in order to do this (Araujo et 
al., 2005; Liu et al., 2005; Stracker et al., 2002) (see sections 1.1.8 and 1.1.11.6). 
1.1.11.4 E4orf4 
(see section 1.2) 
25 
,.--. 
1.1.11.5 E4orJ3/4 
Little is known about the adenovirus early region 4 (E4) open reading frame 3/4 
(ORF3/4) (E40rf3/4) protein since it has never been detected during infection. 
cDNA sequence analysis as weIl as Northem blots have indicated that it is a 
fusion between the frrst 33 amino-terminal residues from E40rf3 and the last 28 
carboxy-terminal residues from E4orf4 (Virtanen et al., 1984). 
1.1.11.6 E4orJ6 
E4orf6 is a small 34 KDa protein encoded by the E4 region of the adenovirus 
genome. E4orf6 starts being expressed early during infection and protein levels 
remain high until the end of the late phase when host cell shutoff occurs (Boivin 
et al., 1999). 
E4orf6 is a shuttling prote in and therefore contains both an arginine-faced 
amphipathic a-helix that serves as a nuclear localization signal (NLS) (Orlando 
and OmeIles, 1999) as weIl as a nuclear export signal (Weigel and Dobbelstein, 
2000). The a-helix of E4orf6 comprises residues 239 to 255 and has been shown 
to be important not only for nuclear localization but also for viral replication and 
interaction with E1B55K. Consequently, E4orf6 has been demonstrated to 
relocalize E1B55K from the cytoplasm to the nucleus (Orlando and OmeIles, 
1999). However, the ability of E4orf6 to induce viral replication appears to be 
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separate from its ability to relocalize EIB55K to the nucleus as the arginine 
residues required to direct EIB55K nuclear import differed than those required to 
support a productive viral infection (Orlando and Omelles, 2002). The 
importance of E4orf6's nuclear export for efficient virus replication has been 
shown to be more controversial. Indeed, the classical leucine-rich NES 
mediating nuclear export has been shown by one group to be essential for virus 
replication (Weigel and Dobbelstein, 2000), while the opposite conclusion has 
been reached by another group (Rabino et al., 2000). While this matter is still 
being sorted out, evidence now suggests that nuclear export of E4orf6, even 
though it is Crm-l-independent, nonetheless appears to play an important role in 
the export and stabilization of sorne cellular rnRNA during infection (Higashino 
et al., 2005) (see further for details). 
Many functions have been ascribed to E4orf6. E4orf6 has first been shown to 
inhibit p53-mediated transcriptional activation (Dobner et al., 1996) and 
apoptosis, and consequently, to enhance oncogenic transformation both in vitro 
and in vivo. E4orf6 has indeed been found to bind p53 and to prevent T AFII32 , a 
component of the basal transcription factor IID, from interacting with it (Dobner 
et al., 1996). Similarly, it has been shown to bind to p73, a p53 family member, 
and to inhibit its transcriptional activation (Dobner et al., 1996). Since EIB55K 
also binds to p53 and mediates p53 transcriptional activation, E4orf6, EIB55K 
and p53 have been proposed to act as a protein complex. In addition to inhibiting 
p53 transcriptional activation, E4orf6 has been shown to inhibit p53-dependent 
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apoptosis and conversely, to induce oncogenic transformation. E4orf6 was 
demonstrated to inhibit apoptosis, first, by degrading p53 in an Mdm2- and 
p19ARF-independent fashion and in a manner different than that used by the 
human papilloma virus protein E6. Degradation has been shown to be blocked by 
MG 132, an inhibitor of the 26S proteasome (Bridge, 2000). Formation of 
ubiquitin ligase degradation complex involving E4orf6, E1B55K, elongin B and 
elongin Chas been shown to be essential for degradation (see sections 1.1.8) and 
is now thought to be critical for most E4orf6/E1B55K-mediated functions 
(Blanchette et al., 2004). Second, E4orf6 was found to inhibit apoptosis by 
binding BNIP3 and Bik, two BH3-only Bc1-2 family pro-apoptotic proteins 
required for activation of the apoptotic mitochondrial pathway. This inhibition 
was shown to depend on the NES of E4orf6 and its export to the cytoplasm 
(Aoyagi et al., 2003). Lastly, E4orf6 was also demonstrated to induce malignant 
transformation in cooperation with ElA alone or with a combination of ElA and 
E1B55K or ElA and E1B19K both in vitro in BRK cells as well as in vivo upon 
injection in nude mice. (Moore et al., 1996; Nevels et al., 1997). E4orf6 was 
shown to contribute to malignant transformation by antagonizing E1A-induced 
accumulation of p53. This effect is now believed to be due to the formation of 
the E4orf6/E1B55K complex and subsequent degradation of target proteins (see 
section 1.1.8 and above). Regions located in both the amino-terminus and 
carboxy-terminus of the E4orf6 protein were shown to play an important role in 
the destabilization of p53, particularly the cysteine-rich motif and arginine-faced 
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amphipathic alpha-helix located in the oncodomain of the carboxy-terminal 
portion of the protein (Nevels et al., 2000). 
During the late phase of the infection, Crml-mediated export of cellular mRNAs 
is inhibited, while viral mRNAs are preferentially transported to the cytoplasm 
(Babiss et al., 1985; Beltz and Flint, 1979) via what is thought to be a Crm-l-
independent pathway. In addition to its many other roles, E4orf6 together with 
EIB55K has also been proposed to play a role in this process (Dosch et al., 2001; 
Weigel and Dobbelstein, 2000). E4orf6, in particular, has recently been 
demonstrated to control the fate of AU-rich element (ARE)-containing mRNAs 
by binding the cellular protein pp32 and by perturbing Crm-1 dependent export 
(Higashino et al., 2005). However, further studies are required in order to better 
understand the role of E1B55K and E4orf6 in this process as the above results 
remain controversial. 
1.1.11.7 E4orf6/7 
E4orf617 is an altematively spliced product encoded by the E4 region of the 
genome that contains the carboxy-terminus of E4orf6 in addition to other unique 
amino acids. E4orf617 has been shown to associate with E2FIDB heterodimers, 
to stabilize the complex, and to induce E2 trancriptional activity during 
adenovirus infection (Helin and Harlow, 1994). In addition, E4orf617 together 
with ElA has also been demonstrated to transform baby rat kidney cells and to 
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induce p53-dependent apoptosis. The carboxy-terminus half of this protein has 
been found to be required for all these activities (Yamano et al., 1999). 
1.1.12 Viral DNA replication 
Following sufficient expression and accumulation of its early viral proteins, 
adenovirus starts the replication of its DNA at around 8 hours post-infection. 
Adenovirus DNA replication is divided into two steps. First, DNA synthesis is 
initiated at either end of the doubled-stranded linear viral chromosome due to the 
presence of inverted terminal repeats. Only one strand serves as the parental 
strand, while the other strand is displaced. As synthesis proceeds, this gives rise 
to a heteroduplex DNA molecule containing one parental strand and one daughter 
strand as well as the remaining parental single strand. During the second step of 
replication, the ends of the remaining single-strand molecule will join and 
complement each other and the DNA molecule will form a panhandle-like 
structure, from which DNA replication will then be able to proceed (Lechner and 
Kelly, 1977). 
Three functional domains, A to C, present in the inverted repeats of the DNA 
ends have been shown to be required for efficient adenovirus DNA replication to 
occur. Domain A spanning the frrst 18 bp is the minimal origin of replication 
and is essential for DNA replication. This domain is bound by the E2-encoded 
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proteins pTP and Ad pol involved in initation of DNA replication and replication, 
respectively. Domains B and C, on the other hand, spanning base pairs 19 to 39 
and 40 to 51, respectively, are not essential for replication but have been shown 
to be important in enhancing the efficiency of initiation. Domain B binds nuclear 
factor l, whereas domain C binds nuclear factor III. Cellular nuclear factors 1 and 
III are important in stabilizating and promoting initiation of replication (Mul et 
al., 1990). Chain elongation is promoted by the E2-encoded DBP protein and 
Oct-1 (van der Vliet and Levine, 1973). One or more E4-encoded products have 
been determined to be important for efficient DNA replication. However, the 
products are thought to act indirectl y in the replication process (Medghalchi et 
al., 1997). 
1.1.13 Late gene expression 
Adenovirus late genes start being efficiently transcribed at the onset of viral 
DNA replication. AlI gene products originate from one single primary transcript 
that gives rise to several other transcripts following alternative splicing and the 
use of different polyadenylation sites (Chow et al., 1977; Nevins and Damell, 
1978). These transcripts, produced by the LI to L5 regions of the genome, all 
share a common promoter, the major late promoter (MLP). The cellular and viral 
factors SpI and MAZ and ElA proteins, respectively, have been shown to 
strongly activate the MLP during the late phase of the infection; only basal 
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transcription levels have been detected during the early phase (Parks and Shenk, 
1997). MLP transactivation gives rise to 20 structural and non-structural proteins 
involved in different aspects of host cell shutoff and assembly and packaging of 
viral partic1es. The best characterized structural proteins inc1ude the L2-penton 
base, L3-hexon and L5-fiber proteins, while L1-52/55K, lA-lOOK and lA-22K 
are the best characterized non-structural proteins (see section 1.1.3). Functions 
of other late viral proteins are still under investigation. 
1.1.14 Host cell shutoff 
One major consequence of viral DNA replication and late gene expression is the 
block of cellular mRNA transport to the cytoplasm and the preferential export of 
viral mRNAs. These effects have been shown to be mediated at least in part by 
the E1B55K (Babiss and Ginsberg, 1984) and E4orf6 (Halbert et al., 1985) early 
viral proteins separately or possibly together as a complex (Blanchette et al., 
2004; Sarnow et al., 1984). However, the mechanism underlying this effect is 
still unc1ear even though E1B55K and E4orf6 both harbor nuc1ear export signaIs 
that could be involved in viral mRNA export (Dobbelstein et al., 1997), while 
E1B55K has been shown to have non-specific RNA binding activity (Horridge 
and Leppard, 1998) . 
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In addition to being selectively transported to the cytoplasm, viral rnRNAs are 
also preferentially translated (Babich et al., 1983). Two components produced by 
the virus are responsible for this: the delayed early VA RNA (Thimmappaya et 
al., 1982) and the late protein lA-lOOK (Hayes et al., 1990). VA RNA first 
serves to bind protein kinase R (PKR) , a cellular kinase activated by double-
stranded RNA present in infected cells. Inactivation of PKR in turn prevents 
phosphorylation of the translation factor eIF2a and its subsequent block of 
translation (O'Malley et al., 1986). lA-lOOK, on the other hand, disrupts cap-
dependent translation and promotes ribosome shunting, an alternative mechanism 
analogous to cap-independent internaI ribosome entry site (IRES)-mediated 
translation. Binding to the translation initiation factor eIF4G and subsequent 
displacement of the cellular kinase Mnk1 followed by a decrease in eIF4E 
phosphorylation have been shown to be important for this process (Cuesta et al., 
2000). 
1.1.15 Assembly and packaging of virions 
Assembly and packaging of adenovirus virions has been suggested to occur in 
four steps. First, the viral proteins IVa2 and L1-52/55K bind to a packaging 
domain located in the ITRs at the end of the double-stranded linear genome. 
Second, this promotes procapsid formation or the interaction of the viral DNA 
with the empty capsid. Third, encapsidation of the viral DNA into the procapsid 
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occurs by virtue of a packaging motor protein providing ATPase activity. 
Fourth, sorne viral components present in the virus partic1e are c1eaved leading to 
maturation of the virion (Ostapchuk et al., 2006) (see section 1.1.3). However, 
only the frrst step of this process has been weIl documented. 
Interaction of the viral DNA with the procapsid has been shown to be mediated 
by the packaging domain which consists of seven A repeats present in the ITRs 
of the viral genome. These AT -rich repeats are conserved thoughout the different 
adenovirus serotypes and have been shown to be essential for packaging (Hearing 
et al., 1987). They are functionally redundant but not equivalent and must be 
situated within approximately 600 bp of either end of the genome for packaging 
to occur (Ostapchuk and Hearing, 2003). The delayed early protein IVa2 and the 
late protein LI-52/55K have been found to interact with the packaging domain 
(Perez-Romero et al., 2005), while IVa2 has also been shown to be essential for 
virion production (Zhang and Imperiale, 2003). In addition, the cellular proteins 
octamer-l (OCT-l), the CAAT displacement protein (CAD) (Erturk et al., 2003) 
and the chicken ovabulmin upstream promoter transcription factor (COUP-TF) 
(Cooney et al., 1992) have also been found to interact with this domain. 
However, efforts to identify additional proteins involved in the packaging process 
have been hampered by the fact that the packaging domain overlaps with 
enhancer sequences important in the transactivation of early viral genes. 
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1.1.16 Celllysis and viral spread 
Adenovirus has devised at least two ways to promote celllysis and viral spread 
following synthesis of new virions. First, it has been found to dismantle the 
cytoskeleton at least in part by cleavage of the vimentin and cytokeratin 
intermediate filament network (Zhai et al., 1988). Collapse of this system is 
thought to promote viral spread by affecting cellular integrity. Second, 
adenovirus encodes an early viral protein, E3-11.6K also called ADP (see section 
1.1.16), that has been shown to promote cell lysis and viral spread. Virus 
mutants lacking ADP have indeed been shown to cause smaller plaque formation 
(Tollefson et al., 1996). Conversely, virus mutants that overexpress ADP have 
been demonstrated to be more proficient at lysing cells and causing virus spread 
(Doronin et al., 2003). While the mechanism of action of ADP is still unknown, 
recent findings have indicated that ADP could be involved in the control of the 
cell cycle, error-prone DNA synthesis or cell-cell interactions since this protein 
has been found associated with MAD2B in a yeast two-hybrid screen. Mad2B is 
a cellular protein that is 25% identical to MAD2, a well-characterized spindle 
assembly checkpoint protein. However, MAD2B still remains largely 
uncharacterized (Ying and Wold, 2003). 
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1.2 THE ADENOVIRUS E40RF4 PROTEIN 
1.2.1 E4orf4 protein 
E4orf4 is a 114 amino acid-protein that has a molecular weight of around 13.4 
kilodaltons. E4orf4 is conserved throughout aIl adenovirus serotypes but has no 
extended sequence homology with any known protein; however, two short motifs 
are apparent: a proline-rich motif at its amino-terminus and an arginine-rich motif 
in the second half of the protein (Figure 1-7). Mutations in the proline-rich motif 
do not affect the association of E4orf4 with c-Src, a protein known to bind these 
motifs, whereas mutations in the arginine-rich motif clearly affects nuclear and 
nucleolar localization as weIl as E4orf4-mediated cell death (see chapter 3). 
Even though the structure of E4orf4 is not known, deleting portions of the protein 
also appears to affect its expression levels and stability suggesting that the 
tertiary structure is important for its functions (Marcellus et al., 2000). 
1.2.2 E4orf4 and early viral gene expression 
E4orf4 was frrst shown to modulate AP-1 transcriptional activity during infection 
by counteracting the synergistic action of ElA and cyclic AMP (cAMP) on cell 
growth (Muller et al., 1992; Muller et al., 1989). AP-1 is a cellular transcription 
factor composed of different subunits such as JunB and c-Fos and has been 
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Figure 1-7. E4orf4 is conserved throughout Most human adenovirus 
serotypes. 
Amino acid alignment of E4orf4 encoded by different human adenovirus 
serotypes. Black boxes indicate conserved residues; triangles, residues involved 
in E4orf4-mediated cell death; the black bar, residues involved in binding protein 
phosphatase 2A (PP2A). Adapted from (Tauber and Dobner, 2001). 
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implicated in the control of cell growth as weIl as cell death (Hess et al., 2004). 
Deleting part of E4orf4 in the virus was demonstrated to cause an increase in AP-
l DNA binding activity due to an increased production of JunB and c-Fos 
proteins. In addition, hyperphosphorylated forms of JunB and c-Fos proteins 
were also shown to accumulate under the same conditions. Finally, deletion of 
E4orf4 from the virus was shown to enhance cell detachment and cell death of rat 
embryo fibroblasts infected with the virus. E4orf4 was therefore concluded to 
downregulate AP-1 transcriptional activity possibly by binding and modulating 
the activity of a cellular kinase important for transcription. Downregulation of 
AP-1 was also thought to be important for the infectious cycle with E4orf4 
possibly contributing to celllysis and virus spread at the end of the infection and 
therefore to cell death (Muller et al., 1992). 
In addition to modulating AP-1 trancriptional activity, E4orf4 was also shown to 
strongly inhibit viral DNA accumulation. Inhibition of viral DNA replication 
was shown to be counteracted by two other early viral proteins, E3orf3 and 
E4orf6. Since in vitro adenovirus DNA synthesis does not require any of the E4 
products, results from these studies concluded that E4orf4 participates indirectly 
in the inhibition of viral DNA synthesis rather than directly (Bridge et al., 1993; 
Medghalchi et al., 1997). The mechanism for this effect remains unknown. 
Furthermore, E4orf4 was also implicated in transcriptional inhibition of the viral 
E2 and E4 promoters. E4orf4 was first shown to inhibit ElA CR3-mediated 
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transactivation of the E4 promoter in transient transfections as well as during 
infection. Okadaic acid, a reasonably specifie inhibitor of protein phosphatase 
2A (PP2A) (E4orf4 associates with PP2A; see section 1.2.5), was demonstrated 
to relieve this inhibition. Since ElA prote in was not found to be the primary 
inhibition target, results from these studies suggested that an E4orf4-PP2A 
complex may affect the phosphorylation of transcription factors involved in the 
transactivation of the E4 promoter (Bondesson et al., 1996). E4orf4 was also 
shown to play a similar role in inhibiting E1A-mediated transactivation of the E2 
promoter. The stability of E2F-DNA complexes were thought to be affected 
(Mannervik et al., 1999). 
Finally, a role for E4orf4 in viral RNA splicing was established in which E4orf4 
was demonstrated to induce the dephosphorylation of SR proteins, a family of 
essential splicing factors, during infection inducing an early to late switch in the 
splicing of the LI transcript (Kanopka et al., 1998). More specifically, E4orf4 
was demonstrated to associate with two SR proteins, ASF/SF and SRP30c, 
through their RNA recognition motif as well as with PP2A, allowing the 
phosphatase to come in close proximity with the splicing factors at the splicing 
site junctions and promoting the dephosphorylation and release of the factors 
from this site (Estmer Nilsson et al., 2001). 
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1.2.3 Activation of mTOR 
The mTOR pathway is a signaling pathway central to the control of cell growth 
and proliferation that links positive and negative cellular growth stimuli with the 
translation machinery. Positive stimuli such as growth factors, glucose, amino 
acids, and oxygen signal to PI3K, which then signaIs to AKT and to the central 
kinase mTOR. mTOR in turn activates cap-dependent translation via the 
phosphorylation of two main downstream effectors: the kinase p70S6K and the 
eIF4E translation initiation factor inhibitor 4E-BPI. Negative regulators of the 
mTOR pathway involve PTEN and the TSC complex upstream of mTOR 
(Wullschleger et al., 2006). 
E4orf4 has been shown to activate the mTOR pathway together with another 
early viral protein, E4orfl, independently of nutrients and of other cellular 
stimuli. While E40rfl has been shown to mimic growth factor signaling and to 
activate PI3K upstream of mTOR, E4orf4 has been shown to mimic glucose 
signaling and to activate p70S6K and 4EBPI phosphorylation at the level of cap-
dependent translation downstream of mTOR in a PP2A-dependent manner. 
Moreover, activation of the mTOR pathway by these proteins has been shown to 
be essential for E2F-independent cell cycle entry and viral replication in primary 
SAEC (O'Shea et al., 2005). 
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1.2.4 Atypical form of cell death 
ElA expression has been shown to cause cell death both in a p53-dependent and 
p53-independent fashion (Teodoro et al., 1995). Further investigation of p53-
independent apoptosis both when E4orf4 was overexpressed alone in transfection 
(Lavoie et al., 1998) and in the presence of other viral proteins in the context of 
an infection (Marcellus et al., 1998) has indicated that E4orf4 is responsible for 
this type of cell death. Hallmarks of apoptosis such as phosphotidylserine flip, 
loss of mitochondria membrane potential and chromatin condensation have been 
observed in rodent CHO cells (Lavoie et al., 1998) and in manY human 
transformed celllines (Robert et al., 2002; Shtrichman and Kleinberger, 1998). 
However, incubation of cells expressing E4orf4 with the pan caspase inhibitor 
zV AD-fmk has not been shown to prevent E4orf4-induced cell death in most cell 
lines (Lavoie et al., 1998; Livne et al., 2001; Robert et al., 2002) indicating that 
caspases, the main effectors of apoptosis, are dispensable. 
Evidence for caspase-independent cell death is recent and contrasts with the well-
documented apoptotic program in which caspases, death effector molecules that 
cleave key cellular sub strates , are activated leading to controlled non-
inflammatory cell death. Caspase-independent cell death programs include 
apoptosis-like cell death, necrosis-like cell death, paraptosis, autophagy, slow cell 
death and mitotic catastrophy. These programs all exhibit various hallmarks of 
apoptosis like those observed upon expression of E4orf4 (see above) but caspases 
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are not activated. Instead, activation of proteases such as calpains or cathepsins 
is sometimes observed. Furthermore, organelles other than mitochondria 
(c1assically involved in apoptosis) such as lysosomes and the endoplasmic 
reticulum play a role in these processes. Since different caspase-independent 
programs exhibit similar features, studies are currently under way trying to 
understand the involvement of different signaling pathways in these processes 
(Broker et al., 2005). 
In addition to inducing caspase-independent cell death, E4orf4 was also shown to 
sensitize transformed cells to cell death. A high percentage of condensed nuc1ei 
was observed upon expression of E4orf4 in baby rat kidney cells together with 
ElA and E1B or ElA and activated Ras. In contrast, much less condensation 
was observed when E4orf4 only was overexpressed (Shtrichman and 
Kleinberger, 1998). Since most cancer cells have mutations in the p53 pathway 
as well as in genes involved in apoptosis, E4orf4 was thus conc1uded to be an 
interesting tool for cancer therapy. Consequently, a few studies have since 
emerged that have started addressing this issue testing the suitability of E4orf4 
for gene therapy of tumours (Mitrus et al., 2005) or the cytotoxicity of an E4orf4-
containing recombinant fusion proteins (Wang et al., 2006). 
Finally, E4orf4 has been shown to kill transformed cells at least in part by a 
mechanism involving PP2A (Shtrichman and Kleinberger, 1998), a ubiquitous 
serine/threonine phosphatase central to the control of cell growth and apoptosis 
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(Van Roof and Goris, 2003). Studies are therefore under way to better 
understand the molecular mechanisms (see section 1.2.6). 
1.2.5 E4orf4-PP2A interaction 
PP2A was the first protein identified to bind to E4orf4 in immunoprecipitation 
experiments. While the three subunits composing the holoenzyme were found 
associated with E4orf4 in vivo, PP2A Ba was the only subunit found to contact 
E4orf4 directly in vitro. In addition, the E4orf4-PP2A complex was also shown 
to be associated with phosphatase activity, while okadaic acid, an inhibitor of 
PP2A, was demonstrated to inhibit this activity at low concentrations (5 nm) 
(Kleinberger and Shenk, 1993). These results strongly suggested that E4orf4 
associates with an active PP2A enzyme, possibly in order to redirect its substrate 
specificity or functions as is the case with sorne other viral proteins (see section 
1.3.3). 
Subsequent binding analyses of E4orf4 proteins carrying various point mutations 
to PP2A Ba in mammalian cells showed that many residues largely present in the 
carboxy-terminus half of E4orf4 are important for binding and that, importantly, 
E4or4-induced cell death greatly becomes impaired when these residues are 
mutated (Marcellus et al., 2000; Shtrichman et al., 2000). Two classes of E4orf4 
mutants were thus defined: those that exhibit a reduction in PP2A binding and 
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killing (class 1) and those that exhibit a reduction in killing even when relatively 
normal PP2A binding levels are observed (class II) (Marcellus et al., 2000). 
Conversely, efforts to map the E4orf4 binding site on PP2A Ba were undertaken 
by our group by constructing PP2A Ba point mutants as well as deletion mutants 
and by testing them in immunoprecipitation experiments. Results obtained with 
the point mutants clearly showed that two leucine residues, 1A3 and Ll12 located 
within WD-repeats 1 and 2 of PP2A Ba, play an important role in binding to 
E4orf4. However, results obtained with the deletion mutants indicated that 
overall binding may be complex as E4orf4 appeared to interact with many 
different regions of the subunit (Chan and Branton, unpublished results). 
Finally, the effects of E4orf4 on PP2A activity and the role of PP2A in E4orf4-
induced cell death were examined. Initial models had proposed that E4orf4 
binding activates PP2A since proteins such as ElA, c-Fos (Kleinberger and 
Shenk, 1993), SR proteins (Kanopka et al., 1998), cortactin (Lavoie et al., 2000), 
p70S6K and 4E-BP1 (O'Shea et al., 2005) had been found to be 
hyperphosphorylated in the presence of E4orf4. However, further studies 
demonstrated that in vitro, E4orf4 reduces the activity of purified PP2A against 
the substrates phosphorylase A and histone Hl (Marcellus et al., 2000). In 
addition, phosphorylation of focal adhesion kinase and paxillin in vivo are 
reduced (Lavoie et al., 2000), Thus our group has proposed that the binding of 
E4orf4 to Ba inhibits PP2A activity. Consequently, studies using okadaic acid as 
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well as the ItP2A inhibitor together with E4orf4 confirmed that E4orf4 inhibits 
PP2A towards certain substrates and that, interestingly, cell death is enhanced 
(Brignole and Branton, unpublished results). The mechanism of this inhibition is 
presently under investigation. 
1.2.6 E4orf4-induced eH cycle arrest 
Since Saccharomyces cerevisiae (budding yeast) is a genetically amenable 
system and since PP2A is conserved in higher organisms such as yeast, flies and 
mammals, experiments involving E4orf4 point mutants and PP2A were 
recapitulated in yeast and functional interactions were investigated further. 
Results demonstrated that E4orf4 is toxie to yeast and induces an elongated 
morphology phenotype in 25-35% of cells as weIl as a G2/M arrest and high 
Cdc28/Cdkl kinase activity. Additional experiments also showed that an 
interaction with the B55/Ba subunit of PP2A but not with B56/B' subunit is 
required for E4orf4-induced toxicity, while E4orf4 depends on the B55/Ba 
subunit for recruitment of the whole PP2A holoenzyme (Komitzer et al., 2001; 
Roopchand et al., 2001). Hence, E4orf4-induced cell death is largely PP2A-
dependent although sorne toxicity was also observed with a mutant that failed to 
bind PP2A, indicating that E4orf4 may also possess a PP2A-independent killing 
activity (Roopchand et al., 2001). 
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Since PP2A has long been implicated in many aspects of ceIl cycle regulation 
and particularly in the control of mitosis (Jiang, 2006), a role for E4orf4-PP2A in 
G2/M cell cycle progression was further investigated. Expression of E4orf4 was 
found to be synthetically lethal in yeast ceIls defective in mitosis such as in 
Cdc28/Cdkl and anaphase promoting complex (APC/C) mutants. A physical 
interaction with the Cdc16 APC/C subunit was also reported although this result 
could not be reproduced by our group (Komitzer et al., 2001). 
APC/C is a high molecular weight ubiquination complex that induces the 
degradation of mitotic proteins and thereby regulates proper chromosome 
segregation and cytokinesis. APC/C exists in at least two forms:APC/CCdc2o and 
APC/CCdh1. Cdc20 and Cdhl are co-activators of the active APC/C complex that 
serve to direct the degradation of different mitotic substrates during the 
metaphase to anaphase transition or the anaphase to cytokinesis transition, 
respectively. APC/CCdc20 has indeed been shown to degrade securin/Pdsl, an 
inhibitor of Espl, which is a protein that activates Scc1 and subsequent 
metaphase to anaphase transition (Peters, 2006). Interestingly, recent studies by 
our group have demonstrated that E4orf4 prematurely activates APC/CCdc20 and 
prematurely degrades Pdsl and Sccl in a PP2A Cdc55/Ba-dependent manner, 
resulting in higher sister chromatid separation. However, no change in 
APC/CCdh1 activity or in its substrates levels have been detected (Roopchand and 
Branton, unpublished results). Hence, E4orf4 appears to induce a block during 
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the metaphase to anaphase transition of mitosis presumably by inhibiting PP2A 
and possibly by redirecting its activity away or towards specific substrates. 
1.2.7 Extranuclear cell death 
In addition to contributing to nuclear changes, E4orf4-induced cell death was 
also found to induce cellular cytoplasmic changes. Extensive membrane 
blebbing and inhibition of ceH spreading on fibronectin-coated plates were first 
observed upon overexpression of E4orf4. Since Src family kinases have long 
been associated with such changes through modulation of tyrosine 
phosphorylation of certain substrates (Angers-Loustau et al., 1999), E4orf4 
binding to Src family kinases was investigated and E4orf4 was found to associate 
with the latter both in vitro and in vivo. In addition, when overexpressed, E4orf4 
was found to become enriched at the plasma membrane in fractionation and 
immunofluorescence experiments, while activated c-Src was shown to exacerbate 
this effect. Conversely, inhibition of c-Src using the pharmalogical inhibitor PP2 
or a construct expressing kinase-dead Src prevented these effects and greatl y 
diminished cell death. FinaIly, E4orf4 was shown to cause the 
hypophosphorylation of focal adhesion kinase and paxillin and the 
hyperphosphorylation of cortactin. Focal adhesion kinase, paxillin and cortactin 
are aH phosphorylation substrates of c-Src. These results therefore suggested that 
E4orf4-induced cytoplasmic events are modulated through the association of 
E4orf4 with Src family kinases and most probably c-Src (Lavoie et al., 2000). 
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In addition to modulating the tyrosine phosphorylation of certain cytoplasmic 
substrates, c-Src was also demonstrated to modulate the tyrosine phosphorylation 
of E4orf4 on residues 26, 42, 59 and 60, and this phosphorylation was shown to 
be important in the translocation of E4orf4 to the plasma membrane and in the 
induction of membrane blebbing and cell death. Consequently, a non-
phosphorylatable form of E4orf4 was predominantly enriched in the nucleus, had 
less tyrosine phosphorylated substrates associated with it and exhibited reduced 
cell killing, whereas an activated phosphorylated form of E4orf4 was 
predominantly enriched at the plasma membrane, associated with more tyrosine 
phosphorylated substrates and exhibited increased membrane blebbing and cell 
death. c-Src tyrosine phosphorylation of E4orf4 was therefore concluded to be 
important in E4orf4-induced cytoplasmic events and cell death (Gingras et al., 
2002). 
Further studies investigating the interaction of E4orf4 with Src family kinases 
confirmed that E4orf4 physcially interacts with c-Src both in vitro and in vivo 
and that this interaction is mediated by the arginine-rich region of E4orf4 located 
between residues 66 and 75. Even though this region overlaps with the carboxy-
terminal region shown to be important for binding to PP2A Ba., a mutant binding 
exclusively c-Src was identified and investigated. This mutant, E4orf4 
R811F84A, was shown to specifically mediate deregulation of Src signaling, 
activation of the Jun kinase pathway and induction of membrane blebbing in a 
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PP2A-independent fashion. Thus, E4orf4 was concluded to have distinct PP2A-
and Src-dependent activities (Champagne et al., 2004). 
FinaIly, a recent study investigating further E4orf4-mediated remodeling of the 
actin cytoskeleton as weIl as induction of membrane blebbing showed that 
E4orf4 translocates to a juxtanuclear region in the vicinity of the centrosome. 
Once there, it induces the assembly of an actin-myosin ring through the 
activation of myosin II and the de novo polymerization of actin and induces the 
recruitment of endosomes in a Src-dependent fashion. Furthermore, this study 
also showns that these Src-dependent effects require the activation of the small 
Rho GTPases Cdc42, RhoA and Rac1, as knockdowns of the latter greatly reduce 
membrane blebbling as weIl as cell death. Hence, E4orf4 is thought to highjack 
RhoGTPases in order to remodel the actin cytoskeleton, a process that thereby 
directly contributes to killing of transformed cells (Robert et al., 2006). 
1.3 PROTEIN PHOSPHATASE 2A (PP2A) 
1.3.1 Phosphatase classes 
Phosphorylation is an important, reversible, post-translational modification 
performed on proteins in eukaryotic cells. While kinases mediate the addition of 
phosphate groups, phosphatas es mediate their removal. 
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Eukaryotic phosphatases are classified into three groups based on the structure of 
their catalytic domain: the phosphoprotein phosphatas es (PPP), the 
phosphoprotein phosphatases M (PPM) and the phospho-tyrosine phosphatases 
(PTP). The PPP family comprises the following serine/threonine phosphatases: 
PP1, PP2A, PP2B, PP4, PP5, PP6 and PP7. The PPM family is stimulated my 
magnesium ions and is composed of the PP2C phosphatases. Finally, the PTP 
family encompasses tyrosine phosphatas es and dual-specificity phosphatas es that 
can dephosphorylate phospho-tyrosine alone or phospho-serine and phospho-
threonine residues on proteins, respectively (Cohen et al., 1990). 
1.3.2 PP2A structure and funetions 
PP2A is a ubiquitous serine/threonine phosphatase conserved across eukaryotes. 
It makes up around 1 % of the total cellular protein content and is expressed in 
many tissues. PP2A has been shown to be involved in many fundamental 
cellular processes such as DNA replication (Lin et al., 1998), RNA splicing 
(Mermoud et al., 1992), translation (Andjelkovic et al., 1996) and cell cycle 
regulation (Jiang, 2006). In addition, its different activities have been shown to 
be targeted and modulated by sorne viruses (see further for details). 
PP2A is a trimeric enzyme composed of a scaffolding A subunit, a regulatory B 
subunit and a catalytic C subunit. The trimeric enzyme is also called the 
holoenzyme, while the enzyme consisting of only the A and C subunits is called 
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the core enzyme. Holoenzymes and core enzymes have been observed in cells 
(Ruediger et al., 1994) but the presence of functional single subunits remains 
controversial. 
1.3.2.1 A subunit 
Two classes of PP2A A subunits exist in mammalian cells, An and A~ (see table 
1-1). These subunits are 87% identical but An is approximately ten-fold more 
abundant than A~ (Hemmings et al., 1990). The A subunit serves as a scaffold 
for the PP2A holoenzyme. Crystal structure studies have shown that it is a rod-
shape molecule and that it contains fifteen nonidentical HEA T repeats, each 
repeat being composed of two packed amphipathic helices connected by a short 
loop (Ruediger et al., 1994). HEAT repeats were initially identified in the 
Huntingtin, ~longation factor 3, A subunit of PP2A and TOR proteins, thus the 
name. The frrst ten amino-terminal HEAT repeats of the A subunit are involved 
in binding to the B subunit, whereas the last five repeats bind the C subunit 
(Ruediger et al., 1992). Mutations in A can abolish binding to certain B subunits, 
thus suggesting that Amay regulate the composition of the enzyme (Ruediger et 
al.,2001). 
1.3.2.2 B subunit 
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Four classes of B regulatory subunits exist, B/B55/PR55, B' /B56/PR61, 
B"/PR72 and B'" comprising a total of about twenty subunits (see table 1-1). 
Subunits from these different classes share little to no homology but yet bind to 
the core enzyme via the same binding site, making binding mutually exclusive. 
B subunits serve as regulatory subunits and have been shown to confer distinct 
cellular localization (Sontag et al., 1995) and substrate specificity (Mumby et al., 
1987) to the PP2A holoenzyme. Sorne B subunits are also tissue-specifie or are 
regulated during development (McCright and Virshup, 1995). Ba and Bô from 
the B subunit family are widely distributed among tissues, for example, whereas 
B~ and B'Y are only found in the brain. Likewise, Ba is found in the nucleus and 
cell body of neurons, while B~ is excluded from the nucleus and extends into 
dendrites (Strack et al., 1998). 
An important structural feature of the B family regulatory subunits is that they 
each contain 7 WD-repeats. WD-repeats are sequences of about 40 amino acids 
that typically end with tryptophan-aspartate residues and that mediate protein-
protein interactions (Smith et al., 1999). More than 100 different proteins have 
been shown to contain WD-repeats (Venter et al., 2001) including PP2A B'Y 
(Strack et al., 2002). The WD-repeat secondary structure of PP2A B'Y forms a ~­
propeller-like structure and is composed of ~-sheets and tums. This structure is 
believed to be important in the PP2A tridimensional holoenzyme assembly and 
function (Strack et al., 2002). 
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1.3.2.3 C subunit 
Two classes of C catalytic subunits exist, Ca and Cp (see table 1-1), that are 97% 
identical at the amino acid level. Ca levels are ten times more elevated than Cp 
levels in cells. PP2A Chas been purified from the core enzyme in vitro and 
results have shown that phosphatase activity is associated with it (Usui et al., 
1988). Additional results have also demonstrated that PP2A C is regulated by 
phosphorylation and methylation at tyrosine residue 307 and leucine residue 309, 
respectively (Lee and Stock, 1993; Xie and Clarke, 1993). How the activity of 
PP2A C is regulated by association with the B subunit remains unknown. 
Table 1-1: PP2A subunits in mammalian cells 
a, [3 
a, [3, tJ,y 
a, [3, tJ,y, E 
PR72/PR130, PR59, PR48 
PR93/SG2NA, PR110/Striatin 
a,[3 
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1.3.3 Interaction with small DNA tumour viruses 
PP2A has typically been shown to be targeted and modulated by small DNA 
tumour viruses. SV40 small T antigen (ST), polyoma ST (Pallas et al., 1990) and 
middle T (MT) antigens (Walter et al., 1990) and adenovirus E4orf4 (Kleinberger 
and Shenk, 1993) (see section 1.2.5) have all been found to bind and modulate 
PP2A. However, their modes of action differ. While SV40 and polyoma ST and 
MT bind PP2A A and C subunits and substitute for the B, thereby releasing it 
from the enzyme, adenovirus E4orf4 associates with the trimeric enzyme via its 
binding to the Ba regulatory subunit (Kleinberger and Shenk, 1993; Pallas et al., 
1990; Walter et al., 1990). Association of these viral antigens with PP2A is 
generally assumed to modify the enzymatic activity of PP2A either by inhibiting 
the enzyme or by activating it. This effect, in turn, results in cell cycle 
progression and cell growth and promotes efficient viral replication. 
Consequently, SV40 ST and polyoma ST and MT binding to PP2A have been 
shown to be key interactions in the transformation of human cells (Pallas et al., 
1990). Mechanisms underlying transformation are now being investigated and 
are thought to involve the modulation of whole PP2A-dependent signaling 
pathways such as those regulated by PI3K, for instance (Ahuja et al., 2005; 
Arroyo and Hahn, 2005). 
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1.4 NUCLEAR TRANSPORT AND SUBNUCLEAR ORGANIZATION 
1.4.1 Nucleocytoplasmic transport: overview 
Transport of proteins in and out of the nucleus of eukaryotic cells occurs through 
the nuclear pore complex (NPC) and is mediated by the karyopherin superfamily 
proteins. Karyopherins generally named importins recognize nuclear localization 
signaIs (NLS) present at the surface of cytoplasmic proteins and transport these 
proteins to the nucleus. Similarly, karyopherins termed exportins bind nuclear 
export signaIs (NES) present at the surface of nuclear proteins and transport the 
latter to the cytoplasm. ARan GTP/GDP gradient across the nuclear membrane 
provides an energy source and ensures that transport is directional. Importins 
preferentially bind GTP, while exportins prefer GDP. Conversion of RanGTP 
into RanGDP is catalyzed by the exchange factor RanGAP in the cytoplasm, 
whereas conversion of RanGDP into RanGTP is catalyzed by RanGEF/RCC1 in 
the nucleus (Pemberton and Paschal, 2005). 
1.4.2 Import 
At least ten different kinds of importins have been characterized, importin a 
mediating the import of most NLS-containing proteins (Pemberton and Paschal, 
2005). Importin a is an adaptor molecule that binds importin ~, a key player that 
mediates import in the nucleus through the NPC (Gorlich et al., 1994). The 
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crystal structure of irnportin a bound to SV40 LT has been determined and the 
SV40 LT NLS has been found to contact armadillo repeats at the center of the 
super helix formed by the adaptor protein and to be retained in this groove 
through several electrostatic interactions (Conti et al., 1998). Not all NLS-
containing proteins need an adaptor protein to enter the nucleus however. Sorne 
proteins can contact only irnportin f3 directly. This is the case for proteins 
containing large (up to 100 residues), less well defined NLS such as the ones 
present in sorne RNA-binding proteins (Senger et al., 1998), core histones 
(Mosammaparast et al., 2001) and ribosornal proteins (Jake! and Gorlich, 1998) 
and for proteins containing sequences rich in arginines like HIV -1 Rev and Tat 
(Henderson and Percipalle, 1997). Why sorne proteins are irnported into the 
nucleus solely by irnportin f3 and others are not rernains unknown. The tri-
dirnensional structure of the protein has been suggested to rnake a difference. 
1.4.3 Nuclear localization signais 
Classical NLS were initially discovered in the viral protein SV40 LT and in the 
cellular protein nucleoplasrnin. These NLS were found to be cornposed of one or 
two stretches of basic residues and were therefore called rnonopartite (Kalderon 
et al., 1984) or bipartite (Robbins et al., 1991) NLS, respectively. Surprisingly, a 
single lysine residue within the SV40 LT NLS was dernonstrated to be critical for 
nuclear localization (Kalderon et al., 1984). This is contrary to other NLS 
cornposed of rnany arginine residues for which we (Miron et al., 2004) and others 
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(Kubota et al., 1999) have demonstrated that the overall charge is important in 
mediating import in the nucleus as well as in the nucleolus. 
Arginine-rich signals targeting to both the nucleus and nucleoli are short, 
compact sequences 10-20 amino acids long (Hauber et al., 1987). They have been 
identified and characterized in the Tat (Hauber et al., 1987; Kuppuswamyet al., 
1989; Malim et al., 1989a; Malim et al., 1989b; Ruben et al., 1989; Siomi et al., 
1990) and Rev (Kubota et al., 1989; Malim et al., 1989a) proteins encoded by 
human immunodeficiency virus 1 (HIV -1), and in the Rex protein of human T-
cell leukemia virus 1 (HTLV-1) (Siomi et al., 1988), as well as in the cellular 
ribosomal protein RPS25 (Kubota et al., 1999). Even though the HIV-1 Tat and 
Rev ARMs have been shown to bind viral RNA structures and to mediate viral 
transcriptional elongation (Malim et al., 1989b; Rosen et al., 1985b; Seiki et al., 
1988) and the stabilization and export of viral rnRNAs (Felber et al., 1989), no 
general role in the nucleolus has been identified for these proteins. Recent 
studies have, however, demonstrated that shuttling of HIV-1 Rev in and out of 
the nucleolus is crucial for HIV -1 replication as a nucleolus-targeted decoy 
containing the Rev binding element retains Rev in nucleoli and greatly impairs 
viral growth (Michienzi et al., 2006). Since Rev can also relocalize the export 
receptor CRM1 and the NPC proteins Nup98 and Nup114 to the nucleolus 
(Zolotukhin and Felber, 1999) as well as bind to the nucleolar protein 
B23/nucleophosmin via its ARM (Fankhauser et al., 1991), Rev could be 
involved in nucleocytoplasmic transport (Pemberton and Paschal, 2005), 
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regulation of cell growth, proliferation or cell death (Grisendi et al., 2006) as 
these proteins have been shown to play a role in the se cellular processes. 
Properties of ARM have been studied extensively as the HIV -1 Tat prote in was 
accidentally discovered to be intemalized by cells when added to tissue culture 
medium and as its ARM was shown to be responsible for this effect (Frankel and 
Pabo, 1988). More than seven arginine residues were found to be necessary for 
efficient intemalization (Futaki et al., 2001), while this process was shown not to 
depend on the overall charge nor linear sequence (Futaki et al., 2002) but on the 
nature and number of arginine guanidino groups (Wright et al., 2003). Many 
efforts are presently being made to use ARM as peptide delivery vectors. 
1.4.4 Nuclear bodies 
Nuclear bodies (NB) are discrete, non-membranous structures that form in the 
nucleus of cells and that are generally attached to the nuclear matrix. They differ 
in shape and components, are very dynamic, and can thus perform different 
functions that pertain to gene expression, signaling, packaging and transport 
within the nucleus or to the cytoplasm. Functional disruption of NB has been 
linked with many diseases including neurodegenerative diseases and cancer and 
has been observed during many viral infections. These findings therefore 
highlight the important role that these structures play in nuclear organization and 
function as well as in cellular integrity. The best characterized NB found in 
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mammalian cells include splicing speckles, Cajal bodies, nucleoli and PML 
bodies (Zimber et al., 2004). 
1.4.5 Splicing speckles 
Splicing speckles are small bodies that form in the nucleus of mammalian cells. 
They range in size from 20-25 nm and 25-50 of them can be found in the 
interchromatin space of each nucleus. Just like for Cajal bodies, the number of 
splicing speckles vary depending on the cell cycle stage. Splicing speckles are 
enriched in pre-mRNA splicing factors such as small nuclear ribonucleoproteins 
(snRNP) and serine-arginine (SR) proteins and have been shown to be involved 
in the assembly and storage of the splicing machinery. Phosphorylation and 
dephosphorylation cycles of splicing factors such as Clk-Sty (Colwill et al., 
1996) have been shown to drive the dissociation or enlargement of these bodies, 
respectively (Misteli et al., 1997). 
1.4.6 Cajal bodies 
Cajal bodies are small structures found in the nuclei of plant and animal cells. 
They range in size from 0.1-2 J.1m and 0-10 of these bodies can be found per 
nucleus. Cajal bodies are highly dynamic and their size varies according to the 
cell cycle. They are often found in close proximity to nucleoli and splicing 
speckles and are thought to interact with these NB. Many factors have been 
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found in Cajal bodies including proteins such as fibrillarin and p80-coilin, RNA 
polymerase II transcription factors, heteronuclear ribonucleoproteins (hnRNP) as 
well as splicing snRNPs and small nucleolar RNP (snRNP) (Carmo-Fonseca et 
al., 1992; Raska et al., 1991). Rowever, transcription does not occur in these 
structures (Thiry, 1994). Cajal bodies are therefore believed to play a role in the 
assembly and maturation of nuclear RNPs. 
1.4.7 Nucleoli 
Nucleoli are the most prominent structures observed in the nucleus of cells under 
a light microscope. These structures assemble around ribosomal RNA (rRNA) 
genes and are only visible when ribosomal transcription is occurring. Thus, 
highly proliferating cells like cancer cells exhibit many big nucleoli, while 
primary cells have no or a small number of tiny nucleoli. Nucleoli are also 
present throughout interphase, disassemble at mitosis and reformed thereafter. 
They are membrane-free bodies divided into three compartments: the fibrillar 
center (FC) where rRNA genes start being transcribed, the dense fibrillar 
component (DFC) where transcription and rRNA processing occurs, and the 
granular component (GC) where ribosome subunits are assembled. Each 
compartment is associated with specifie proteins, which are routinely used as 
markers for nucleolar compartment identification in immunofluorescence studies. 
RNA polymerase I, fibrillarin and B23/nucleophosmin are used as markers for 
the FC, DFC and GC, respectively, for example (Scheer and Rock, 1999). A 
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fourth compartment called the perinucleolar compartment peripheral to the GC 
has recently been discovered (Fox et al., 2002). Even though its role still remains 
unknown many small RNA and RNA-binding proteins have been shown to 
associate with this region (Fox et al., 2005). 
Nucleoli have long been associated with ribosomal RNA (rRNA) transcription, 
processing and ribosome subunit assembly (Carmo-Fonseca et al., 2000). 
However, recent studies have shown that these bodies also perform unrelated 
functions and are thus involved in cell cycle regulation, DNA damage repair, 
RNA editing, telomere metabolism, transfer RNA (tRNA) processing as weIl as 
regulation of protein stability (Carmo-Fonseca et al., 2000). In fact, more than 
700 nucleolar proteins have been identified to this day due to recent advances in 
NB purification and mass spectrometry techniques (Lam et al., 2005). Since 30% 
of these proteins still have unknown functions, new nucleolar roI es will 
undoubtedly be discovered in the near future. Furthermore, the composition of 
nucleoli has also been reported to change upon transcription inhibition using 
actinomycin D (Andersen et al., 2002), while nucleolar components have been 
found to shuttle between nucleoli and other NB (Leung and Lamond, 2002; 
Sleeman et al., 1998). These results therefore strongly suggest that the nucleolar 
proteome is dynamic and that proteins can associate transiently or constitutively 
with nucleoli. 
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Not surprisingly, many proteins encoded by several RNA or DNA virus es have 
been shown to associate with and/or disrupt nuc1eoli during infection. This is the 
case for the Tat and Rev proteins encoded by HIV-I as mentioned previously 
(see section 1.4.3), the nuc1eoproteins encoded by coronavirus and influenza A 
virus, the delta antigen encoded by hepatitis delta virus, the EBNA5 protein 
encoded by Epstein-Barr virus, the USII and ICP27 proteins encoded by herpes 
simplex virus-l and proteins V, VII and mJl encoded by adenovirus. However, 
the exact role played by these proteins in nuc1eoli during the course of an 
infection largely remains misunderstood but may be important for viral 
replication as has been shown for HIV-I Rev (Hiscox, 2002) (see section 1.4.3). 
Interestingly, a recent report investigating the nuc1eolar localization of the capsid 
protein encoded by the West Nile virus (WNVCp) has reported that this protein 
becomes redistributed to the cytoplasm and degraded upon interaction with the 
cellular protein Jabl part of the COPI signalosome. Constitutive removal of 
WNVCp from nuc1eoli followed by degradation during West Nile virus infection 
has been shown to be important in protecting cells against WNVCp-induced 
cytotoxicity and subsequent G2/M arrest (Oh et al., 2006). These results 
therefore support the notion that nuc1eolar functions are dynamically linked to 
other cellular functions like protein degradation and are more complex than 
initially thought. 
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1.4.8 PML bodies 
1.4.8.1 Structure 
PML bodies (also called nuclear domains 10 (NDlO), PML oncogenic domains 
(POD) or Kremer (Kr) bodies) are structures 0.3 to 1 !lm in diameter (Ascoli and 
Maul, 1991). They are not spherical in shape but, rather, contain channels and 
pores (Boisvert et al., 2000). PML bodies vary in size and number in a cell type-
and cell cycle-dependent manner. Consequently, 5-30 PML bodies are found in 
the nucleus of many mammalian cell types (Zhong et al., 2000). PML bodies are 
also often found juxtaposed to other nuclear bodies such as Cajal bodies and 
splicing speckles. However, no DNA or RNA has been found inside their core 
structure. Rather, newly synthesized RNA has been found associated with their 
periphery (Boisvert et al., 2000). 
1.4.8.2 Identification 
PML bodies were first characterized as targets of autoimmune antibodies in 
biliary cirrhosis (Bernstein et al., 1984). They then started drawing interest when 
they were shown to be natural sites of accumulation for the PML protein, which 
were disrupted in patients with acute promyelocytic leukemia (APL) due to a 
PML-retinoic acid receptor (RAR) chromosomal translocation t(15;17) resulting 
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in a PML-RAR fusion protein. This fusion protein was shown to prevent the 
fonnation of PML bodies and to contribute to the disease (Dyck et al., 1994; 
Koken et al., 1994; Weis et al., 1994). Treatment with retinoic acid (Dyck et al., 
1994; Koken et al., 1994; Weis et al., 1994), arsenic trioxide (Chen et al., 1996) 
or trivalent antimonials (Muller et al., 1998) was found to completely reverse the 
condition of the patients, restoring the integrity of PML bodies in the process. 
1.4.8.3 PML protein 
Knockout of the PML gene in mice has demonstrated that the PML protein is, 
however, not essential for cell viability (Wang et al., 1998). Nevertheless, PML 
is required for the fonnation of PML bodies and must be sumoylated in order to 
do so (lshov et al., 1999). Sumoylation is a post-translational modification that 
occurs on the lysine residue of the sumoylation consensus site 'l'KXE (where '1' 
is a hydrophobie amino acid and X, any amino acid) (Wang et al., 1998) and that 
generally modulates protein-protein interactions as well as the stability of high 
molecular weight protein complexes (Seeler and Dejean, 2001). 
PML cornes in several isofonns that differ at their C-tenninus due to alternative 
splicing (Fagioli et al., 1992). PML 1 and IV are the best characterized isofonns. 
Different isofonns are thought to induce the fonnation of PML bodies with 
different compositions and functions. For instance, PML IV (also refered to as 
clastosomes) is increasingly believed to associate with components of the 
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proteasome degradation machinery (Lafarga et al., 2002) and to play a role in the 
degradation of nuc1ear misfolded proteins (Fu et al., 2005b) or polyglutamine 
proteins (Janer et al., 2006). 
1.4.8.4 PML body components and functions 
Over 77 different proteins have been found to associate with PML bodies. These 
proteins inc1ude the p53 and pRB tumour suppressor proteins; transcription 
factors and co-regulators such as CBP and Daxx; DNA repair proteins such as 
Mre11, Rad50 and Chk2; apoptotic proteins such as Mdm2, Bax and TRADD; 
11S proteasome subunits as well as proteins involved in antivral defense 
(Dellaire and Bazett-Jones, 2004). Association with PML bodies has been shown 
to be constitutive or transient. In addition, only a subset of PML bodies has been 
shown to be associated with given proteins under certain conditions. Cellular 
stress such as heat shock, DNA damage or viral infection has also been 
demonstrated to influence the size and function of these structures (Dellaire and 
Bazett-Jones, 2004). Altogether, even though many PML body components have 
been identified thus far, PML body functions remain misunderstood. Possible 
functions inc1ude the regulation of apoptosis, senescence, protein degradation, 
gene regulation, tumour suppression, DNA repair as well as antiviral response. 
The importance of functional and intact PML bodies can only be highlighted by 
the fact that these latter are disrupted in many cancers and viral infections. For 
65 
instance, PML protein expression has been shown to be significantly reduced or 
abolished, and linked to higher grade tumours and tumour progression in 
prostate, breast, colon and lung cancer (Gurrieri et al., 2004). Indeed, PML is 
now emerging to be a tumour suppressor of AKT (Trotman et al., 2006) and 
mTOR signaling and to suppress neoangiogenesis (the formation of new blood 
vessels) (Bemardi et al., 2006). 
In addition, PML bodies have also been shown to be frequently targeted by RNA 
and DNA tumour viruses such as herpesviruses, arenaviruses, papilloma viruses, 
papovaviruses and adenoviruses (Everett, 2001). These viruses either disrupt 
PML bodies by associating with PML or PML body components and by 
dispersing or degrading them or, altematively, their genome associate with PML 
bodies and the viruses use these structures to enhance their replication and/or 
gene expression (Everett, 2001). The best characterized example is that of herpes 
simplex virus-1 which encodes 2 proteins, ICP4 and ICPO, performing both 
functions. While ICP4 associates with the viral genome in the vicinity of PML 
bodies during early viral replication (Everett et al., 2003), ICPO binds to and 
degrades many PML isoforms as weIl as the PML body component SplOO 
through its RING motif and the proteasome-dependent pathway (Chelbi-Alix and 
de The, 1999). Adenovirus also disrupts PML bodies (see section 1.1.11.3). 
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1.5 THESIS PROPOS AL 
In order to better understand the mechanisms of action of the adenovirus E4orf4 
protein, my work focused on studying the localization to function relationship of 
this protein in transformed human cells. Preliminary results had indicated that 
when overexpressed in cells following DNA transfection E4orf4 was 
predominantly enriched in the nucleus but that small amounts were also present 
in the cytoplasm. 1 therefore first set out to identify the primary cellular site(s) of 
action of E4orf4-mediated cell death by artificially targeting E4orf4 fused to GFP 
to different cellular locations (the nucleus, the cytoplasm, the plasma membrane) 
and by monitoring the onset of two distinct E4orf4-specific cell death markers, 
membrane blebbing and nuclear condensation. Since our results showed that 
E4orf4 could induce cell death from both the nucleus and the cytoplasm, 1 then 
went on to identify the molecular determinants of E4orf4 mediating nuclear 
localization. U sing site-directed mutagenesis combined with direct fluorescence 
microscopy 1 identified an arginine-rich region that served not only as a nuclear 
localization signal but also as a nucleolar localization signal (E4ARM). 
Importantly, 1 showed that the presence of E4orf4 in the nucleus via the E4ARM 
contributed to at least 50% of E4orf4-induced cell death activity. Finally, in 
order to validate the functional role of E4orf4 in the nucleus when overexpressed 
in cells, 1 investigated the localization to function relationship of E4orf4 during 
an adenovirus infection when E4orf4 is expressed at lower levels in the presence 
of other viral proteins. To do this, 1 generated for the frrst time E4orf4 virus 
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mutants, monitored the localization of E4orf4 fused to GFP in live cell imaging 
studies and identified new nuc1ear bodies with which E4orf4 is associated 
transiently. Furthermore, 1 demonstrated that even though E4orf4 is not essential 
for efficient adenovirus replication, accumulation of a mutant form of E4orf4 at 
PML bodies can significantly impair virus growth. 
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CHAPTER 2: DISTINCT CELL DEATH PATHWAYS 
TRIGGERED BY THE ADENOVIRUS EARL Y 
REGION 4 ORF 4 PROTEIN 
2.1 Introduction 
Adenovirus type 2 (Ad2)-early region 4 ORF 4 (E4orf4) is a small 14-kD Ad 
protein that may play multiple roles during Ad infection (Bondesson et al., 1996; 
Estmer Nilsson et al., 2001; Kleinberger and Shenk, 1993; Muller et al., 1992). In 
mammalian celllines, expression of Ad2 E4orf4 triggers a p53-independent cell 
death pro gram that is selective to transformed cells (Shtrichman et al., 1999). 
Thus, uncovering the molecular mechanisms involved in E4orf4-mediated death 
may help in deciphering the cellular components linking cell division to cell 
death programs and unravel novel strategies for cancer therapy. 
Early work in mammalian cells revealed that cell death induced by Ad2 E4orf4 is 
associated with classic apoptotic hallmarks, including nuclear condensation, cell 
shrinkage, and extemalization of phosphatidylserines (Lavoie et al., 1998). 
Nevertheless, activation of the zV AD.fmk-inhibitable caspases is not required for 
execution of the death program in most cell types (Lavoie et al., 2000; Livne et 
al., 2001). E4orf4 binding to the BQ subunit of protein phosphatase (PP)2A was 
linked to cell death induction in mammalian cells (Marcellus et al., 2000; 
Shtrichman et al., 1999), and to induction of irreversible growth arrest in yeast 
(Komitzer et al., 2001; Roopchand et al., 2001). However, the exact mechanisms 
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involved remain ill defined. In addition, these studies indicated that extra 
functions are required for cell killing, and furthermore, that a PP2A1Cdc55-
independent function also exists. Recently, Ad2 E4orf4 was found to induce a 
Src-mediated cytoplasmic apoptotic signal requiring the tyrosine phosphorylation 
of E4orf4, which rapidly leads to caspase-independent membrane blebbing and 
cell death (Gingras et al., 2002; Lavoie et al., 2000). Analysis of E4orf4 
distribution in various cell lines revealed that the protein is first expressed 
preferentially in nuclear regions; however, induction of early membrane blebbing 
correlates with rapid accumulation of E4orf4 in cytoplasmic membrane regions. 
In the present study, we provide evidence that both the cytoplasmic membrane-
associated and the nuclear E4orf4 induce specific cell death programs in human 
transformed cells. Our data indicate that the cell death programs induced by the 
differentially localized E4orf4 proteins are associated with distinct morphological 
features and kinetics which may involve different death effector pathways. 
2.2 Materials and methods 
2.2.1 Expression vectors and mutagenesis 
The Flag-E4orf4-GFP and Flag-E4orf4 (3Y-F)-GFP were described previously 
(Gingras et al., 2002). The expression vectors Flag-GFP-NLS, which contain the 
NLS from SV40 large T antigen (PKKKRKKV) (Kalderon et al., 1984) and the 
Flag-GFP-NES, containing the leucine-rich nuclear export signal from REV-l 
(LPPLERLTL) (Fischer et al., 1995), were described previously (Lee et al., 1999) 
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and were obtained from Dr. Stephen Lee (McGill University, Montréal, Québec, 
Canada). The Flag-GFP-CAAX contains a COOH terminus CAAX-box from ras 
(CMSCKCVLS) (Ruta et al., 1986) and was obtained by inserting a peptide 
sequence coding for the CAAX-box with cohesive extensions into EcoRI-EcoRV 
sites of the Flag-GFP vector. To generate the Flag-E4orf4-GFP constructs, Ad2 
E4orf4 sequence was amplified by the PCR method using an HA-
E4orf4/PUHDlO-3 as the template as described (Gingras et al., 2002) and 
inserted into ApaI-XhoI sites of the Flag-GFP vectors. The Flag-E4orf4 (3Y-F)-
GFP-NLS and Flag-E4orf4 (3Y-F)-CAAX were obtained using the same method 
except that Flag-E4orf4 (3Y-F) was used as thetemplate. The Myr-GFP construct 
containing the Myr consensus signal from chicken c-src (MGSSKSK) (Resh, 
1999) was generated by standard PCR method and subcloned into the EGFP-C1 
expression vector (CLONTECH Laboratories). The Myr-GFP-HA-E4orf4 
construct was generated by digesting pHA04 hygromycin (unpublished data) to 
obtain HA-tagged E4orf4, which was subcloned into the ec113611 site of Myr-
GFP. The chicken c-src(K295R) in pLNCX vector was provided by Dr. J.S. 
Brugge (Harvard Medical School, Boston, MA) and was described previously 
(Thomas et al., 1991). 
2.2.2 Cell culture and transfection 
293 cells were derived from human embryonic kidney cells and express Ad5 ElA 
and E1B proteins and so are 293T cells that also express large T antigen (Graham 
et al., 1977). Human C-33A (American Type Culture Collection HTB-31) are 
71 
from cervical carcinoma and are deficient for p53 expression. 293 and 293T were 
maintained in DME and C-33A were culture in a-modified Eagle medium, both 
supplemented with 10% fetal bovine serum and streptomycin sulfate-penicillin 
(100 U/ml). Transfections were performed by the calcium phosphate method as 
described (Gingras et al., 2002). Transfections were processed during 5 to 6 h in 
presence of chloroquine (25 IlM for 293T and 50 IlM for 293 and C-33A; Sigma-
Aldrich). For an experiments using 293T and C-33A, the cens were seeded on 
polylysine-coated culture dishes as described previously (Lavoie et al., 2000). 
2.2.3 In vivo localization, morphological assays and apoptosis assays 
Live cells expressing the various GFP fusion proteins were observed using a 
Nikon TE-300 inverted microscope equipped with a x60 0.85 MA objective. 
Images were captured as 16-bit TIFF files with a Micromax 1300YHS (B/W) 
cooled CCD camera (-30°C; Princeton Instruments) driven by Metamorph 
software version 4.5 (Univers al Imaging Corp.). Confocal microscopy was 
performed using a Bio-Rad MRC-1024 imaging system mounted on a Nikon 
Diaphot-TMD equipped with a x20 objective lens. The blebbing-inducing activity 
was measured in live cells, and apoptosis was determined after cell fixation by 
analyzing the nuclear morphology as described (Gingras et al., 2002). Aliquots of 
transfected cells were kept for Western blot analysis of protein expression. 
Immunodetection was performed as described (Lavoie et al., 2000). At the 
indicated times, cens were washed in PBS containing 1 mM MgClz, fixed in 
3.7% formaldehyde/PBS for 20 min and postfixation was performed in ice-cold 
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70% ethanol for 12 h at 4°C. Immunofluorescence analyses were performed using 
the following antibodies: chicken c-src (K295R) was revealed using rabbit anti-
SRC2 antibody (Santa Cruz Biotechnology); rabbit anti-GFP was used 
occasionally to label the GFP fusion proteins (CIONETECH Laboratories, Inc.); 
followed by either ALEXA-594- or ALEXA-488-labeled goat anti-rabbit, or 
anti-mouse immunoglobulin G (Molecular Probes). DNA was labeled using 
DAPI (Molecular Probes). 
2.2.4 Western blotting 
Cells were washed in PBS and lysed in SDS sample buffer (Lavoie et al., 2000). 
Equal amounts of total cell proteins (determined using the Bio-Rad De Protein 
Assay) were loaded in SDS-PAGE gels (12% acrylamide) and transferred onto 
nitrocellulose membrane. Blots were developed with mouse monoclonal anti-Flag 
M2 (Sigma-Aldrich), mouse Ab-l anti-v-src (Calbiochem; Novabiochem), or 
mouse HA.ll anti-HA antibody (BabCO). Horseradish peroxidase-linked goat 
anti-mouse immunoglobulin G (J ackson ImmunoResearch Laboratories), 
revealed by the enhanced chemiluminescence detection system (Renaissance; 
NEN Life Science Products) was used for detection. 
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2.3 Results 
2.3.1 Expression of Ad2 E4orf4 in cell membranes is sufficient to trigger a 
cytoplasmic death signal 
When expressed in mammalian cens, Ad2 E4orf4 shows a typical 
nucleocytoplasmic distribution and the onset of extranuclear apoptosis correlates 
with its accumulation in the cytoplasm and membranes (Fig. 2-1A) (Gingras et 
al., 2002; Lavoie et al., 2000). To address the significance of the nuclear versus 
the cytoplasm membranes distribution of E4orf4 for its killing function, E4orf4-
GFP proteins were engineered to target or enrich the protein in the different cell 
compartments, using specific targeting sequences (nuclear exclusion signal 
[NES], CAAX, myristylation [Myr], NLS) as described in Materials and methods 
(Fig. 2-1B). The blebbing-inducing activity in live cens and the appearance of 
nuclear condensation were measured in cens expressing comparable levels of the 
E4orf4 proteins in the proper cell compartments, in the three transformed cell 
lines 293T, 293, and C-33A. As expected, the GFP control proteins did not 
induce membrane blebbing or nuclear condensation over a period of 3 d (Figs. 2-
1C and 2-2). Remarkably, overexpression of the E4orf4-GFP-NES or the 
membrane-anchored E4orf4-GFP proteins (E4orf4-GFP-CAAX and Myr-GFP-
E4orf4) induced membrane blebbing to equivalent or even higher efficiency 
relative to the wild-type (WT) E4orf4-GFP protein (Fig. 2-2A; Table 2-1). 
Furthermore, nuclear condensation typical of that induced by WT E4orf4 was 
triggered by the cytoplasmic and membrane-anchored E4orf4 proteins (Fig. 2-
2A). In contrast, the nuclear E4orf4 (E4orf4-GFP-NLS) did not lead to early 
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Figure 2-1. GFP fusions and protein targeting 
(A) Immunostaining of transfected E4orf4 protein in H1299 cells using rabbit 
anti-2418 E4orf4 antibody; C, cell cytoplasm of a blebbing cell; N, nucleus. (B) 
GFP and E4orf4-GFP constructs engineered to target proteins to the cytoplasm 
(NES), to cell membranes (CAAX and Myr), and to the nucleus (NLS). (C) In 
vivo localization of GFP control proteins expressed in 293T cells (confocal 
micrographs). Protein targeting efficiencies were evaluated 24 h after transfection 
by counting positive cells expressing the GFP proteins in the targeted cell 
compartment, by fluorescence microscopy in live cells, n = 600. Bars, 10 Jlm. 
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Figure 2-2. Functional activities of the E4orf4-GFP proteins 
(A) 293T cens were transfected with the indicated Flag-E4orf4-GFP constructs 
(WT, NLS, NES, CAAX, and Myr), or with the relevant Flag-GFP controls 
(GFP, GNLS, GNES, GCAAX, and MyrG). At various times after transfection, 
the amounts of GFP-positive cens undergoing membrane blebbing were 
determined by fluorescence microscopy in live cens. Data are expressed as 
percent blebbing cens relative to the total number of GFP- positive cens. Other 
cultures of transfected cens were fixed and counterstained with DAPI and the 
nuclear morphology of GFP-positive cens was analyzed by fluorescence 
microscopy (representative phenotypes are shown). Apoptosis was determined by 
counting the number of cens expressing the relevant GFP proteins strictly in the 
targeted cen compartments that presented nuclear shrinkage and condensation 
(arrows). Data are expressed as the number of apoptotic cens relative to the total 
number of GFP-positive (means ± SE of at least four independent experiments, n 
> 2,000). Bars, 10 Jlm. (B) Aliquots of transfected cens were kept for Western 
blot analyses of expression levels using anti-Flag M2 antibody, or anti-GFP, 16-
24 h after transfection. 
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induction of membrane blebbing. Nevertheless, nuclear condensation was 
induced by E4orf4-GFP-NLS, but cell death was markedly delayed relative to 
that induced by WT and membrane-associated E4orf4-GFP (Fig. 2-2A). Thus, the 
results strongly suggest that membrane-associated E4orf4 directly signaIs 
membrane blebbing followed by rapid cell death, and that nuclear E4orf4 
in...,duces a distinct death process. 
Table 2-1: Targeting efficiencies and blebbing-inducing activities of the 
E4orf4-GFP proteins 
61 N=42 39 
N=65 18 N=91 3 
M=93 55 M=92 76 
n>600 n=500 n>150 
Transfection of the indicated GFP constructs was performed in 293T, 293, and C-33A, and the 
protein targeting efficiencies and blebbing-inducing activities (percentage blebbing) were 
determined by fluorescence microscopy in live cells 24 h after transfection; C, cytoplasmic; M, 
cell membranes; N, nuclear. 
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2.3.2 The cytoplasm membrane-associated and the nuclear Ad2 E4orf4 
death activities are distinct 
Recent work indicated that E4orf4-induced apoptosis involves dysregulation of 
Src family kinases (Lavoie et al., 2000). To delineate the mechanisms involved 
in induction of cell death mediated by the different E4orf4-GFP proteins, we 
therefore measured the effects of a kinase-deficient c-src and of a selective Src 
family kinase inhibitor, SU6656 (Blake et al., 2000), on apoptosis induced by 
both pathways. In agreement with our previous findings, overexpression of 
kinase-deficient c-src markedly inhibited the appearance of nuclear condensation 
in cells expressing the WT E4orf4-GFP (Lavoie et al., 2000) and a similar effect 
was measured in presence of SU6656 (Fig. 2-3). Importantly, these treatments 
also inhibited apoptosis induced by the E4orf4-GFP-CAAX, but not apoptosis 
induced by the nuclear E4orf4 (E4orf4-GFP-NLS) (Fig. 2-3). As another 
approach, the effect of Src-induced tyrosine phosphorylation of E4orf4 was also 
looked at (data not shown; Robert et al., 2002) since it has been shown to be a 
prerequisite for induction of the cytoplasmic death signal (Gingras et al., 2002). 
Briefly, a previously characterized nonphosphorylatable E4orf4 (3Y-F)-GFP, in 
which tyrosine 26, 42, and 59 are replaced by phenylalanines, was found to 
accumulate to higher levels in the cell nucleus and to induce delayed apoptosis in 
293T, 293 and C-33A cells. Furthermore, when the nonphosphorylatable mutant 
was targeted to the nucleus, no change was observed in apoptosis compared to 
the wild-type protein but when this same mutant was targeted to the plasma 
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membrane, apoptosis was significantl y abrogated indicating that expression of 
Ad2 E4orf4 in the cell nucleus is required to trigger the Src-independent cell 
death signal (Robert et al., 2002). Thus, both sets of results strongly suggested 
that the nuclear death pathway induced by E4orf4 was distinct from the Src-
regulated cytoplasmic pathway. 
2.4 Discussion 
When expressed in mammalian cells, Ad2 E4orf4 distributes in both the cell 
nucleus and the cytoplasm and membranes. The nuclear accumulation of Ad2 
E4orf4 is regulated at the molecular level through a stretch of basic residues 
spanning amino acids 68-75 (KRRDRRRR) that serves as an NLS (unpublished 
data), whereas its cytoplasmic accumulation likely results from a passive 
diffusion out of the nucleus. Indeed, the cytoplasmic distribution of the prote in is 
not affected by leptomycin B, an inhibitor of the CRMI-mediated nuclear export 
pathway (Ossareh-Nazari et al., 1997). It has been suggested that E4orf4 binding 
to Src kinases followed by tyrosine phosphorylation inhibits the nuclear import of 
E4orf4 and promotes its cytoplasmic retention (Gingras et al., 2002). Because the 
onset of the apoptotic response mediated by E4orf4 correlates better with its 
accumulation in the cell cytoplasm membranes, the relevance of E4orf4 nuclear 
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Figure 2-3. Role of Src kinases in regulation of both cell death pathways 
293T, 293, and C-33A cells were transfected with the indicated E4orf4-GFP 
constructs with or without c-src (K295R). The Src inhibitor SU6656 was added at 
a concentration of 1 IlM 6 h after the transfection. Apoptosis was evaluated after 
cell fixation and DAPI staining, couple to immunostaining of c-src (K295R). 
Data are expressed as the percent inhibition of apoptosis (of apoptotic nuclei) 
relative to cells expressing equivalent levels of E4orf4-GFP proteins only (means 
± SE of two independent experiments). Aliquots of transfected cells were kept for 
Western blot analyses of E4orf4-GFP (anti-Flag M2) and c-src (K295R) (anti-v-
src Abl). The effect of SU6656 was determined only in those cells expressing 
equivalent levels (intensity) of GFP proteins in presence and absence of the 
inhibitor and data are representative of two independent experiments, n > 800. 
Bar, 10 !lm . 
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localization for cell killing is somewhat unclear. Surprisingly, E4orf4 targeting to 
different cell compartments has uncovered a delayed novel killing function 
associated with its nuclear localization. This approach also confirmed that the 
presence of E4orf4 in the cell cytoplasm membranes is necessary and sufficient 
for triggering the Src-regulated cytoplasmic death signal that rapidly leads to cell 
death. Several observations indicated that the cell death pathway induced by 
nuclear E4orf4 is functionally distinct. When expressed in 293T, C-33A, or 293 
ceIls, the E4orf4-GFP-NLS was mainly nuclear in the majority of cells over a 
period of 3 d. Presumably, the strong NLS from large T antigen took over the 
natural molecular determinants of Ad2 E4orf4 localization and allowed for 
continuaI import of the fusion protein into the cell nucleus, at least in the cell 
types used. In these ceIls, the onset of apoptosis was not associated with a 
dramaticextranuclear apoptotic phase (early membrane blebbing), didnot require 
tyrosine phosphorylation of E4orf4 nor Src kinase activity, and was markedly 
delayed relative to the cytoplasmic Src-regulated cell death pathway. Although 
fluorescence microscopy is not sensitive enough to exclude the possibility that 
small amounts of E4orf4-GFP-NLS may accumulate in the cytoplasm to sorne 
extent, altogether, the data presented here strongly support the existence of two 
distinct E4orf4-mediated cell death pathways and make it very unlikely that 
delayed apoptosis resulted from protein leakage out of the nucleus. We therefore 
propose that Ad2 E4orf4 triggers two caspase-independent cell death programs 
that rely on distinct death effectors for execution. A Src-regulated death pathway 
requires E4orf4 accumulation in the cell cytoplasm membranes. A distinct Src-
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independent death signal results from E4orf4 accumulation in the cell nucleus 
and is mediated by unknown death effectors. We believe that the contribution of 
either pathway to cell death will be determined by the availability of specific 
targets of Ad2 E4orf4 and the activity of signaling pathways involved in a given 
transformed cell types Ce.g., Srckinases). Accordingly, the low killing efficacy of 
the nuclear E4orf4 in 293T relative to 293 cells may result from a decreased 
accessibility of sorne critical nuclear target of E4orf4, which may be sequestered 
by simian virus large T antigen. Nevertheless, the contribution of Src kinases and 
the role of E4orf4 tyrosine phosphorylation have been firmly assigned 
exclusively to regulation of the cytoplasmic pathway. It remains to be determined 
whether PP2A is involved in the Src-regulated cytoplasmic, and/or the nuclear 
cell death pathways mediated by E4orf4, and whether the tumor-selective killing 
of Ad2 E4orf4 can be assigned to one specific pathway or both. Nevertheless, the 
data obtained using E4orf4 as a model system suggest that specific modulation of 
Src family kinases may induce efficient tumor-selective cell death. 
In future work, we hope to clarify the mechanisms that may mediate calpain 
activation by E4orf4-Src signaling and the downstream events that trigger 
caspase-independent and -dependent apoptotic alterations. 
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CHAPTER 3: NUCLEAR LOCALIZATION OF THE 
ADENOVIRUS E40RF4 PROTEIN IS MEDIATED 
THROUGH AN ARGININE-RICH MOTIF AND 
CORRELATES WITH CELL DEATH 
3.1 Introduction 
Previous studies indicated that one of the products of the early region 4 (E4) 
transcription unit of human adenoviruses, termed E4orf4, induces p53-
independent cell death in human cancer cells (Marcellus et al., 1998; Shtrichman 
and Kleinberger, 1998) but not in normal human primary cells (Shtrichman et al., 
1999). E4orf4 was also found to be toxic in Saccharomyces cerevisiae (Afifi et 
al., 2001; Roopchand et al., 2001; Shtrichman et al., 2000). In both human and 
yeast cells, cell killing appears to require interactions with the Ba/Cdc55 subunit 
of protein phosphatase 2A (PP2A) (Afifi et al., 2001; Marcellus et al., 2000; 
Roopchand et al., 2001; Shtrichman et al., 2000). E4orf4-dependent death of 
human cancer cells is associated with sorne hallmarks of apoptosis, including in 
certain cases induction of caspases (Livne et al., 2001; Robert et al., 2002); 
however, caspase activation does not seem to be essential (Lavoie et al., 2000; 
Lavoie et al., 1998; Livne et al., 2001; Robert et al., 2002). Thus E4orf4 appears 
to kill by a caspase-independent pathway. 
Previous work has suggested that while E4orf4 is present largely in cell nuclei, it 
can also be detected in the cytoplasm and cell membranes at later times following 
expression (Robert et al., 2002). Localization of E4orf4 to the cytoplasm 
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correlates with cell death (Gingras et al., 2002; Robert et al., 2002) and appears 
to occur via a mechanism involving tyrosine phosphorylation, recruitment of c-
Src, as weIl as activation of calpains (Gingras et al., 2002; Lavoie et al., 2000; 
Robert et al., 2002). Although E4orf4 nuclear targeting correlates with cell death, 
the mechanisms regulating this nuclear activity remain unknown. Indeed, it was 
suggested that this activity may be related to the induction of a G2/M arrest (Ben-
Israel and Kleinberger, 2002; Komitzer et al., 2001; Robert et al., 2002; 
Roopchand et al., 2001). 
To understand the functional relevance of the ARM of E4orf4, we studied its 
function and effect on the subcellular distribution as weIl as on the killing activity 
of E4orf4. We identified a lO-amino-acid ARM in E4orf4 (E4ARM) that is 
highly similar to the ARM found in HIV-1 Tat and Rev and in the Rex protein of 
HTLV-1, and that when fused to green fluorescent protein (GFP) induced both 
nuclear and nucleolar targeting. Analysis of point mutations in E4ARM indicated 
that this sequence is necessary and sufficient to target heterologous proteins and 
full-Iength E4orf4 to the nucleus and nucleolus, and that the targeting properties 
of E4ARM are based on its overall positive charge rather than on the presence of 
specifie arginine residues. FinaIly, we showed that mutations in full-Iength 
E4orf4 correlate with a loss of E4orf4-dependent cell death, and that 
coexpression of any of three different ARM sequences, namely GFP-E4ARM, 
GFP-TatARM or GFP-RevARM, along with E4orf4 inhibits E4orf4-mediated 
cell death. Therefore, our results establish that E4orf4 nuclear localization is 
mediated by E4ARM and is critical for the onset ofE4orf4-induced cell death. 
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3.2 Materials and Methods 
3.2.1 CeU culture, DNA transfection, protein expression 
Human H1299 cells (ATCC CRL-5803), which are deficient for p53, were 
cultured in a-minimal essential medium (a-MEM) (Bio-Whittaker) 
supplemented with 10% fetal bovine serum (Bio-Whittaker), 100 U of penicillin 
and streptomycin/ml, and 0.292 mg L-glutamine/ml. DNA transfections were 
performed using the liposome reagent DMRIE-C (Gibco-BRL), as described by 
the manufacturer. 1 Jlg of cDNA was transfected in each assay except in the co-
expression assay (fig. 8) where a total of 3 Jlg was transfected following a ratio of 
1:3 of HA-E4orf4:ARM cDNA. Protein expression was normally assayed at 24 
or 48 h post-transfection. 
3.2.2 Expression vector and mutagenesis 
Preparation of cDNAs expressing Flag-GFP and Flag-E4orf4-GFP has been 
described elsewhere (Robert et al., 2002). Preparation of Flag-E4orf4 (amino 
acids 1-63)-GFP designated Flag-E4(NT)-GFP and of Flag-E4orf4 (amino acids 
64-114)-GFP designated Flag-E4(CT)-GFP were obtained by PCR using Flag-
E4orf4-GFP as template DNA and the forward and reverse oligonucleotides 5'-
CGC GGA TCC GCG GGC CCA CAG AGC GAG CTA AGC GAC GA-3', and 
5'-GCA GAA TTC CTC GAG CTG TAC GGA GTG CGC-3', respectively. The 
resulting fragments were digested with ApaI and XhoI and inserted into ApaI-
XhoI sites of the Flag-GFP vector (Robert et al., 2002). Preparation of cDNAs 
expressing GFP or GFP-HA-E4orf4 has been described elsewhere (Brignole et al. 
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2003, submitted). To generate constructs expressing GFP-E4(62-79), GFP-
E4(66-75) (also designated GFP-E4ARM), GFP-TatARM or GFP-RevARM the 
GFP-specific cDNA sequence was excised from vector EGFP-Cl (Clontech) by 
standard PCR techniques with the addition of the appropriate amino acid codon 
sequences as well as flanking BamHl (5') and EcaRl (3') restriction enzyme 
sites. The sense oligonuc1eotide was 5'-CGC GGA TCC ATG GTG AGC AAG 
GGC GAG GAG-3', and the reverse oligonuc1eotides were 5'-CGC GAA TIC 
CTA GTG ACA AAC AGA TCT GCG TCT CCG GTC TCG TCG CTI AGC 
TCG CTC TGT GTA GTA CTI GTA CAG CTC GTC CAT GCC GAG AG-3'; 
5' -CGC GAA TIC CTA TCT GCG TCT CCG GTC TCG TCG CTI AGC TCG 
CTI GTA CAG CTC GTC CAT GCC-3'; 5'-CGG AAT TCC TAT TGA TGA 
GCT CTI CGT CGC TGT CTC CGC TIC TIC CTG CCC TIG TAC AGC 
TCG TCC ATG CCG AGA GTG'3' and 5'-CGG AAT TCC TAT CTC TGT 
CTC TCT CTC CAC CTI CTI CTI CTA TIC CTI CGG GCC TGT CGC 
TIG TAC AGC TCG TCC ATG CCG AGA GTG-3', respectively. The GFP-
E4(62-95) construct was generated as mentioned above using the GFP-E4(62-79) 
construct as a template, using the forward oligonuc1eotide described above and 
the following reverse nuc1eotide: 5'-CGC GAA TIC CTA GGA ACG CCG 
GAC GTA GTC ATA TTI CCT GAA GCA AAA CCA GGT GCG GGC GTG 
ACA AAC AGA TCT G-3'. Digested PCR products were aIl c10ned into 
pCDNA3. The PCR Quick Change technique (Stratagene) was used to generate 
the GFP-(E4ARM)R69-R70A, GFP-(E4ARM)R74-R75A constructs using GFP-
E4ARM as a template and appropriate altered oligonuc1eotides. Similarly, the 
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GFP-(E4ARM)R66A-R70A and GFP-(E4ARM)R72A-R75A constructs were 
generated using the GFP-(E4ARM)R69A1R70A and GFP-(E4ARM)R74A1R75A 
constructs, respectively, as templates. Constructs expressing GFP-
(E4ARM)R66K, GFP-(E4ARM)R66-70K, GFP-(E4ARM)R66-73K and GFP-
(E4ARM)R66-75K were generated using the PCR Quick Change technique 
(Stratagene). GFP-(E4ARM)R66K was generated using GFP-E4ARM as the 
template and 5' -GAG GAG CTG TAC AAG AAA GCT AAG CGA CGA GAC-
3' and 5'-GTC TCG TCG CTT AGC TTT CTT GTA CAG CTC GTC-3' as the 
forward and reverse oligonuc1eotides, respectively. GFP-(E4ARM)R66-70K was 
generated using GFP-(E4ARM)R66K as the template and 5'-G TAC AAG AAA 
GCT AAG AAA AAA GAC CGG AGA CGC AG'3' and 5'-CT GCG TCT CCG 
GTC TTT TTT CTT AGC TTT CTT GTA C-3' as the forward and reverse 
oligonuc1eotides, respectively. GFP-(E4ARM)R66-73K was generated using 
GFP-(E4ARM)R66-70K and 5' -GCT AAG AAA AAA GAC AAG AAA CGC 
AGA TAG GAA TTC-3' and 5'-GAA TTC CTA TCT GCG TTT CTT GTC 
TTT TTT CTT AGC-3' as the forward and reverse oligonuc1eotides, 
respectively. GFP-(E4ARM)R66-75K was generated using GFP-(E4ARM)R66-
73K as the template and 5' -GAA AAA AGA CAA GAA AAA GAA AT A GGA 
ATT CTG CAG-3' and 5'-CTG CAG AAT TCC TAT TTC TTT TTC TTG 
TCT TTT TTC-3' as the forward and reverse oligonuc1eotides, respectively. 
Myc-PK was a kind gift from Gideon Dreyfuss and has been described elsewhere 
(Siomi and Dreyfus s, 1995). The construct expressing myc-PK-E4ARM was 
prepared by inserting amino acids 66 to 75 of E4orf4 in the myc-PK vector using 
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standard PCR technique. Myc-PK was used as the template and 5' -CTG GTG 
TCC CGG TAC CGC CCG CGG-3' and 5'-ATA GTT TAG CGG CCG CTC 
ATC TGC GTC TCC GGT CTC GTC GCT TAG CTC GTG GCA CGG GCA 
CCA CCC GCA TGG TGT TGG T-3' as the forward and reverse 
oligonucleoltides, respectively. The resulting fragment was digested with KpnI 
and NotI and inserted in the KpnI-NotI sites of the myc-PK vector. AlI constructs 
were verified by DNA sequencing. HA-E4orf4, HA-E4orf4-R73-75A and HA-
E4orf4-R69-75A have been described elsewhere (Marcellus et al., 2000). 
Likewise, fusion of GFP to these mutants has also been described elsewhere 
(Szymborski et al., submitted). HA-E4orf4-R66-73K was made much like GFP-
(E4ARM)R66-73K as described above using subsequently HA-E4orf4-R66K and 
HA-E4orf4-R66-70K as templates (Miron and Branton, unpublished) and 5'-
GAC AAA GCT AAG AAA AAA GAC AAG AAA CGC AGA TCT GTT TGT 
CAC GCC-3' and 5' -GGC GTG ACA AAC AGA TCT GCG TTT CTT GTC 
TTT TTT CTT AGC TTT GTC-3' as the forward and reverse oligonucleotides, 
respectively. 
3.2.3 Microscopy 
For in vivo localization studies, live cells expressing the various GFP fusion 
proteins were observed using a Zeiss LSM 510 Axiovert 100M confocal 
microscope equipped with a Plan-Achromat 63X11.4 oil DIC objective. Samples 
were scanned at a speed of 8 using the linear mode and the mean method as weIl 
as a pinhole of 106 (optical slice < 2.2 um) and a zoom setting of 2. 8 scans were 
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compiled and averaged by the computer software to give the final image, which 
was captured as an 8-bit TIF file. For aIl pictures, the detector gain was set 
between 800-1000 while the amplifier offset and the amplifier gain were set at -
150 and 1, respectively, so as to ensure that all signaIs were recorded the same 
way. The palette tool was also used to ensure that the signaIs recorded did not 
reach pixel saturation. The intensity of fluorescence signaIs was recorded in the 
cytoplasm, nucleus and nucleoli of ceIls after the pictures were taken using the 
profile tool available with the Zeiss 510 software. Briefly, a line was randomly 
drawn through each picture representing 1 plane of a ceIl taken about halfway 
through the ceIl thickness (at around 5 um). Markers were set in the cytoplasm, 
nucleus or nucleolus along this line and fluorescence signals were recorded. In 
order to account for variations in fluorescence intensities from one ceIl to 
another, measurements were taken in the cytoplasm, nucleus and nucleoli of each 
cell and cytoplasmic/nuclear or nucleolar/nuclear ratios were computed. A total 
of 30 measurements were taken for each sample, in each cell compartment, 
across at least 3 different experiments. Standard deviation and statistical analysis 
was performed using Microsoft Excel to ensure that aIl results were significant. 
Immunofluorescence studies using the myc-PK and myc-PK-E4ARM vectors 
was performed as described elsewhere (Szymborski et al., submitted) using anti-
c-myc (9ElO) antibody (Covance) foIlowed by anti-mouse antibody conjugated 
to ALEXA 594 (Molecular Probes). Nuclei were stained using 6'diamidino-2-
phenylindole (DAPI). For light microscopy ceIl morphology was observed using 
a Zeiss Axiovert 25 microscope equipped with a LD A-PLAN 20XlO.3 PhI 
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objective. Images were recorded using a Carl Zeiss Vario-Sonnar, 
MPEGMOVIE EX, digital still camera DSC-S75. 
3.2.4 Cell death assays 
Colony formation assays have been described elsewhere (Marcellus et al., 2000). 
Briefly, cells were grown in 6-well culture dishes and transfected with 
appropriate cDNAs. At 24 h following transfection cells were collected, diluted 
and aliquots were plated onto 60-mm culture dishes in triplicate and cells 
expressing the transfected plasmids were selected with geneticin (Sigma) for 15 
days. Colonies were then fixed, stained and counted. For competition of HA-
E4orf4 and GFP-E4ARM, GFP-TatARM or GFP-RevARM, cells were grown in 
6-well culture dishes and transfected with the appropriate cDNAs. At 48 h 
following transfection, cells were photographed, washed in PBS, and the total 
protein content was extracted from the cells for western blotting. 
3.2.5 Western blotting 
Cells were washed in phosphate-buffered saline (PBS) and lysed on ice in lysis 
buffer (20mM Tris-HCl, pH 7.5, 150mM NaCI, 2mM EDTA and 1 % Triton X-
100) containing protease inhibitors. Protein content was quantified using Bio-
Rad reagent (Bio-Rad) and equal amounts were separated by SDS-
polyacrylamide gel electrophoreses (SDS-PAGE). Proteins were transfered to 
PVDF membranes and probed using mouse anti-HA antibody (Babco), mouse 
anti-tubulin antibody (Sigma), or mouse anti-GFP antibody (Santa-Cruz). 
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r--- .. Visualization was completed using a goat anti-mouse antibodies conjugated to 
horseradish peroxidase (HRP) (Jackson ImmunoResearch) followed by enhanced 
chemiluminescence (ECL) detection (NEN Life Science Products). 
3.3 Results 
3.3.1 The carboxy-terminus of E40rf4 targets both to the nucleus and 
nucleoli 
E4orf4 is known to have a nuclear and cytoplasmic distribution when expressed 
in mammalian cells, although nuclear localization is more prominent early 
following expression (Robert et al., 2002). To determine if E4orf4 contains a 
nuclear targeting sequence, a construct was generated that encodes Green 
Fluorescent Protein (GFP) fused to the carboxy terminus of E4orf4. In addition, 
cDNAs were prepared that encode the amino terminal half [residues 1-63; Flag-
E4orf4(NT)-GFP] and the carboxy terminal half [residues 64-114; Flag-
E4orf4(CT)-GFP] of Flag-E4orf4 fused to GFP (Fig. 3-1A). These cDNAs were 
transfected into human H1299 cells and localization of their products examined 
by direct fluorescence microscopy. Fig. 3-1B shows that whereas Flag-GFP 
alone was present throughout the cell, apart from nucleoli, Flag-E4orf4-GFP was 
largely nuclear, as found previously (Gingras et al., 2002; Lavoie et al., 2000; 
Lavoie et al., 1998; Robert et al., 2002). Flag-E4orf4(NT)-GFP had a similar 
distribution to Flag-GFP alone; however, Flag-E4orf4(CT)-GFP was present 
largely in the nucleus, with a clear accumulation in nucleoli. These 
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Figure 3-1: Analysis of the localization of the amino- and carboxy-terminal 
halves ofE4orf4 
H1299 cells were transfected with cDNAs expressing Flag-E4orf4-GFP, Flag-
E4orf4(NT)-GFP or Flag-E4orf4(CT)-GFP and were examined at 24 h post-
transfection. Fig. 3-1A - Schematic representation of proteins (not to scale). 
Open boxes represent E4orf4 protein sequences while shaded boxes indicate Flag 
or GFP sequences. The numbers above indicate the specifie E4orf4 residues 
involved. Fig. 3-1B - Subcellular localization as seen by direct fluorescence 
microscopy. The scale bar indicates 20 um. 
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results indicated that the region required for nuclear localization resides in the 
carboxy terminus of E4orf4. Further, they suggest that this region may contain a 
NoLS that may be less active in full-Iength E4orf4 (compare Flag-E4orf4-GFP 
and Flag-E4orf4(CT)-GFP). Alternatively, these results suggest that residues 
such as tyrosines present in the amino terminus of the protein may play an 
important role in causing full-Iength Flag-E4orf4-GFP to localize outside the 
nucleus and nucleoli, as has been suggested in other studies (Gingras et al., 
2002). 
3.3.2 E4ARM directs E4orf4 nuclear and nucleolar localization 
Fig. 3-2 shows that the E4orf4 carboxy terminus contains an extended arginine-
rich sequence from amino acids 66-75 that resembles more the NLS-NoLS found 
in HN-1 Tat and Rev and HTLV-1 Rex than the SV40 LT NLS. To determine if 
this region is involved in nuclear and nucleolar targeting, cDNAs were generated 
that encode fusion products containing GFP linked to increasing deletions from 
the E4orf4 carboxy terminus, or to the ARM of Tat or Rev (Fig. 3-3A). Fig. 3-
3B shows again that full-Iength GFP-HA-E4orf4 was present at low levels in the 
cytoplasm, with much higher amounts in the nucleus and with no major 
accumulation in nucleoli. Elimination of the amino terminal 61 residues and 
amino acids 96-114 at the carboxy terminus of E40rf4 produced a striking effect 
in that no GFP-E4orf4(62-95) was evident in the cytoplasm and high levels were 
present in the nucleus, particularly in nucleoli. This pattern was similar to that 
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Figure 3-2: Comparison of the ARM of E4orf4 (E4ARM) with the ARM of 
other viral proteins 
The sequence of the E4orf4 E4ARM is shown at the top, and below are those of 
the ARM of HIV-l Tat and Rev and HTLV-l Rex, and the NLS of SV40 LT. 
The numbers above identify residue positions. Identical residues are underlined 
while positively-charged residues are in boldo 
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Figure 3-3: Identification of the E4orf4 NLS-NoLS 
H1299 cells were transfected with cDNAs expressing the GFP fusion products 
indicated in the figure. Fig. 3-3A - Schematic representation of fusion products 
(not to scale). Open boxes represent E4orf4 prote in sequences white shaded 
boxes represent GFP, HA or TatARM or RevARM sequences, and black boxes, 
the E4ARM of E4orf4. Vertical lines indicate regions that may be involved in 
nuc1ear localization. (b) Subcellular localization of fusion products. Direct 
fluorescence microscopy was as in Fig. 1 B. The scale bar indicates 20 um. 
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observed in Fig. 3-1 with E4orf4 residues 64-144 (Flag-E4orf4(CT)-GFP) and to 
that presented in Fig. 3-3B for GFP-RevARM, and suggested that the presence of 
amino terminal sequences in E4orf4 greatly reduces localization to nucleoli and 
somewhat enhances cytoplasmic localization. Fig. 3-3B shows that the further 
removal of residues 76-95 [GFP-E4(62-79) and GFP-E4(66-75)] enhanced the 
cytoplasmic localization of the GFP fusion products resulting in a localization 
pattern similar to that of GFP-TatARM, although sorne targeting to both the 
nucleus and nucleoli was retained. Thus these results suggested that residues 62-
95 are sufficient for both nuclear and nucleolar targeting and that this targeting 
pattern resembles that of GFP-RevARM. Residues 66-75, on the other hand, 
appeared sufficient for nucleolar targeting but residues 80-95 also seem to be 
required for more efficient nuclear targetinglretention. In addition, nuclear and 
nucleolar targeting by residues 66-75 resembles that of GFP-TatARM. The close 
proximity of E4ARM to the amino acids 80-95 suggests that the NLS and NoLS 
of E4orf4 overlap. 
GFP is a rather small protein (27 KDa) and thus potentially capable of diffusion 
in and out of the nucleus when fused to localization signaIs. Consequently, we 
also studied the ability of the E4ARM to target a much larger protein, pyruvate 
kinase (PK; 90kDa) to the nucleus and nucleoli. PK has been used for such a 
purpose in other localization studies (Dang and Lee, 1989; Kalderon et al., 1984; 
Siomi and Dreyfuss, 1995) and thus was fused to E4ARM, as shown in Fig. 3-
4A. Fig. 3-4B shows results obtained in which cDNAs expressing myc-PK-
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Figure 3-4: Targeting of pyruvate kinase (PK) by the E4ARM. H1299 were 
transfecled with cDNAs expressing myc-tagged PK and a myc-tagged PK-
E4orf4 fusion product (myc-PK-E4ARM) 
LoealizAtion of PK was detennined by immunofluorescence (IF), and cells were 
also stained with DAPI, as deseribed in Materials and Methods. Fig. 3-4A -
Sehematie representation of proteins (not to seale). Fig. 3-4B - IF and DAPI. 
The seale bar indieates 20 Uffi. 
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E4ARM were transfected into H1299 cells and subcellular localization evaluated 
by indirect immunofluorescence. Clearly myc-PK was present exclusively in the 
cytoplasm, as seen in other studies (Dang and Lee, 1989; Kalderon et al., 1984; 
Siomi and Dreyfuss, 1995), whereas significant amounts of myc-PK-E4ARM 
were present in nucleoli. Thus these results confirm that the E4ARM functions 
as a NLS-NoLS that can actively transport heterologous proteins through to the 
nucleus to nucleoli. 
3.3.3 Nuclear and nucleolar targeting depends on the overall positive charge 
ofE4ARM 
Studies on SV40 LT NLS have shown that nuclear targeting is lost upon 
alteration of a single basic residue (Kalderon et al., 1984). To examine the role 
of individual arginine residues in the E4ARM, a series of alanine substitutions 
(Fig. 3-5A) were introduced and the localization of wild-type and mutant GFP-
E4ARM was examined by fluorescence microscopy. Substitution of alanine 
residues at R69 and R70, or R74 and R75 reduced but did not eliminate nucleolar 
accumulation [Fig. 3-5B, GFP-(E4ARM)R69-70A and GFP-(E4ARM)R74-75A, 
respectively]; however, alanine substitutions at three arginine residues at the 
carboxy end of E4ARM or four arginine residues at either the amino or carboxy 
ends of the E4ARM resulted in complete exclusion from nucleoli [Fig. 3-5B, 
GFP-(E4ARM)R73-75A, GFP-(E4ARM)R66-70A and GFP-(E4ARM)72-75A, 
respectively]. These results demonstrated the importance of these positively-
charged residues in nucleolar targeting. Moreover, Fig. 3-5A and 3-5B also show 
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Figure 3-5: Targeting of GFP by alanine or lysine substitution mutants in 
E4ARM 
H1299 cells were transfected with cDNAs expressing various substitution 
mutants of the E4ARM fused to GFP. Fig. 3-5A - List of E4ARM mutants. Fig. 
3-5B - Subcellular localization by direct fluorescence microscopy. The scale bar 
indicates 20 um. 
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results in which lysine substitutions were introduced in place of one [GFP-
(E4ARM)R66K], three [GFP-(E4ARM)R66-70K], five [GFP-(E4ARM)R66-
73K] or seven arginine residues [GFP-(E4ARM))R66-75K]. These changes had 
no effect on nucleolar targeting. Thus function of the E4ARM depends strictly 
on the presence of sufficient positive charge, regardless whether arginine or 
lysine is present. 
3.3.4 Mutation of E4ARM results in a loss of nuclear and nucleolar 
localization 
To detennine if the E4ARM plays a role in the localization of full-Iength E4orf4 
to the nucleus and nucleoli, the presence of mutant fonns of GFP-HA-E4orf4 
containing alanine substitutions at critical arginine residues within the E4ARM 
(Fig. 3-6A) was studied quantitatively using high resolution confocal laser 
scanning microscopy. H1299 cells were transfected with cDNAs encoding GFP, 
GFP-HA-E4orf4, GFP-HA-E4orf4-R73-75A or GFP-HA-E4orf4-R69-75A, and 
cytoplasmic, nuclear and nucleolar fluorescence was measured. 
Cytoplasmic/nuclear or nucleolar/nuclear ratios were then computed in order to 
account for nuclear and nucleolar localization, respectively (see Materials and 
Methods for details). Fig. 3-6B shows that GFP-HA-E4orf4 was significantly 
enriched in the nucleus and nucleoli compared to GFP (p<0.00015). Indeed, 
ratios of 3.63 and 0.78 were obtained for the nuclear and nucleolar localization of 
GFP-HA-E4orf4, respectively, compared to 1.05 and 0.49 for the nuclear and 
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Figure 3-6: Nuclear and nucleolar localization of full-length E40rf4 and 
E40rf4 E4ARM mutants fused to GFP 
Figs. 3-6A and B - H1299 cells were transfected with cDNAs expressing GFP, 
GFP-HA-E4orf4, GFP-HA-E40rf4-R73-75A or GFP-HA-E4orf4-R69-75A and 
cells were examined by direct fluorescence microscopy. Regions of the 
cytoplasm, the nucleus and nucleoli were also anaIyzed by high resolution 
confocaI laser scanning microscopy using the appropriate software to measure 
the intensity of the fluorescence signal, as described in Materials and Methods. 
Fig. 3-6A - Schematic representation of full-Iength GFP-HA-E4orf4, GFP-HA-
E4orf4-R73-75A or GFP-HA-E4orf4-R69-75A (not to scaIe). The upper 
sequence indicates the residues comprising the wild-type E4ARM while lower 
sequences indicate the residues comprising the mutant E4ARM with mutations in 
bold characters. Fig. 3-6B - Representative micrographs of cells expressing GFP, 
GFP-HA-E4orf4, GFP-HA-E4orf4-R73-75A or GFP-HA-E4orf4-R69-75A; 
Summary of the intensity of the fluorescence signaIs recorded. Measurements of 
fluorescence in the cytoplasm, nucleus and nucleoli of a total of 30 cells observed 
in at least three separate experiments were obtained and the cytoplasmic/nuclear 
or nucleolar/nuclear ratios were ca1culated (p<0.00015) as described in Materials 
and Methods. GFP-HA-E4orf4, GFP-HA-E4orf4-R73-75A and GFP-E4orf4-
R69-75A are aIso designated as G-WT, G-R73-75A and G-R69-75A, 
respectively. The scale bar indicates 20 um. 
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nucleolar localization of GFP, respectively. However, this enrichment appeared 
to decrease significantly (p<0.00015) in both compartments when the E4ARM of 
E4orf4 was mutated. Ratios of 2.05 and 0.33 were obtained for the nuclear and 
nucleolar localization of GFP-HA-E4orf4-R73-75A, respectively, and of 1.74 
and 0.26 for the nuclear and nucleolar localization of GFP-HA-E4orf4-R69-75A, 
respectively, compared to 3.63 and 0.78 for the nuclear and nucleolar localization 
of the wild-type protein fused to GFP, respectively. Similar results were 
obtained for the HA-tagged proteins (data not shown). These results therefore 
suggested that the E4ARM functions to target E4orf4 to the nucleus and nucleoli. 
Mutation of additional basic residues clustered between residues 80-95 (Fig. 3-
3B) of E4orf4 may be required to get better exclusion of the protein from the 
nucleus. 
3.3.5 Exclusion of E4orf4 from the nucleus and nucleoli correlates with 
reduced cell death 
To examine the effect of altering the E4ARM on induction of ceIl death by 
E4orf4, H1299 ceIls were transfected with cDNAs expressing HA-tagged wild-
type E4orf4, or the mutant forms described in Fig. 3-6A, or with empty vector 
DNA that harbors the neomycin resistance gene. After 24 h the ceIls were 
harvested and diluted and equal numbers of ceIls were replated in triplicate and 
grown for 15 days in the presence of geneticin to measure ceIl killing by 
inhibition of colony formation, much as described previously (Marcellus et al., 
2000). Fig. 3-7B (inset) shows that aIl E4orf4 species were expressed in these 
106 
cells, as detennined by western blotting using anti-HA antibody. Fig. 3-7 A 
shows the typical colony fonnation obtained with control DNA (high number of 
colonies, thus no cell killing), wild-type HA-E4orf4 (few colonies, thus a high 
degree of cell killing), and the two mutants. Fig. 3-7B shows that both E4ARM 
mutants were significantly reduced in toxicity relative to wild-type (38% and 
55% cell growth for HA-E4orf4-R73-75A and HA-E4orf4-R69-75A, 
respectively, compared to 16% for HA-E4orf4; p<0.015), suggesting that nuclear 
and nucleolar targeting may be of importance in induction of cell death. We 
were concerned that, in addition to functioning as a nuclear/nucleolar targeting 
sequence, the E4ARM region might also be involved in other functions of 
E4orf4, including protein-protein interactions with key targets. We therefore also 
examined the toxicity of mutant HA-E4orf4-R66-73K in a similar colony 
fonnation assay. This mutant contains lysine substitutions for five of the seven 
critical arginine residues in the E4ARM, and although differing in sequence from 
wild-type, this mutant fonn of the E4ARM was shown in Fig. 3-5B to target GFP 
very efficiently to the nucleus and nucleoli, presumably due to its overall highly 
basic charge. Fig. 3-7B shows that HA-E4orf4-R66-73K kills about as well as 
wild-type HA-E4orf4 (20% compared to 16%, respectively; p<0.015). Thus 
again these results support the contention that nuclear and nucleolar targeting 
may be of importance in induction of cell death by E4orf4. 
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Figure 3-7: Cell killing induced by wild-type and E40rf4 E4ARM mutants 
H1299 cells were transfected with cDNAs expressing wild-type HA-E4orf4 or 
mutants HA-E4orf4-R73-75A and HA-E4orf4-R69-75A or empty vector (EV), 
which harbors the neomycin resistance gene, and cells were replated and grown 
in the presence of G418, as described in Materials and Methods. The number of 
colonies were counted after 15 days. Fig. 3-7 A - Representative colony assays. 
Fig. 3-7B - Summary of colony inhibition data (number of colonies with empty 
vector control set at 100%). Values represent the average of five separate 
experiments, each containing samples done in triplicate. The inset shows 
expression of E4orf4 species and tubulin, as determined by western blotting 
using anti-HA or anti-tubulin antibodies. HA-E4orf4, HA-E4orf4-R73-75A and 
HA-E4orf4-R69-75A are also designated as WT, R73-75A, R69-75A and R66-
73K, respectively. 
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The role of the E4ARM in cell killing was also investigated using another 
approach. H1299 cells were cotransfected with cDNAs expressing wild-type 
HA-E4orf4 and GFP-E4ARM, GFP-TatARM or GFP-RevARM. We believed it 
reasonable that if nuclear/nucleolar targeting was functionally important in 
E4orf4-induced cell killing that overexpression of the E4ARM and perhaps other 
ARM sequences might compete with the endogenous E4ARM for nuclear and/or 
nucleolar targeting factors, thus affecting E4orf4 localization and cell killing. 
Approximately 60% of the cells were transfected in this experiment, as observed 
by fluorescence microscopy (data not shown). Cell killing was measured using a 
short-term assay that takes advantage of our earlier observations that E4orf4-
induced killing is associated with a rapid rounding of cells (Marcellus et al., 
2000) as weIl as induction of membrane blebbing (Robert et al., 2002). Fig. 3-
8A shows the effects of co-expression of GFP-E4ARM, GFP-TatARM or GFP-
Rev ARM expression on the induction of cell rounding and membrane blebbing 
by E4orf4 while Fig. 3-8B shows the expression of the various protein species by 
western blotting. Fig. 3-8A shows that cells expressing HA-E4orf4 and only 
empty vector DNA (EV), or both HA-E4orf4 and GFP, undergo extensive 
rounding and membrane blebbing typical of E4orf4-induced cell death (Robert et 
al., 2002). In marked contrast, cells expressing both HA-E4orf4 and GFP-
E4ARM, GFP-TatARM or GFP-RevARM exhibited very little of these death-
related markers and appeared to have a flatter morphology much like the empty 
vector control (EV). Hence, co-expression of GFP-E4ARM, GFP-TatARM or 
GFP-RevARM effectively blocked E4orf4-induced morphological cell death 
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Figure 3-8: Effect of overexpression of the ARM of Ad E40rf4, mV-l Tat or 
mV-l Rev on cell killing by full-Iength HA-E40rf4 
H1299 cells were co-transfected with cDNAs expressing HA-E4orf4 (or empty 
vector) along with cDNAs expressing either GFP or GFP-E4ARM, GFP-
TatARM or GFP-RevARM at a ratio of 1:3 as described in Materials and 
Methods. After 48 h cell morphology was examined by light microscopy. Fig. 
3-8A - Light microscopy of cultures. Upper panels - left, HA-E4orf4 and EV; 
right, HA-E4orf4 and GFP. Middle panels - left, HA-E4orf4 and GFP- E4ARM; 
middle, HA-E4orf4 and GFP-TatARM; right, HA-E4orf4 and GFP-RevARM. 
Lower panels - left, EV; right, EV and GFP. Fig. 3-8B - Expression of HA-
E4orf4, GFP species and tubulin, as determined by western blotting using anti-
HA, anti-GFP or anti-tubulin antibodies. 
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effects. These results suggested that nuclear and/or nucleolar targeting of E4orf4 
is critically important for its toxicity. 
3.4 Discussion 
ln this study we identified a domain that affects both the subcellular distribution 
and the killing activity of E4orf4. Indeed, we demonstrated that the ten residues 
of the E4ARM are necessary and sufficient to target E4orf4 to the nucleus and 
nucleolus as weIl as to regulate its ability to induce cell death. We demonstrated 
that like other ARMs E4ARM is able to target heterologous proteins such as GFP 
and PK to the nucleus and nucleoli. Interestingly, using point mutants, we 
showed that E4ARM targeting properties are based on the overall positive charge 
and not on the specific presence of arginine residues. Furthermore, we showed 
that mutations in E4ARM affecting nuclear/nucleolar targeting correlate with a 
loss of E4orf4-dependent cell death and that co-expression of full-iength E4orf4 
with E4ARM or the ARM of HIV-1 Tat or Rev inhibits E4orf4-induced cell 
death. Therefore, our results strongly suggest that E4orf4 nuclear localization is 
mediated by E4ARM and is critical for the onset ofE4orf4-induced cell death. 
The primary sequence and functional features of E4ARM indicate that it is highly 
homologous to the ARM of other lentiviral proteins such as those of HIV -1 Tat 
(Hauber et al., 1987; Kuppuswamy et al., 1989; Malim et al., 1989a; Malim et al., 
1989b; Ruben. et al., 1989; Siomi et al., 1990), HIV-1 Rev (Kubota et al., 1989; 
Malim et al., 1989a) or HTLV-1 Rex (Siomi et al., 1988). Like these domains, 
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E4ARM is composed of a continuous, compact, stretch of basic residues 
approximately 10-20 amino acid in length (Fig. 3-2) and is necessary and 
sufficient to target heterologous proteins such as GFP or PK to the nucleus and 
nucleoli (Fig. 3-3 and 3-4). In addition, the overall charge appears to be essential 
for nuclear and nucleolar localization (Fig. 3-5 and 3-6), as has been suggested 
for the ARM of HIV-l Tat and Rev (Dang and Lee, 1989; Kubota et al., 1999) 
and other similar basic motifs present in viral (Hiscox, 2002) and cellular 
proteins (Kubota et al., 1999). E4ARM, like other basic compact motifs, differs 
from the well-characterized classical SV40 LT NLS in that the overall charge is 
generally greater than that of the SV40 LT NLS (>+8 compared to <+5) and in 
that E4ARM is not sensitive to alterations at single amino acids (Fig. 5) as with 
the SV40 LT NLS (Kalderon et al., 1984). The data presented here therefore 
strongly suggest that E4ARM functions as a NLS-NoLS in full-Iength E4orf4. 
E4orf4 has been shown to induce cell death both from the nucleus and cytoplasm. 
While cytoplasmic death targets involve the regulation of Src, nuclear cell death 
targets remain unknown (Gingras et al., 2002; Lavoie et al., 2000; Lavoie et al., 
1998; Robert et al., 2002). Importantly, this study shows that nuclear and 
nucleolar localization of E4orf4 is mediated by E4ARM and is crucial for 
induction of cell death as E4orf4 mutants carrying point mutations in E4ARM 
not only display reduced nuclear and nucleolar localization (Fig. 3-6) but also a 
significantly decreased induction of cell death (Fig. 3-7). It is likely that 
complete inhibition of cell death was not observed because E4orf4 is believed to 
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.-----. exhibit more than one cell death activity (Roopchand et al., 2001; Robert et al., 
2002), including a c-Src-dependent cytoplasmic pathway (Robert et al., 2002). 
Co-expression of full-iength HA-E4orf4 with GFP-E4ARM or GFP-TatARM or 
GFP-RevARM also resulted in a decrease in the ons et of cell death (Fig. 3-8), 
suggesting not only that E4ARM can compete with full-iength HA-E4orf4 for 
nuclear/nucleolar targeting factors but also that other comparable ARM 
sequences can achieve a similar effect. Of note is the fact that Tat and Rev have 
both been shown to be imported into the nucleus via the association of their 
ARM with the import receptor importin beta (Truant and CuIlen, 1999). Hence, 
it is likely that overexpression of ARM sequences saturate the import machinery 
and prevent E4orf4 from gaining access to the nucleus to sorne extent. 
Preliminary results indeed show that incubation of cells expressing GFP-HA-
E4orf4 on ice results in decreased nuclear localization (data not shown), thus 
indicating that E4orf4 is actively transported into or retained in the nucleus. It 
should be noted that it has been difficult to demonstrate large changes in nuclear 
and nucleolar localization of E4orf4 following co-expression of ARM sequences 
(data not shown). This lack of effect could be explained by the inability of GFP-
E4ARM, GFP-TatARM or GFP-RevARM to prevent all HA-E4orf4 molecules 
from gaining access to the nucleus, especially if E4orf4 also diffuses through the 
nuclear pores into the nucleus instead of being actively transported (E4orf4 is 
quite small at 14 KDa). Altematively, the binding sites with which GFP-
E4ARM, GFP-TatARM or GFP-RevARM interact could remain unsaturated at 
expression levels used in the present experiments, thereby allowing significant, 
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though perhaps insufficient lethal levels, of HA-E4orf4 to be observed in the 
nucleus and nucleoli. It also remains possible that, rather than affecting 
localization, co-expression of HA-E4orf4 with E4ARM disrupts E4orf4 protein-
protein interactions important for cell death, as the ARM sequences of Tat and 
Rev have been shown to be multifunctional domains (Felber et al., 1989; Hauber 
et al., 1987; Kubota et al., 1989; Kuppuswamy et al., 1989; Malim et al., 1989a; 
Malim et al., 1989b; Ruben et al., 1989; Seiki et al., 1988; Siomi et al., 1990; 
Siomi et al., 1988). Sorne of the mutants in full-Iength E4orf4 affecting the 
E4ARM motif presented in Fig. 3-7 have been found previously to be defective 
both for cell killing and for interactions with the Ba subunit of PP2A (Marcellus 
et al., 2000), an event considered important in E4orf4-induced cell death (Afifi et 
al., 2001; Marcellus et al., 2000; Roopchand et al., 2001; Shtrichman et al., 
2000); however, we think it unlikely that effects of ARM overexpression on 
interactions of E4orf4 with the Ba subunit of PP2A represent a likely explanation 
for the observed reduction in E4orf4 killing for three reasons. First, E4ARM 
does not bind to detectable levels of the Ba subunit of PP2A (data not shown). 
Second, co-expresion of heterologous GFP-TatARM or GFP-RevARM 
sequences had a similar effect. And third, although mutant HA-E4orf4-R66-73K 
contains five arginine to lysine substitutions in the E4ARM, it was similar to 
wild-type in both nuclear/nucleolar targeting and cell killing (Fig. 3-7). Thus it 
seems most likely that the effects relate to interference of interactions of E4orf4 
with critical nuclear/nucleolar targeting molecules. Further studies will be 
required to elucidate the basis for this phenomenon. 
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Although the role of HIV -1 Tat or Rev in nucleoli is not understood, studies have 
shown that the ARM sequences of these proteins interact with B23 and C23. B23 
and C23 are nucleolar shuttling proteins involved in rRNA processing and 
ribosome assembly (Fankhauser et al., 1991; Li, 1997; Marasco et al., 1994). It 
is thus possible, although not proven, that nucleolar localization of GFP-E4orf4 
results from the association of E4ARM with the same proteins. However, 
nucleolar localization of E4orf4 may be regulated differently from Tat or Rev. 
Indeed, and in contrast to these proteins (Hauber et al., 1987; Kuppuswamy et al., 
1989; Malim et al., 1989a; Malim et al., 1989b; Ruben et al., 1989; Siomi et al., 
1990) and Rev (Dundr et al., 1995; Kubota et al., 1989; Malim et al., 1989a) full-
length GFP-E4orf4 does not seem to accumulate in nucleoli in large amounts 
under steady state conditions (Fig. 3-1 and 3-6), even though the C-terminal half 
of E4orf4 containing the E4ARM does (Fig. 3-3). In addition, as with a known 
subset of proteins found to be part of the nucleolar proteome (Andersen et al., 
2002), full-Iength GFP-E4orf4 can be enriched in nucleoli when transcription is 
inhibited using actinomycin D (data not shown). Further, association of E4orf4 
with nucleoli may depend on the availability of the E4ARM at the surface of the 
E4orf4 molecule and/or may depend on the posttranslational modification of 
certain residues present in or next to the motif, as has been shown with other 
cellular cellular or viral proteins (Catez et al., 2002; Lohrum et al., 2000). Thus 
association of E4orf4 with nucleoli may be transient. 
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Interestingly, adenovirus infection has been shown to interfere with nucleolar 
functions by blocking the production and nuclear export of the 18S and 28S 
rRNA species (Castiglia and Flint, 1983; Ledinko, 1972; Raskas et al., 1970). 
Likewise, adenovirus infection has also been shown to cause the relocalization of 
the nucleolar proteins RNA poymerase I, B23 (Walton et al., 1989) and fibrillarin 
(Puvion-Dutilleul and Christensen, 1993) involved in ribosome production to 
viral replication centers in the nucleoplasm; however, no viral protein containing 
basic NLS-NoLS and targeting to nucleoli (Lee et al., 2003; Lee et al., 2004; 
Lutz et al., 1996; Matthews, 2001) has been shown so far to cause nucleolar 
dysfunction. E4orf4 is thus an interesting candidate for induction of nucleolar 
dysfunction, which perhaps could play a role in cell death. 
Altogether, the present data indicate that E4ARM plays an important role in the 
regulation of nuclear and nucleolar localization of E4orf4 as well as in induction 
of cell death from the nucleus. It is therefore not surprising that all adenovirus 
serotypes have conserved this motif (data not shown). Continuing studies are 
under way to investigate further the possible functions of E4ARM in E40rf4-
induced cell death. 
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CHAPTER 4: CHARACTERIZATION OF 
ADENOVIRUS E40RF4 VIRUS MUTANTS 
4.1 Introduction 
The effect of the adenovirus early viral protein E4orf4 expressed in cells alone 
following DNA transfection or infection with adenovirus vectors has been 
studied extensively during the past fifteen years. E4orf4 has been shown to 
induce p53-independent cell death of cancer cells (Marcellus et al., 1998; 
Shtrichman and Kleinberger, 1998) for which caspases have been shown to be 
dispensable in many celllines (Lavoie et al., 2000; Lavoie et al., 1998; Livne et 
al., 2001; Robert et al., 2002). Binding to the Ba subunit of protein phosphatase 
2A (PP2A) both in yeast and mammalian cells has been shown to be essential for 
induction of cell death (Mifi et al., 2001; Marcellus et al., 2000; Roopchand et 
al., 2001; Shtrichman et al., 2000). Both nuclear and cytoplasmic cell death 
targets, including the APC/cyclosome complex (Komitzer et al., 2001) as well as 
Src family kinases (Champagne et al., 2004; Gingras et al., 2002; Lavoie et al., 
2000; Robert et al., 2006), have been identified and proposed to play a role in 
mitotic arrest and remodeling of the actin cytoskeleton, respectively. 
In contrast, less is known about the role of E4orf4 during an adenovirus infection. 
Studies using E4orf4-deleted viruses (d1358 and d1359) (Halbert et al., 1985) 
have shown that E4orf4 downregulates the response of ElA and cAMP 
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-----.. (Kleinberger and Shenk, 1993) as weIl as viral gene expression (Bondesson et al., 
1996; Bridge et al., 1993; Mannervik et al., 1999; Medghalchi et al., 1997), 
controls alternative splicing of the LI transcript (Estmer Nilsson et al., 2001; 
Kanopka et al., 1998), and activates mTOR signaling in nutrient-deprived ceIls 
(O'Shea et al., 2005). Modulation of PP2A activity by E4orf4 towards certain 
substrates is believed to mediate these effects (Bondesson et al., 1996; Estmer 
Nilsson et al., 2001; Kanopka et al., 1998; Kleinberger and Shenk, 1993; 
Mannervik et al., 1999; Muller et al., 1992). 
To gain better insights into the role of E4orf4 during virus infection 1 have made 
for the first time a series of E4orf4 virus mutants in a common Ad5 genetic 
background. Such mutants include viruses that express various E4orf4 point 
mutants, mutants defective entirely in E4orf4 expression, and a mutant 
expressing wild-type E4orf4 fused to green fluorescent protein. In this study, we 
identify novel nuclear structures targeted by E4orf4 during infection, namely 
viral replication centers, nucleoli and perinuc1ear bodies. In addition, we show 
that localization of E4orf4 to these nuclear bodies is c1early not essential for virus 
growth as, with the single exception of d1359, a mutant prepared previously by 
another group (Halbert et al., 1985), aIl E4orf4 mutants were found to be wild-
type with regard to expression of late viral proteins and virus yield. Upon further 
investigation of d1359, we demonstrate the unique nature and behavior of its 
altered E4orf4 product in that: it contains an internai 30 bp deletion in the E4orf4 
gene; it encodes a protein that is unusually enriched at PML bodies; its 
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localization at PML bodies appears to depend upon mutations affecting two 
leucine residues, leucines 51 and 54; and it recruits and co-Iocalizes with the 
chaperone protein Hsp72. Taken together, our results demonstrate that E4orf4 
appears to associate transiently with several nuclear bodies during infection but 
that unusual accumulation at sorne of these sites like at PML bodies may interfere 
with transport of nuclear factors and/or nuclear body functions and thus impair 
virus growth. 
4.2 MateriaIs and Methods 
4.2.1 Cell culture, viral infections, DNA transfection 
Human non-small cell lung carcinoma H1299 cells (ATCC CRL-5803), which 
are deficient for p53; human lung carcinoma A549 cells (ATCC CRL-CCL185); 
or human non-small cell lung carcinoma H1299 cells stably expressing HA-
E4orf4 were cultured in Dulbecco's minimal essential medium (D-MEM) (Bio-
Whittaker) supplemented with 10% fetal bovine serum (Bio-Whittaker), 100 U of 
penicillin and streptomycinlml, and 0.292 mg L-glutamine/ml. HI299-HA-
E4orf4 (Li and Branton, unpublished results) were generated by transfecting the 
pCDNA3 plasmid expressing Ad2 HA-tagged E4orf4 (Marcellus, 2000) 
containing a geniticin resistance cassette and by selecting cells with G418 for a 
period of 14 days. Discrete colonies were then picked and expanded. The clone 
used to grow viruses is clone #15. Protein expression was verified by western 
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blotting (data not shown). Viral infections were perforrned as described 
elsewhere (Groitl and Dobner, 2006). Briefly, viruses were diluted in infection 
medium (1 % MgCh, 1 % CaCh, 1 % FBS, 1 % penicillinlstreptomycinlL-
glutamine in phosphate-buffered saline) and incubated on cells for 1 hour. The 
infection medium was aspirated, replaced with fresh complete medium, and cells 
were incubated anew for the desired time period. DNA transfections were 
perforrned using the liposome reagent DMRIE-C (Gibco-BRL), as described by 
the manufacturer. 1 Ilg of cDNA was transfected per 6-cm dish unless otherwise 
indicated. 
4.2.2 Viruses 
Virus mutants were generated, grown, titered and sequenced as described in 
(Groitl and Dobner, 2006). Sequencing results confirrned that the E4orf4 gene 
contained the desired mutation, while no mutations were present in the E4orf6 
and E1B55K genes. d1359 and d1358 (Halbert et al., 1985) were grown, titered 
and sequenced in a similar way. Sequencing results showed that residues 46 to 
55 of E4orf4 were deleted in d1359, while residues 48 to 54 were deleted in 
d1358. 
4.2.3 Expression vectors and mutagenesis 
Cloning of cDNAs expressing HA-E4orf4, HA-E4orf4-L51A, HA-E4orf4-L54A 
and HA-E4orf4-L51/54A has been described elsewhere (Marcellus et al., 2000). 
HA-359 and HA-358 were generated using QuickChange PCR (Stratagene) 
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according to the manufacturer' s instructions. Briefly, deletion of residues 46 to 
55 (HA-359) or of residues 48 to 54 (HA-358) were performed using the forward 
and reverse oligonudeotides 5'-GAA GGA GTT TAC ATA GAA CCC GAG 
TGG ATA TAC TAC AAC TAC-3' and 5-GTA GTT GTA GTA TAT CCA 
CTC GGG TTC TAT GTA AAC TCC TTC-3' or 5'-GTT TAC ATA GAA CCC 
GAA GCC G AGA GAG TGG ATA TAC TAC-3' and 5'-GTA GTA TAT CCA 
CTC TCT GGC TTC GGG TTC TAT GTA AAC-3', respectively. Deletions 
were made according to the deletions present in d1359 and d1358 (see above for 
details). AIl mutations were confirmed by sequencing. 
4.2.4 Microscopy 
For in vivo locaIization studies, live cells expressing GFP-E4orf4 were observed 
using a Zeiss LSM 510 Axiovert 100M confocal microscope equipped with a 
Plan-Achromat 63X/1.4 oil DIC objective. For regular confocal microscopy, 
samples were scanned at a speed of 7 using the linear mode and the mean method 
as weIl as a pinhole of 106 (optical slice < 2.2 um) and a zoom setting of 2. Eight 
scans were compiled and averaged using the Zeiss LSM 510 software to give the 
final image, which was captured as an 8-bit TIF file. The detector gain was set 
between 800-1000, while the amplifier onset and amplifier gain were kept 
constant. The palette tool was also used in order to ensure that the signais 
recorded did not reach pixel saturation. For live cell imaging, pictures were 
taken in a similar manner except that 4 scans instead of 8 were compiled per 
picture in order not to overbleach the samples, while the detector gain was set at 
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around 800 at the beginning of the procedure and left untouched during the whole 
duration of the procedure. Pictures were taken every 15 minutes between 8 and 
21 hpi. cens were kept in a 37 degree-chamber supplemented with 5% C02. 
Co-Iocalization of GFP-E4orf4 and fibrillarin, E1B55K or DBP during infection 
was performed using mouse anti-fibrillarin (Abcam), mouse anti-E1B55K clone 
2A6 (Boivin et al., 1999) or mouse anti-DBP (Xu et al., 2001) antibodies 
followed by anti-mouse or anti-rabbit antibodies conjugated to ALEXA 488 or 
594 (Molecular Probes). Nuclei were stained using 6'diamidino-2-phenylindole 
(DAPI). cens were visualized with a Zeiss Axiovision 3.1 microscope (63x oil 
objective) and signaIs were captured using an Axiocam HR (Zeiss) digital 
camera. Detection of transfected HA-E4orf4, HA-359 or HA-358 in 
immunofluorescence was performed using mouse anti-HA.ll (Babco) or rabbit 
anti-HA (Santa Cruz Biotechnology) antibodies; endogenous PML was detected 
using mouse anti-PML antibodies (Abcam); endogenous Hsp72 was detected 
using rabbit anti-Hsp72 antibodies (Sressgen). 
4.2.5 Western blotting 
cens were washed in phosphate-buffered saline (PBS) and lysed on ice in Ripa 
Light lysis buffer (50mM Tris-HCI pH 8.0, 150 mM NaCI, 5 mM EDTA, 1% 
NP40, 0.1 % SDS and 0.1 % Triton X-lOO) containing protease inhibitors. Protein 
content was quantified using Bio-Rad reagent (Bio-Rad) and equal amounts were 
separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins 
were transfered to PVDF membranes (Millipore) and probed using mouse anti-
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Flag (Sigma), mouse anti-DBP (Xu et al., 2001), rabbit anti-poly late 
(Kindsmül1er et al., 2006) or rabbit anti-E4orf4 2420 (Lavoie et al., 2000) 
antibodies. Visualization was completed using goat anti-mouse or anti-rabbit 
antibodies conjugated to horseradish peroxidase (HRP) (Jackson 
ImmunoResearch) followed by enhanced chemiluminescence (EeL) detection 
(NEN Life Science Products). 
4.2.6 Virus yield 
Virus yield has been described elsewhere (Kindsmüller et al., 2006). Briefly, 
cells were first infected at an MOI of 5 with the appropriate viruses, harvested at 
24, 48 or 72 hpi, rinsed, resuspended in serum-free media and lysed by 
freeze/thaw cycles. Debris as separated by centifugation and the supematants 
containing infectious virus particles were then used for another round of 
infection. Newly infected cells were fixed 20 hpi, subjected to 
immunfluorescence against DBP using mouse anti-DBP antibodies (Xu et al., 
2001) and fluorescent forming units (FFU) were counted. Two different 
dilutions were counted per sample, while 6 different fields were recorded for 
each dilution. The two averages obtained for the number of infectious virus 
particles for each dilution were used to generate a fmal average. This average 
represents the number of infectious virus particles per ml of medium used for the 
virus stock. 
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4.3 Results 
4.3.1 Generation of E4orf4 virus point mutants 
The adenovirus E4orf4 protein has been studied extensively in transfection 
studies but less is known about its role during viral infection (Ben-Israel and 
Kleinberger, 2002; Branton and Roopchand, 2001; Kleinberger, 2000). Since a 
recent study has demonstrated that E4orf4 is essential in activating the mTOR 
pathway for viral replication (O'Shea et al., 2005), we were interested in 
investigating the phenotype of a number of mutants affecting regions of the 
E4orf4 protein shown previously to be of functional importance or those that 
were totally defective for E4orf4 production (Marcellus et al., 2000; Miron et al., 
2004; Roopchand et al., 2001). A collection of E4orf4 virus mutants was 
generated in an Ad5 genetic background using a direct cloning approach (Figure 
4-1) (Kindsmüller et al. 2006), and in addition, an E4orf4-null virus, a Flag-
tagged E4orf4 virus, and a GFP-tagged virus were generated. Virus point 
mutants were chosen based on their ability to bind PP2A and kill transformed 
cells, exhibit nuclear localization, as weIl induce extranuclear cell death in a Src-
dependent manner. The viruses were grown, amplified and titered in H1299 or 
H1299 cells stably expressing E4orf4 (HI299-E4orf4) (see Materials and 
Methods for details) (Figure 4-1). Viral DNA was isolated and sorne adenovirus 
genes were sequenced to ensure that the viruses contained the desired mutations 
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in the E4orf4 gene but not in other genes important for the virus life cycle (data 
not shown). 
4.3.2 GFP-E4orf4 localizes to severaI nuclear bodies during infection 
E4orf4 has previously been shown by us and others to be predominantly 
localized in the nucleus of cells following transfection with small amounts also 
present in the cytoplasm (Miron et al., 2004; Robert et al., 2002). A nuclear-
nucleolar localization signal rich in arginine residues has also been shown with 
E4orf4 protein expressed from plasmids following DNA transfection to mediate 
this localization and to be important for E4orf4-induced cell death (Miron et al., 
2004). Using a GFP-tagged E4orf4 virus (GFP-E4orf4), we therefore set out to 
determine if GFP-E4orf4 produced using the viral E4 promoter was also enriched 
in the nucleus during the course of an infection. H1299 cells were infected at an 
MOI of 5 and the localization of GFP-E4orf4 was monitored between 8 and 24 
hpi using live cell imaging and confocal microscopy. Low and uniform amounts 
of GFP-E4orf4 were frrst observed in the nucleus of infected cells at around 8 hpi 
(data not shown). Occasionally, distinct, small and very intense dots could also 
be noticed (Fig. 4-2A panel d). As GFP-E4orf4 levels built up and as infection 
progressed, however, GFP-E4orf4 appeared to become enriched in distinct 
nuclear bodies that looked like replication centers (Fig. 4-2A panel a), nucleoli 
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Figure 4-1. Overview of the direct cloning strategy used to generate Ad5 
E4orf4 virus mutants 
The human Ad5 adenovirus genome lacking most of the E3 region was fused to a 
bacterial sequence to form a bacmid. The E4 region of the genome was also 
fused separately to a bacterial sequence to form an E4-Box plasmid. Site-
directed mutagenesis was performed in the E4orf4 gene contained in the E4-Box 
plasmid. The mutagenized E4-Box was then swapped with the wild-type E4-Box 
of the bacmid using standard c10ning techniques. Bacmids containing mutations 
in the E4orf4 gene were then transfected separately into human cells using a 
standard liposome reagent. Cells were then incubated and allowed to pro duce 
E4orf4 mutant viruses. Viruses were amplified and stocks were made. The viral 
DNA was then recovered and the E4orf4 gene as weIl as other essential genes 
were sequenced in order to verify the presence of the desired mutations and the 
absence of other unwanted mutations. 
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(Fig. 4-2A panel b) and perinuclear bodies also known as aggresomes (Fig. 4-2A 
panel c). Finally, as the infection cycle was completed (>18 hpi) and as cells 
started swelling, rounding up, blebbing and finally detaching from the plate, 
GFP-E4orf4 also became enriched in cytoplasmic structures as weIl as at the 
plasma membrane (live cell imaging, data not shown). Representative pictures 
taken during the course of live cell imaging of an infection are shown in figure 4-
2 and summarize these results. In order to confmn the identity of the nuclear 
bodies in which GFP-E4orf4 was enriched, co-Iocalization of GFP-E4orf4 and 
the adenovirus proteins DNA binding protein (DBP) or E1B55K was performed. 
Similarly, co-Iocalization of GFP-E4orf4 and the cellular protein fibrillarin was 
also carried out. DBP, E1B55K and fibrillarin are known markers of viral 
replication centers, perinuclear bodies and nucleoli, respectively. GFP-E4orf4 
was found to co-Iocalize with E1B55K and fibrillarin as seen by the yellow color 
in Figure 4-2B panels i and f, respectively. However, no co-Iocalization of GFP-
E4orf4 and DBP could be observed as seen by the absence of yellow color in 
Figure 4-2B panel c. Rather, GFP-E4orf4 appeared to surround replication 
centers as did viral mRNAs and small nuclear ribonucleolproteins (snRNPs) 
(Bridge et al., 1995). Identification of the small, dense and bright structures 
could not be performed because antibodies against candidate proteins such as 
splicing factors or PML protein, known to enriched in such small structures, were 
not available for immunofluorescence at the time of the study. However, results 
shown in Figure 4-2 clearly indicate that GFP-E4orf4 not only goes to the 
nucleus during infection but also surrounds viral replication centers and is also 
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Figure 4-2. GFP-tagged E4orf4 localizes to different nuclear bodies during 
Ad5 infection 
H1299 cells infected with a virus encoding GFP-tagged E4orf4 at an MOI of 20 
FFU/cell and were subjected to direct or indirect fluorescence confocal 
microscopy between 8 and 22 hpi. A) GFP-E4orf4 was frrst found enriched in 
different nuclear bodies reminiscent of replication centers (A-a), nucleoli (A-b), 
perinuclear bodies (A-c) and small, dense structures that remain to be identified 
(A-d) in live cells. B) GFP-E4orf4 was found associated with viral replication 
centers (B-a to B-c) and to co-Iocalize with nucleoli (B-d to B-f) and perinuclear 
bodies (B-g to B-i) upon fixation and detection using anti-DBP (B-b and Bc), 
anti-fibrillarin (B-e and B-f)) and anti-EIB55K antibodies (B-h and B-i), 
respectively. 
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enriched in nucleoli and perinuclear bodies. 
Association of E4orf4 with nucleoli had previously been reported (Miron et al., 
2004), while adenovirus infection had also been shown to cause a redistribution 
of certain nucleolar proteins essential for ribosome production (Puvion-Dutilleul 
and Christensen, 1993; Walton et al., 1989) and a decrease in rRNA production 
(Castiglia and Flint, 1983; Ledinko, 1972; Raskas et al., 1970). In an attempt to 
determine whether E4orf4 was responsible for mediating these effects during 
infection, different E4orf4-null and E4orf4-deleted virus es were tested in 
immunofluorescence assays to determine if they still caused a redistribution of 
the endogenous nucleolar protein fibrillarin during infection. The results 
obtained showed that fibrillarin was still redistributed outside nucleoli during 
infection with our E4orf4-null virus, pm1020, d1358 or d1359 just as was the case 
for the wild-type virus (data not shown). Hence, it was unlikely that E4orf4 
plays an essential role in the disruption of nucleoli during viral infection. 
4.3.3 Aberrant growth defect of dl359 virus 
In studies using mutant d1359, deletion of E4orf4 in the virus has been reported to 
induce an important decrease in the production of late viral proteins as well as in 
virion progeny during the virus life cycle (Q'Shea et al., 2005). Consequently, 
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Figure 4-3. Normal growth of a newly generated E4orf4-null virus 
A549 cells were infected with our newly generated wild-type adenovirus 
H5pg4100, E4orf4-null virus (E4orf4-) or a Flag-tagged E4orf4 virus (Flag-
E4orf4) at an MOI of 5 and cells were lysed at 0, 8, 18, 24, 48 and 72 hpi. A) 
Protein expression was assessed by SDS-PAGE and western blotting followed by 
detection of Flag-tagged E4orf4, DBP and late viral proteins using anti-Flag, 
anti-DBP and anti-poly late antibodies. B) Alternatively, virus yield was 
detennined by perfonning a second round of infection followed by a virus count 
detennination using a fluorescent fonning assay as described in Materials and 
Methods. The results shown in this Figure are representative of those obtained in 
at least two separate experiments both in A549 and H1299 cells. 
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we chose to monitor the expression of late viral proteins and virion progeny of 
our newly made viruses, in order to study the phenotype of these new constructs. 
A549 cells were infected with wild-type adenovirus H5pg4100, a Flag-tagged 
E4orf4 virus (Flag-E4orf4) and an E4orf4-null virus (E4orf4-). Cell samples 
were harvested and lysed at 24, 48 or 72 hpi, in order to assay protein expression. 
An identical set of samples was harvested, lysed and used to reinfect a fresh set 
of plates, in order to quantify virus yield. Protein expression was assayed using 
SDS-PAGE followed by western blotting. E4orf4, DBP and late viral protein 
expression was monitored using anti-Flag, anti-DBP and anti-Iate viral protein 
antibodies. Flag-E4orf4 expression was detected for cells infected with the Flag-
E4orf4 virus starting at 18 hpi, increasing and being maximal at 24 and 48 hpi 
and finally decreasing at 72 hpi; however, no Flag-E4orf4 expression was 
detected for the wild-type and E4orf4-null virus es (Fig. 4-3A). Of sorne interest 
was the detection of similar DBP and late viral protein expression patterns for 
cells infected with either one of the 3 virus es (Fig. 4-3A), indicating that the 
samples had been exposed to similar MOIs at the time of infection and that viral 
replication and late viral protein expression had proceeded normally. Similarly, 
virus yield was measured by counting the number of nuclei that expressed DBP 
in a fluorescence forming unit assay. As shown on the graph of Figure 4-3B, no 
difference in virus yield was evident between the wild-type H5pg4100, Flag-
E4orf4 and E4orf4-null viruses. Therefore, these results suggest that E4orf4 is 
not essential for the virus life cycle. 
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Figure 4-4. Defective growth of d1359, an E4orf4-deleted virus 
A549 cells were infected with our newly generated wild-type virus H5pg4100 or 
E4orf4-null virus, or with previously generated wild-type (d1309) or E4orf4-
deleted (d1359) viruses at an MOI of 5 FFU/cell. A) Protein expression was 
assessed as described in Figure 4-3A except that only late viral proteins were 
detected. B) Virus yield was assessed as described in Figure 4-3B. The results 
shown in this Figure are representative of those obtained in at least two separate 
experiments both in A549 and H1299 cells. 
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Since a major difference in virus yield had been reported between the E4orf4-
deleted virus d1359 and the wild-type adenovirus d1309, both present in another 
genetic background (O'Shea et al., 2005), we decided to repeat these assays and 
compare the late viral protein expression and virus yield of our two newly made 
viruses with those obtained with the previously characterized viruses. While late 
viral protein expression and virus yield were essentially the same for both our 
wild-type and E4orf4-null virus es, results shown in this figure clearly 
demonstrated that d1359 yields a significant reduction in late viral proteins and 
virus progeny (Fig. 4-4A and 4-4B). Similar results were also obtained in H1299 
cells (data not shown). Thus, the results shown here indicate that our E4orf4-null 
virus does not replicate the same way as the E4orf4-deleted d1359 virus does. 
Late viral protein expression and virus yield was also investigated for a few other 
E4orf4-deleted or E4orf4-null viruses that had been made and used by other 
groups in previous studies (Halbert et al., 1985; Medghalchi et al., 1997) as well 
as for our new collection of E4orf4 virus point mutants. Essentially, no reduction 
of late viral protein (data not shown) or virus yield was monitored for the dl358 
and pm1020 viruses (Fig. 4-5A) or for any of the E4orf4 virus point mutants 
known to exhibit defects in PP2A binding and killing or in localization or in 
extranuclear cell death in transfection assays (Fig. 4-5B). Altogether, the results 
presented here strongly suggested that d1359 exhibits an aberrant growth defect 
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Figure 4-5. Mutations or complete deletion of E4orf4 does not affect virus 
growth 
A549 cells were infected with different E4orf4-deleted or E4orf4-null viruses as 
described in the figure legend at an MOI of 5 and virus yield was detennined as 
described in Figure 4-3B. A) Virus yield of different E4orf4-deleted viruses. B) 
Virus yield of different viruses bearing point mutations in the E4orf4 coding 
sequence. The results shown in this figure are representative of those obtained in 
at least two separate experiments both in A549 and H1299 cells. 
l37 
'') 
A 
B 
[2" 1.00E+09 
LL gr 8.00E+08 
"U i 6.00E+08 
~ 4.00E+08 
'S; 
~ 2.00E+08 
r O.OOE+OO 
0 
Virus Growth Curve 
E4orf4- Vi ruses 
50 100 
Time (hpi) 
Virus Growth Curve 
E40rf4 Point Mutants 
-..- Noah (WT) 
-..-04-
-.-d1358 20 bp) 
-.~ dl359 (30 bp) 
-.- pm 1020 (A TG-) 
U) 7.00E+08 ~-------------, -+- Noah (Wl) 
_04-
=@&·-dI359 (04-) 
~4YF 
~7R(E4ARM) 
~ 6.00E+08 +-----------~ __ ____j 
:e 5.00E+08 -!-------~=--___:;;~~______j 
CIS_ 
c.::::) 4.00E+08 -!------~~~~~~.;______j 
U)~ I _____ ~~~~~---~ 2 !:!:. 3.00E+08 + 
.S;: 2.00E+08 ..l-------..~~~~"------___l 
s 
o 
1-
1.00E+08 t 2"ii' 
O.OOE+OO •• ~-_I!!!~ 
.• , ,.' ,,_=---4 
-e-F84A 
-+-R81/F84A 
o 20 40 
Time (hpi) 
60 80 '-7R1R81/F84A 
-D71A 
138 
Figure 4-6. Analysis of the dl359 genome and protein expression 
Schematic representation of the theoretical E4orf4 protein species encoded by the 
different E4orf4-null or E4orf4-deleted viroses described in this Figure. This 
representation is based on results obtained following sequencing of the E4orf4 
gene present in the viral genome of these viruses as described in Materials and 
Methods. B) E4orf4 protein expression of the viruses described in A). A549 
infected cells were lysed at 18 hpi and subjected to immunoprecipitation using 
anti-E4orf4 antibodies followed by SDS-PAGE and western blotting or, 
alternatively, to SDS-PAGE and western blotting only. Infections were 
monitored using DBP expression and anti-DBP antibodies. Detection of E4orf4 
species was performed using anti-E4orf4 antibodies. The results shown in this 
Figure are representative of those obtained in at least two separate experiments 
both in A549 and H1299 cells. 
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compared to other E40rf4-deleted or other E4orf4-null virus es and that this defect 
is independent of the genetic background. 
4.3.4 Deleting residues 46 to 55 in E40rf4 changes the localization of the 
protein 
In order to gain a better understanding of why d1359 replicated differently than 
the other E4orf4-deleted or E4orf4-null viruses, we first looked at the integrity of 
these viruses by purifying infectious virus particles and sequencing the genes 
encoding E4orf4, E4orf6 and EIB55K. Mutations or deletions in the adenovirus 
E4orf6 and EIB55K genes have been shown to result in defective viral 
replication (Halbert et al., 1985). Hence, these genes should not be mutated in 
the viruses tested here, namely, d1359, d1358, pm1020 and our E4orf4-null virus 
(Fig.4-6A). Sequencing results confirmed that there were no mutations in any of 
the E4orf6 and EIB55K genes, that there is no methionine start codon in 
pm1020, and that the 12th codon of the E4orf4-null virus is a stop codon (data not 
shown). Furthermore, they showed that residues 46 to 55 of E4orf4 are deleted 
in d1359, whereas residues 48 to 54 are deleted in d1358 resulting in a 30 base 
pair (bp) in-frame internai or a 20 bp out-of-frame deletions, respectively (data 
not shown). Hence, d1358 should encode the first 47 residues of E4orf4 in 
addition to 14 random amino acids if it uses the frrst internai stop codon 
encountered in that reading frame. Likewise, d1359 should encode the first 46 
amino-terminal residues of E4orf4 fused to residues 55 to 114 of the protein (Fig. 
4-6A), and lacking an internaI E-A-R-G-R-L-D-A-L-R amino acid stretch. 
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Figure 4-7. Subcellular localization of the E4orf4 mutant protein encoded 
by dl359 
H1299 cens were transfected with cDNAs expressing wild-type E4orf4, the 
E40rf4 mutant proteins corresponding to the proteins encoded by the d1359 or 
d1358 viruses (HA-359 and HA-358, respectively) or E4orf4 point mutants (HA-
L51A, HA-L54A or HA-L51154A). An proteins expressed were HA-tagged. A) 
Schematic representation of the mutant proteins. B) and C) Representative 
micrographs of the subcellular localization observed for the different E4orf4 
species following detection of the HA-tagged E4orf4 species using anti-HA 
antibodies and fluorescence microscopy. D) Quantification of the percentage of 
transfected cells expressing a nuc1ear punctuate pattern. These numbers are 
representative of two experiments. 
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ln addition to sequencing part of the virus genomes, we also investigated 
whether these virus es expressed E4orf4 by immunoprecipitation followed by 
SDS-PAGE and western blotting using anti-E4orf4 anitbodies. Results from 
Figure 4-6B show that while a species could be detected at around 14 KDa for 
both wild-type viruses, no E4orf4 species could be observed for any of the other 
viruses at 18 hpi. This observation was surprising as we had hypothesized that 
partial proteins would be encoded by both dl358 and dl359 (see above for 
details). However, one possible explanation for this result could be that the 
partial E4orf4 proteins encoded by d1359 and d1358 are highly unstable, or that 
they are more enriched in the insoluble fraction of the cell extract, which was 
discarded during the experiment. A large portion of wild-type E4orf4 expressed 
at high levels following DNA transfection has recently been shown to be 
enriched in the membrane fraction of the cell (Robert et al., 2006), hence giving 
support to the latter possibility. 
Localization studies using the wild-type, d1358 or d1359 virus were also 
conducted to examine the intracellular localization of E4orf4 products. For 
reasons that remain unclear, our anti-E4orf4 antibodies do not detect wild-type 
E4orf4 during infection. Thus, we generated cDNAs encoding HA-tagged 
E4orf4 proteins harboring the precise deletions present in the d1359 and d1358 
viruses (Fig. 4-6A) to generate E4orf4 species termed HA-358 and HA-359 (Fig. 
4-7A). 
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Figure 4-8. The E4orf4 mutant protein encoded by dl359 co-localizes with 
PML bodies 
H1299 cells were transfected with the cDNA expressing the protein encoded by 
d1359 (HA-359) and cells were subjected to detection of HA-359 and endogenous 
PML using anti-HA and anti-PML antibodies followed by fluorescent 
microscopy. One representative micrograph is shown here (panels a to e). Panel 
a, endogenous PML; panel b, HA-359; Panel c, merge of panels a and b; Panel d, 
DAPI staining; Panel e, merge of HA-359, endogenous PML and DAPI. 
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We wanted to compare the localization of these proteins not only to wild-type 
HA-E4orf4 but also to that of E4orf4 point mutants previously generated and 
characterized by our group. These point mutants carry mutations in the region 
deleted in d1359. HA-E4orf4-L51A (also called HA-L51A) and HA-E4orf4-
L54A (HA-L54A) are mutants that exhibit a defect in PP2A binding and killing, 
whereas HA-E4orf4-L51154A (HA-L51154A) exhibits normal PP2A binding but 
still shows reduced killing (Marcellus et al., 2000). cDNAs depicted in Figure 4-
7 A were therefore transfected into H1299 cells and the cells were subjected to 
indirect immunofluorescence using anti HA-antibodies and fluorescence 
microscopy 24 hours post-transfection. Cells exhibiting fluorescent signaIs were 
then photographed and their localization patterns were quantified. 
Representative localizations are shown in Figure 4-7B and 4-7C, whereas 
quantification of the patterns appears in Figure 4-7D. Interestingly, Figure 4-7B 
shows that HA-359 is enriched in dense, round structures in the nucleus of cells 
(panels d and f) compared to HA-E4orf4, which exhibits a homogeneous nuclear 
staining pattern (panels a and c), whereas HA-358 exhibited a diffuse nuclear and 
cytoplasmic pattern (panels g and i). Nuclei were marked with DAPI (Fig. 4-7B 
panels b, e and h and 4-7C, panels b, e and h). Furthermore, Figure 4-7C shows 
that mutants proteins HA-L51A (panels d and f), HA-L54A (panels g and i) and 
HA-L51/54A (panels a and c) were enriched in the same nuclear dots as HA-359. 
Finally, Figure 4-7D demonstrates that approximately 15-25% of cells expressing 
HA-359, HA-L51A, HA-L54A or HA-L51/44A had this nuclear punctuate 
pattern while the remainder of the cell population exhibited the normal nuclear 
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homogeneous HA-E4orf4 staining pattern and that, conversely, none of the cells 
expressing HA-E4orf4 or HA358 exhibited this nuclear punctuate pattern. 
Altogether, these results therefore seem to indicate that deleting residues 46 to 55 
in E4orf4 appears to affect the localization of the protein that could lead in a 
defect in d1359 viral replication. Furthermore, residue leucine 54 and particularly 
leucine 51 seem to play an active role in the nuclear localization of the full-length 
E4orf4 protein under steady-state conditions as mutations affecting these amino 
acids result in a change of localization, while complete removal of the C-terminal 
portion of E4orf4 including these residues only results in a loss of nuclear 
retention. 
4.3.5 Deleting residues 46 to 55 in E40rf4 promotes its association with PML 
bodies 
Mammalian cells contain many distinct small nuclear bodies in which proteins 
sharing similar functions accumulate (Handwerger and Gall, 2006; Zimber et al., 
2004). Such bodies include splicing speckles, Cajal bodies and PML bodies. 
Since the nuclear staining pattern of HA-359 resembled that of PML bodies, co-
localization of HA-359 with PML bodies was examined using anti-HA and anti-
PML antibodies (Fig. 4-8). Results from indirect immunofluorescence followed 
by confocal microscopy indicated that HA-359 co-localizes with PML bodies 
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Figure 4-9. Hsp72 co-localizes with HA-359 in a nuclear punctuate pattern 
H1299 cells were transfected with cDNAs expressing HA-359 or HA-L51/54A. 
Cells were subjected to detection of HA-tagged species and endogenous Hsp72 
using anti-HA and anti-Hsp72 antibodies followed by fluorescent microscopy. 
Representative micrographs are shown in this Figure. Upper row: normal 
localization of HA-359; Middle row: nuc1ear punctuate localization of HA-359 
observed in a subset of the transfected cell population; Lower row: nuc1ear 
punctuate localization of HA-L51/54A. Localization of HA-tagged E4orf4 
species (panels a, f, k); Localization of Hsp72 (panels b, g, 1); Merge of HA-
tagged E4orf4 species and Hsp72 (panels c, h, m); DAPI (panels d, l, n); Merge 
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(Fig. 4-8 panels c and e) but appears to surround the PML protein (Fig. 4-8 
panels c and e). From these results, we concluded that HA-359 appears to 
associate with PML bodies but may only be present at the periphery of these 
structures. 
4.3.6 Co-localization of the E40rf4 mutant protein containing a deletion of 
residues 46 to 55 with heat shock factor 72 (Hsp72) 
Many polyQ proteins expressed in certain neurodegenerative diseases as well as 
non-polyQ proteins forming nuclear aggregates have been shown to accumulate 
at PML bodies and consequently form enlarged PML structures (Fu et al., 
2005a). These proteins have been shown to inhibit PML body functions by 
recruiting proteasome components and chaperone proteins in addition to a slew 
of other transcription factors (Fu et al., 2005a). Since HA-359 was observed to 
accumulate in large PML bodies in only 15-25% of the transfected cell 
population (Fig. 4-7D) and since these sites appeared to vary slightly in size and 
morphology (data not shown), we performed co-Iocalization studies of HA-359 
or HA-L51/54A with the inducible, endogenous form of heat shock protein 70 
(Hsp70), Hsp72. The results shown in Figure 4-9 demonstrate that while full-
length E4orf4 does not co-Iocalize with Hsp72 in the nucleus of cells and that 
Hsp72 exhibits a diffuse nuclear and cytoplasmic staining pattern (panels b, c and 
e), HA-359 (panels g, h and j) and HA-L51/54A (panels 1, m and 0), both co-
localize perfectly with Hsp72 in a nuclear punctuate pattern reminiscent of PML 
bodies. 
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Figure 4-10. Working model: dl359 inhibits viral growth through the 
inhibition of P:ML body functions 
E4orf4 is predominantly enriched in the nucleus during wild-type adenovirus 
infection where it associates transiently with several nuclear bodies including 
viral replication centers, nucleoli, perinuclear bodies and presumably PML 
bodies. Upon deletion of residues 46 to 55 in E4orf4 such as in d1359 infection, 
E4orf4 starts accumulating in PML bodies of infected cells, inhibits PML body 
functions and ultimately impairs virus growth. 
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Thus, these results appeared to indicate that deletion or mutations of residues 46-
55 in E4orf4 induce cellular stress and recruitment of the chaperone protein 
Hsp72 to nuclear bodies reminiscent of PML bodies. 
4.4 Discussion 
E4orf4 has been studied extensively in cells expressing high amounts of the 
protein from expression vectors in the absence of other viral products. However, 
little is known about its role in the context of an adenovirus infection. Since a 
recent study using d1359, an E4orf4-deleted virus, has shown that removal of 
E4orf4 from the virus results in defective viral replication (O'Shea et al., 2005), 
we were interested in studying the role of E4orf4 during infection in more details. 
Based on previous results obtained in our laboratory (Marcellus et al., 2000; 
Roopchand et al., 2001), we generated a set ofE4orf4 virus mutants (Fig. 4-1) for 
the frrst time and started their characterization. While preliminary results 
allowed us to identify viral replication centers, nucleoli and perinuclear bodies as 
novel nuclear bodies targeted by E4orf4 during infection (Fig. 4-2), results 
obtained with our newly generated E4orf4 virus point mutants or with E4orf4-
deleted or E4orf4-null viruses previously generated in other laboratories (Halbert 
et al., 1985; Medghalchi et al., 1997) clearly showed that E4orf4 is not essential 
for viral replication (Fig. 4-3 and 4-4). Rather, our results demonstrated that 
d1359 is unique in causing defective virus replication (Fig. 4-5) and that this 
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effect may be due to the internal 30 bp deletion contained in the E4orf4 gene 
(Fig. 4-6). Interestingly, the E4orf4 mutant protein encoded by d1359 exhibits a 
distinct, punctuate, nuclear localization that is not observed with the wild-type 
E40rf4 protein (Fig. 4-7). Co-Iocalization studies confirmed that this protein is 
enriched in PML bodies (Fig. 4-8), while mutations of two leucine residues 
located in the deleted region of d1359 showed that leucines 51 and 54 appear to 
be responsible for this localization (Fig. 4-7). Furthermore, recruitment and co-
localization of the chaperone Hsp72 was also observed with the E4orf4 mutant 
protein encoded by d1359 or by the E4orf4 double leucine point mutant but not 
with full-Iength E4orf4 (Fig. 4-9), suggesting that cellular stress may induce 
accumulation in these locations. Altogether, the results presented here suggest 
that while E4orf4 may associate transiently with nuclear bodies during infection, 
accumulation in sorne of these structures (like in PML bodies) may have 
deleterious effects for the virus (Fig. 4-10). 
4.4.1 E4orf4 associates with nuclear bodies during infection but is not 
essential for virus growth 
Previous studies have demonstrated that E4orf4 expressed by DNA transfection 
is predominantly enriched in the nucleus of cells (Miron et al., 2004; Robert et 
al., 2002) and that this enrichment is mediated via the E4ARM, an arginine-rich 
sequence that serves as a nuclear/nucleolar localization signal (Miron et al., 
2004). Results presented here show for the first time that GFP-tagged E4orf4 is 
also predominantly localized in the nucleus of live cells during a lytic infection 
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and that, in addition, it is specifically enriched in nucleoli (Fig. 4-2A panel b and 
4-2B panels d to f), viral replication centers (Fig. 4-2A panel a and 4-2B panels a 
to c), perinuclear bodies (Fig. 4-2A panel c and 4-2B panels g to i) and possibly 
PML bodies (Fig. 4-2A panel d). 
Many cellular and viral proteins have been shown to localize to adenovirus 
replication centers and to participate in DNA replication (Liu et al., 2003). 
However, the results presented here suggest that E4orf4 does not participate 
directly in DNA replication since it does not co-Iocalize with the DNA 
replication protein DBP (Fig. 4-2B panel c). Rather, the results suggest that it 
could be involved in viral transcriptional and/or post-transcriptional processes as 
it exhibits a staining pattern reminiscent of viral RNA and splicing factors 
(Bridge et al., 1995). Indeed, these observations agree with previously published 
results obtained in in vitro assays reporting that E4orf4 is not directly involved in 
viral DNA replication (Medghalchi et al., 1997) and that it participates in the 
switch from proximal to distal splicing of the viral LI transcript during the viral 
life cycle by dephosphorylating SR splicing factors with the help of PP2A 
(Kanopka et al., 1998) and by associating with the splicing factors ASF/SF2 and 
SRp30c (Estmer Nilsson et al., 2001). 
E4orf4 when overexpressed from DNA plasmid vectors had previously been 
reported to associate with nucleoli (Miron et al., 2004). The fact that GFP-
E4orf4 was also found to accumulate to sorne extent in nucleoli of live cells 
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during infection is interesting (Fig. 4-2A panel b and 4-2B panels d to f; live cell 
imaging, data not shown) and suggests a putative role in this compartment. 
However, nucleolar functions of E4orf4 still remain obscure since E4orf4 does 
not appear to be the adenovirus protein responsible for redistribution of key 
nucleolar proteins like fibrillarin outside nucleoli during infection (Puvion-
Dutilleul and Christensen, 1993) (data not shown). It is possible that E4orf4 may 
be involved in modulating RNA functions since other proteins associating with 
nucleoli and containing NLS-NoLS motifs similar to that of E4orf4 perform such 
roles (Feiber et al., 1989; Malim et al., 1989b; Rosen et al., 1985a; Seiki et al., 
1988). 
FinaIly, the localization of GFP-E4orf4 at perinuclear bodies throughout 
infection and following viral replication (Fig. 4-2A panel c and 4-2B panels g to 
i; live cell imaging, data not shown) was observed. Perinuclear bodies, also 
called aggresomes, are regions adjacent to the nucleus surrounding centrosomes 
and microtubule organizing centers (MTOC). This region has generally been 
shown to be involved in cell cycle regulation, cytoskeletal rearrangements, 
endosome transport as weIl as protein degradation (Doxsey et al., 2005). The 
adenovirus EIB55K protein has been shown to sequester p53 in aggresomes 
during infection (Zhao and Liao, 2003), while EIB55K, E4orf3 and E4orf6 
proteins have previously been reported to localize to aggresomes and to be 
involved in the degradation of double-strand break repair system proteins (Araujo 
et al., 2005; Liu et al., 2005). In addition, E4orf4 expressed by DNA 
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transfection has also been recently shown to localize to this area and to induce 
the assembly of an actin-myosin ring, de novo polymerization of actin as weIl as 
recruitment of endosomes in a Src-dependent fashion (Robert et al., 2006). 
Whether E4orf4 is involved in these processes during the course of an infection 
remains to be determined. 
Taken together, the results presented here suggest a role for E4orf4 in certain 
nuclear bodies during infection. However, association with these nuclear 
structures is clearly not essential for virus growth as mutation or complete 
deletion of E4orf4 from the virus does not affect virus growth, at least in culture 
(Fig. 4-3 to 4-5). These results, even though in contradiction with a recent report 
(O'Shea et al., 2005), are in agreement with initial observations that E4orf4 is not 
essential for virus growth during adenovirus infection (Halbert et al., 1985; 
Medghalchi et al., 1997). One possible explanation for this discrepancy could 
arise from the different ceIllines used. Indeed, d1359 was previously reported to 
cause a defect in virus growth in primary cells (O'Shea et al., 2005). However, 
our experiments were performed in transformed cells. While virus growth of our 
newly generated virus es is currently being investigated in primary ceIls, we 
believe that the results presented here are nevertheless accurate conceming d1359 
since we could reproduce its apparent gain of function defect in transformed cells 
(Fig. 4-4 and 4-5). 
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4.4.2 The E40rf4 mutant protein encoded by dl359 appears to exhibit a 
gain-of-function 
Further investigation of the behavior of dl359 led us to uncover that it contains a 
30 bp internaI deletion and is therefore not an E4orf4-deleted virus per se (Fig. 4-
6A) even though expression of the mutant protein could not be detected in 
immunoprecipitation and western blotting experiments following infection (Fig. 
4-6B). One reason for this result could be because the E4orf4 mutant protein 
encoded by d1359 is unstable and therefore degraded. Alternatively, it could also 
be present in the insoluble cellular fraction due to the formation of protein 
aggregates. We tend to favor the latter idea since the influenza viral antigen 
dNPpep (Anton et al., 1999), sorne polyglutamine (polyQ) proteins expressed in 
certain neurodegenerative diseases such as in Huntington's disease (Waelter et 
al., 2001) or spinocerebellar ataxia (Perez et al., 1998), as well as non-polyQ 
proteins accumulating at PML bodies (Fu et al., 2005a) have all been reported to 
be insoluble in lysis buffers containing a low concentration of detergent such as 
in a RIPA buffer containing 0.1 % SDS (Fu et al., 2005a). Hence, experiments 
are under way to verify if the E4orf4 protein encoded by d1359 can be extracted 
from the highly insoluble fraction of the cell. 
The large defect in virus growth observed with d1359 (Fig. 4-5 and 4-6) 
reminiscent of other severe defects observed with viruses harboring mutations in 
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genes essential for virus growth (Halbert et al., 1985), the different subcellular 
localization exhibited by HA-359 (Fig. 4-7B and 7C) as well as its co-
localization with the chaperone protein Hsp72 (Fig. 4-9) compared to HA-E4orf4 
wild-type, led us to hypothesize that d1359 exhibits a gain-of-function mutation 
that is detrimental to virus growth (Fig. 4-10). 
Interestingly, similar toxic gain-of-functions have been reported with polyQ and 
non-polyQ proteins in which proteins accumulate at PML bodies, recruiting in 
the process Hsp70 or Hsp40 chaperone family members, proteasome components 
as well as transcription factors such as CREB binding protein (CBP), p53 and 
SpI. Even though the mechanisms of action are not clearly understood at the 
moment, different models propose that the unusual accumulation of these 
proteins at PML bodies is believed to result in the inhibition of PML body 
functions such as transcriptional repression or protein degradation, ultimately 
leading to cellular toxicity and cell death. Likewise, accumulation of the E4orf4 
mutant protein encoded by d1359 at PML bodies may result in the accumulation 
and sequestration of nuclear factors such transcription factors important for virus 
growth (Fig. 4-10). Subversion of the host cellular transcription machinery by 
adenovirus, and in particular of the transcription factor CBP, has been well 
documented (Brockmann and Esche, 2003). Hence, failure to recruit important 
transcription factors such as CBP to viral replication centers may negatively 
impact virus growth growth. 
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In light of this information and of the data presented here, notably of the fact that 
GFP-tagged E4orf4 naturally localizes to small nuclear structures and perinuclear 
bodies which are both sites of protein degradation during infection (Fig. 4-2), it is 
unclear whether E4orf4 has a natural role in PML bodies that is affected by 
mutations or deletion in the 46 to 55 amino acid region or whether accumulation 
at this site is fortuitous and results from aberrant misfolding (Fig. 4-10). While 
experiments are currently under way to distinguish between these two 
possibilities, a word of caution must be formulated conceming the use of virus 
mutants containing deletions. While these virus mutants were once the norm in 
the adenovirus field for lack of better molecular tools and technology (Halbert et 
al., 1985) we now know that they can clearly be misleading and yield aberrant 
interpretations (data presented here). Consequently, activation of the mTOR 
pathway by E4orf4 during adenovirus infection (O'Shea et al., 2005) needs to be 
readdressed with the proper E4orf4-null virus control in order to be fully valid 
even though the results reported are likel y to be true. 
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CHAPTER 5: GENERAL DISCUSSION 
5.1 E4orf4 induces an aberrant type of cell death 
At the time when the work presented here was initiated, only two types of cell 
death were known: apoptosis and necrosis. Apoptosis or programmed cell death 
(peD) is a genetically-controlled program that results in the activation of 
caspases, death effector molecules that cleave key cellular substrates, and that 
results in controlled non-inflammatory cell death. Necrosis, on the other hand, is 
a general swelling of the cell and breakdown of the plasma membrane that results 
in the cell content leaking into the extracellular environment and causing 
inflammatory cell death. 
Work presented in chapter 2 has shown that even though E4orf4 is predominantly 
enriched in the nucleus following expression it is able to induce cell death both 
from the nucleus and from the cytoplasmlplasma membranes upon being 
artificially targeted to those sites; that E4orf4 appears to induce only certain 
hallmarks of cell apoptosis such as nuclear condensation and membrane blebbing 
but not apoptosis; and that it seems to induce nuclear cell death events that are 
separate and independent from cytoplasmic cell death events and that, unlike that 
latter, are not dependent on Src (Fig. 5-1). These results, together with other 
results from our group demonstrating that E4orf4 does not activate caspases, that 
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it does not result in a loss of mitochondrial membrane potential or a change in 
cellular ATP levels (Szymborski and Branton, unpublished results), that a 
subpopulation of E4orf4-expressing cells are enlarged, swollen and 
multinucleated (Li and Branton, unpublished results), and that E4orf4 ultilmately 
appears to cause a G2/M cell cycle arrest (Roopchand et al., 2001) indicated to us 
that E4orf4 does not induce apoptosis or necrosis but, rather, a mixture of both. 
We therefore proposed that E4orf4 induces an aberrant type of cell death due at 
least in part to nuclear events triggering a cell cycle arrest. 
Since these studies were carried out, many more types of caspase-independent 
cell death pathways distinct from apoptosis and necrosis such as autophagy, 
paraptosis and mitotic catastrophe have been discovered and/or further 
characterized (Broker et al., 2005), therefore lending support to the results 
mentioned above. In fact, we now believe that E4orf4-induced cell death results 
at least in part from a mitotic catastrophe. Mitotic catastrophe is characterized by 
a cell cycle arrest close to or at the mitosis-metaphase stage (King and Cidlowski, 
1995). They do not involve caspase activation but, rather, cell swelling and 
multinucleation (Roninson et al., 2001). Interestingly, recent work from our 
group has found that E4orf4, through its association with PP2A, prematurely 
activates APC/CCdc20, a ubiquitin ligase complex that controls mitotic progression 
and exit, and prematurely degrades Pds1 and Scc1, substrates of this complex 
(Roopchand and Branton, unpublished results), further supporting the hypothesis 
that E4orf4-induced cell death could be due to mitosis catastrophe. 
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5.2 E4orf4-induced cell death involves nuclear events 
Work presented in chapter 3 demonstrated that E4orf4 has an arginine-rich region 
spanning residues 66 to 75 that serves as a nuclear/nucleolar localization signal 
and that targets E4orf4 to the nucleus and nucleoli of cells. Importantly, nuclear 
and nucleolar localization appears to contribute to at least 50% ofE4orf4-induced 
cell death (Fig. 5-1). 
The results presented in this chapter therefore support our previously stated 
hypothesis that E4orf4 has nuclear cell death targets that include cell cycle 
substrates that may cause an E4orf4-induced mitotic arrest. Altematively, as 
E4orf4 may be a multifunctional protein, nuclear cell death targets may also 
include proteins residing in nucleoli. However, since over 700 cellular proteins 
are now known to associate with nucleoli (Lam et al., 2005), a proteomic 
approach such as the one designed by Andersen and coworkers (Andersen et al., 
2002) should be used to identify nucleolar proteins targeted by E4orf4. Briefly, 
this approach involves the isolation of a relatively pure fraction of nucleoli and 
identification of proteins using advanced mass spectrometry techniques 
(Andersen et al., 2002; Lam et al., 2005). Altematively, since E4orf4 associates 
with PP2A and has already been shown to modulate the phosphorylation state of 
many nuclear cellular substrates such as c-Fos (Muller et al., 1992), SR proteins 
(Kanopka et al., 1998), transcription factors involved in adenovirus E2 and E4 
transcriptional activation (Bondesson et al., 1996; Mannervik et al., 1999), as 
161 
well as p70S6K and 4EBPI (O'Shea et al., 2005), E4orf4 could also act on these 
substrates. Henee, a proteomic approach identifying proteins exhibiting changes 
in phosphorylation state in response to E4orf4 expression would be appropriate. 
5.3 Association of E4orf4 with nuclear bodies may play a role in E4orf4-
induced cell death 
Finally, work in chapter 4 has shown that E4orf4 associates with nuclear bodies 
such as viral replication eenters, nucleoli, perinuclear bodies and possibly PML 
bodies during adenovirus infection but that association with these structures is 
not essential for virus growth as mutants that are defective for E4orf4 expression 
generally replicate as efficiently as wild-type virus. However, results from this 
chapter also demonstrated that a virus encoding a mutant form of E4orf4 that 
accumulates at PML bodies during infection has a dominant negative effect on 
virus growth (Fig. 5-1). 
To date, several viral proteins have been identified that interact with nuclear 
bodies in order to regulate viral replication but these associations remain largely 
uncharacterized (Zimber et al., 2004). One of them, however, the Chicken 
Anemia Virus (CAV) apoptin protein, has been shown to not only associate with 
PML bodies (Heilman et al., 2006) but also to induee the degradation of a subunit 
of the APC/C complex, the ubiquitin ligase complex that promotes mitotic 
progression. This effect induees a G2/M eell cycle arrest (Heilman et al., 2006; 
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Teodoro et al., 2004) and p53-independent (Zhuang et al., 1995b) cell death of 
transformed cells (Zhuang et al., 1995a; Zhuang et al., 1995b). The fact that 
E4orf4 was also shown in this work to associate with nuclear bodies possibly 
including PML bodies, while also targeting the APC/C complex (Roopchand and 
Branton, unpublished) and inducing a G2/M arrest (Roopchand et al., 2001) 
leading to cell death, may reveal a novel way that sorne virus es have evolved to 
target nuclear cellular components of pivotal importance. Such examples have 
indeed been encountered in the past with adenovirus ElA, human papilloma 
virus (HPV) E7 and SV40 LT antigens targeting Rb family members, and 
polyoma ST and MT, SV40 LT, and adenovirus E1B55K and E4orf6 targeting 
p53 (O'Shea, 2005b). Altematively, another level of cell cycle regulation by 
E4orf4 could be also linked to its nucleolar and perinuclear localization. 
Modulation of the expression levels of Cdc14, a highly conserved nucleolar 
phosphatase that regulates centrosome separation and chromosome segregation in 
a PP2A-dependent fashion, has indeed been reported to cause defects such as the 
ones observed with E4orf4 (Mail and et al., 2002). However, this possibility 
remains to be investigated and could easily be addressed using a combination of 
different approaches such as co-immunoprecipation, knockdowns, and advanced 
fluorescence microscopy assays. 
Finally, the fmding that a mutant form of E4orf4 accumulates at PML bodies and 
impairs virus replication underscores the functional importance of nuclear bodies. 
Increasing evidence· supports this idea as modifying nuclear body content or 
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function has been shown to affect many fundamental cellular processes regulated 
at the level of these structures such as gene expression or signaling, thus leading 
to numerous human diseases such as neurodegenerative diseases and cancer 
(Zimber et al., 2004). Importantly, recent work has demonstrated that PML 
protein expression is significantly decreased or lost in most types of cancer 
induding prostate, colon, lung and breast cancer, while this effect has been 
linked with an increase in high grade tumours and in tumour progression 
(Gurrieri et al., 2004). In addition, PML is now emerging to be a suppressor of 
AKT (Trotman et al., 2006) and mTOR signaling and to suppress 
neoangiogenesis (Bemardi et al., 2006). In light of these results and of the fact 
that E4orf4 appears to modulate the mTOR pathway (O'Shea et al., 2005), studies 
on the interaction of E4orf4 with PML bodies with respect to cell death should be 
pursued in transformed cells. E4orf4 may indeed interfere with deregulated 
signaling pathways linked to PML bodies in transformed cells. For instance, 
E4orf4 localization and cell death functions could be tested in PML-1- celllines 
using assays presented in this work. In addition, the relationship between the 
localization, phosphorylation state and functions of mTOR pathway substrates 
could be investigated using standard biochemical and fluorescence microscopy 
assays. Altematively, the E4orf4 d1359 mutant protein accumulating at PML 
bodies discussed in chapter 4 could be used as a negative control to further probe 
the role of E4orf4 and PML bodies in E4orf4-induced cell death. 
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ln conclusion, the work presented in this thesis has addressed the localization to 
function relationship of E4orf4-induced cell death (summarized in Fig. 5-1) in an 
effort to better understand its mechanisms of action and cell death targets. 
Elucidating the mechanisms by which E4orf4 kills cancer cells is of outmost 
importance if we wish to develop drugs that mimick E4orf4 for use in cancer 
therapy. 
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Figure 5-1. General model: localization and functions of E4orf4 in the 
nucleus of eeUs 
E4orf4 is a nucleolcytoplasmic protein that induces cell death both from the 
nucleus and the cytoplasm of cells and that, presumably, has nuclear and 
cytoplasmic death targets. Nuclear targeting of E4orf4 is important in cell death 
and is mediated through an arginine-rich region (residues 66 to 75) that serves as 
a nuclear and nucleolar localization signal. Transient association of E4orf4 with 
several nuclear bodies may be important in E4orf4-induced cell death and virus 
growth. 
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